{"title": "PDF", "author": "PDF", "url": "https://apps.legislature.ky.gov/recorddocuments/bill/22RS/hb136/bill.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "cleaned_text": "UNOFFICIAL COPY 22 RS HB 136/GA Page 1 of 141 HB013610.100 - 50 - XXXX GA AN ACT relating to medicinal cannabis and making an appropriation therefor. 1 Be it enacted by the General Assembly of the Commonwealth o f Kentucky: 2 SECTION 1. A NEW SECTION OF KRS CHAPTER 218A IS CREATED TO 3 READ AS FOLLOWS: 4 For the purposes of Sections 1 to 30 of this Act, unless the context otherwise requires: 5 (1) \"Bona fide practitioner -patient relationship\" means a treating or consulting 6 relationship, during the course of which a medicinal cannabis practitioner has: 7 (a) Completed an initial in -person examination and assessment of the patient's 8 medical history and current medical condition; 9 (b) Consulted with the patient with respect to the possible medical, therapeutic, 10 and palliative properties of medicinal cannabis; 11 (c) Advised the patient of the possible risks and side effects associated with the 12 use of medicina l cannabis, including possible interactions between 13 medicinal cannabis and any other drug or medication that the patient is 14 taking at that time; and 15 (d) Established an expectation that he or she will provide follow -up care and 16 treatment to the patient; 17 (2) \"Cannabis business\" means an entity licensed under this chapter as a cultivator, 18 dispensary, processor, producer, or safety compliance facility; 19 (3) \"Cannabis business agent\" means a principal officer, board member, employee, 20 volunteer, or agent of a cann abis business; 21 (4) \"Cannabis consultation agreement\" means a written agreement between a 22 dispensary and a pharmacist, who shall serve as the dispensary's pharmacy 23 director, to provide medicinal cannabis consultation services to the dispensary; 24 (5) \"Cardhol der\" means: 25 (a) A registered qualified patient, designated caregiver, or visiting qualified 26 patient who has applied for, obtained, and possesses a valid registry 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 2 of 141 HB013610.100 - 50 - XXXX GA identification card issued by the department; or 1 (b) A visiting qualified patient who has obta ined and possesses a valid out -of- 2 state registry identification card; 3 (6) \"Cultivator\" means an entity licensed as such under Sections 16, 17, and 18 of 4 this Act; 5 (7) \"Cultivator agent\" means a principal officer, board member, employee, 6 volunteer, or agent of a cultivator; 7 (8) \"Department\" means the Department for Public Health or its successor agency; 8 (9) \"Designated caregiver\" means a person who has registered as such with the 9 department as required by this chapter; 10 (10) \"Dispensary\" means an entity licensed as such under Sections 16, 17, and 18 of 11 this Act; 12 (11) \"Dispensary agent\" means a principal officer, board member, employee, 13 volunteer, or agent of a dispensary; 14 (12) \"Disqualifying felony offense\" means: 15 (a) A felony offense that would classify the person as a violent offender under 16 KRS 439.3401; or 17 (b) A violation of a state or federal controlled substance law that was classified 18 as a felony in the jurisdiction w here the person was convicted, except: 19 1. An offense for which the sentence, including any term of probation, 20 incarceration, or supervised release, was completed five (5) or more 21 years earlier; or 22 2. An offense that consisted of conduct for which Sections 1 to 30 of this 23 Act would likely have prevented a conviction, but the conduct either 24 occurred prior to the enactment of Sections 1 to 30 of this Act or was 25 prosecuted by an authority other than the Commonwealth of 26 Kentucky; 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 3 of 141 HB013610.100 - 50 - XXXX GA (13) \"Diversion\" or \"divert\" mea ns the act of dispensing, selling, or otherwise 1 transferring possession of medicinal cannabis from a licensed cannabis business 2 or cardholder to any person or entity not authorized under the provisions of 3 Sections 1 to 30 of this Act to legally possess or use medicinal cannabis; 4 (14) \"Enclosed, locked facility\" means an indoor growing space such as a room, 5 greenhouse, building, or other indoor enclosed area that is maintained and 6 operated by a cultivator or producer and is equipped with locks and other secu rity 7 devices that permit only authorized access by agents of the cultivator or producer, 8 as required by the department; 9 (15) \"Gross receipts\" means the total amount or consideration, including cash, credit, 10 property, and services, for which medicinal canna bis is sold, valued in money, 11 whether received in money or otherwise; 12 (16) \"Growth area\" means the same as an enclosed, locked facility; 13 (17) \"Marijuana\" has the same meaning as in Section 37 of this Act; 14 (18) \"Medicinal cannabis\": 15 (a) Means marijuana as d efined in Section 37 of this Act when cultivated, 16 harvested, processed, produced, transported, dispensed, distributed, sold, 17 possessed, or used in accordance with Sections 1 to 30 of this Act; 18 (b) Includes medicinal cannabis products and raw plant material ; and 19 (c) Does not include industrial hemp or industrial hemp products as defined in 20 KRS 260.850; 21 (19) \"Medicinal cannabis accessories\" means any equipment, product, or material of 22 any kind which is used, intended for use, or designed for use in the prepar ing, 23 storing, using, or consuming medicinal cannabis in accordance with Sections 1 24 to 30 of this Act; 25 (20) \"Medicinal cannabis practitioner\" means a physician, a physician assistant, or 26 an advanced practice registered nurse who is authorized by his or her state 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 4 of 141 HB013610.100 - 50 - XXXX GA licensing board to provide written certifications for the use of medicinal cannabis 1 in accordance with Section 9 of this Act; 2 (21) \"Medicinal cannabis product\" means any compound, manufacture, salt, 3 derivative, mixture, or preparation of any part of the plant Cannabis sp., its seeds 4 or its resin; or any compound, mixture, or preparation which contains any 5 quantity of these substances when cultivated, harvested, processed, produced, 6 transported, dispensed, distributed, sold, possessed, or used in accor dance with 7 Sections 1 to 30 of this Act. The term \"medicinal cannabis product\" does not 8 include industrial hemp products as defined in KRS 260.850; 9 (22) \"Minor\" means a person less than eighteen (18) years of age; 10 (23) \"Out -of-state registry identification card\" means a registry identification card, or 11 an equivalent document, that was issued pursuant to the laws of another state, 12 district, territory, commonwealth, or insular possession of the United States, 13 except that the card must be issued for a disease or medical condition that 14 appears on the approved list of qualifying medical conditions created by the 15 department, that allows the person to use medicinal cannabis in the jurisdiction 16 of issuance; 17 (24) \"Pharmacist\" means the same as in KRS 315.010; 18 (25) \"Processor\" means an entity licensed as such under Sections 16, 17, and 18 of 19 this Act; 20 (26) \"Processor agent\" means a principal officer, board member, employee, 21 volunteer, or agent of a processor; 22 (27) \"Producer\" means an entity licensed as such under Sec tions 16, 17, and 18 of 23 this Act; 24 (28) \"Producer agent\" means a principal officer, board member, employee, volunteer, 25 or agent of a producer; 26 (29) \"Qualified patient\" means a person who has obtained a written certification from 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 5 of 141 HB013610.100 - 50 - XXXX GA a medicinal cannabis practit ioner with whom he or she has a bona fide 1 practitioner -patient relationship; 2 (30) \"Qualifying medical condition\" means a disease or medical condition that 3 appears on the approved list of qualifying medical conditions for which a 4 medicinal cannabis practiti oner may provide a patient with a written certification 5 for the use of medicinal cannabis established by the department pursuant Section 6 28 of this Act; 7 (31) \"Raw plant material\" means the trichome -covered part of the female plant 8 Cannabis sp. or any mixtu re of shredded leaves, stems, seeds, and flowers of the 9 Cannabis sp. plant. The term \"raw plant material\" does not include plant 10 material obtained from industrial hemp as defined in KRS 260.850; 11 (32) \"Registered qualified patient\" means a qualified patient who has applied for, 12 obtained, and possesses a valid registry identification card or provisional 13 registration receipt issued by the department; 14 (33) \"Registry identification card\" means a document issued by the department that 15 identifies a person as a reg istered qualified patient, visiting qualified patient, or 16 designated caregiver; 17 (34) \"Safety compliance facility\" means an entity licensed as such under Sections 16, 18 17, and 18 of this Act; 19 (35) \"Safety compliance facility agent\" means a principal officer, board member, 20 employee, volunteer, or agent of a safety compliance facility; 21 (36) \"Seedling\" means a medicinal cannabis plant that has no flowers and is not 22 taller than eight (8) inches; 23 (37) \"Serious violation\" means: 24 (a) Any violation of Sections 1 to 3 0 of this Act or any administrative regulation 25 promulgated thereunder that is capable of causing death or which causes 26 serious and prolonged disfigurement, prolonged impairment of health, or 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 6 of 141 HB013610.100 - 50 - XXXX GA prolonged loss or impairment of the function of any bodily organ; 1 (b) Diversion of medicinal cannabis; or 2 (c) Any act that would constitute a violation of Section 38 of this Act; 3 (38) \"Smoking\" means the inhalation of smoke produced from the combustion of raw 4 plant material when ignited by a flame; 5 (39) \"State licensing board\" means, respectively: 6 (a) The Kentucky Board of Medical Licensure; or 7 (b) The Kentucky Board of Nursing; 8 (40) \"Telehealth\" has the same meaning as in KRS 211.332; 9 (41) \"Use of medicinal cannabis\" includes the acquisition, administration, 10 possession, transfer, transportation, or consumption of medicinal cannabis or 11 medicinal cannabis accessories by a cardholder in accordance with Sections 1 to 12 30 of this Act. The term \"use of medicinal cannabis\" does not include: 13 (a) Cultivation of marijuana by a card holder; 14 (b) The use or consumption of marijuana by smoking; or 15 (c) The use of industrial hemp or industrial hemp products as defined in KRS 16 260.850; 17 (42) \"Visiting qualified patient\" means a person who has registered as such through 18 the department as requi red under Section 11 of this Act or who possesses a valid 19 out-of-state registry identification card; and 20 (43) \"Written certification\" means a document dated and signed by a medicinal 21 cannabis practitioner, that: 22 (a) States, that in the medicinal cannabis p ractitioner's professional medical 23 opinion, the patient may receive medical, therapeutic, or palliative benefit 24 from the use of medicinal cannabis; 25 (b) Specifies the qualifying medical condition or conditions for which the 26 medicinal cannabis practitioner b elieves that the patient may receive 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 7 of 141 HB013610.100 - 50 - XXXX GA medical, therapeutic, or palliative benefit; and 1 (c) Affirms that the medicinal cannabis practitioner has a bona fide 2 practitioner -patient relationship with the patient. 3 SECTION 2. A NEW SECTION OF KRS CHAPTER 218A IS CREATED TO 4 READ AS FOLLOWS: 5 (1) Nothing in Sections 1 to 30 of this Act shall be construed as applying to industrial 6 hemp or industrial hemp products as defined in KRS 260.850. 7 (2) Notwithstanding any provision of l aw to the contrary, and except as provided in 8 subsections (3) and (4) of this section: 9 (a) The use of medicinal cannabis by a cardholder shall be considered lawful if 10 done in accordance with Sections 1 to 30 of this Act and any administrative 11 regulations p romulgated thereunder; 12 (b) The acquisition, blending, cultivation, delivery, distribution, 13 manufacturing, manipulation, packaging for sale, preparation, possession, 14 sale, testing, transportation, or transfer of medicinal cannabis or medicinal 15 cannabis acce ssories by a cannabis business or cannabis business agent 16 shall be considered lawful if done in accordance with Sections 1 to 30 of 17 this Act and any administrative regulations promulgated thereunder; 18 (c) A registered qualified patient or visiting qualified patient shall not be 19 considered to be under the influence of medicinal cannabis solely because 20 of the presence of tetrahydrocannabinol metabolites, including but not 21 limited to the cannabinoid carboxy THC, which is also known as THC - 22 COOH; 23 (d) A medicinal cannabis practitioner shall not be subject to arrest, 24 prosecution, or penalty in any manner, or denied any right or privilege, 25 including but not limited to a civil penalty or disciplinary action by a state 26 licensing board or by any other occupational or pr ofessional licensing 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 8 of 141 HB013610.100 - 50 - XXXX GA board, solely for providing written certifications or for otherwise stating 1 that, in the medicinal cannabis practitioner's professional opinion, a patient 2 may receive medical, therapeutic, or palliative benefit from the use of 3 medicina l cannabis, if done in accordance with Sections 1 to 30 of this Act; 4 (e) A pharmacist shall not be subject to arrest, prosecution, or penalty in any 5 manner, or denied any right or privilege, including but not limited to a civil 6 penalty or disciplinary acti on by the Kentucky Board of Pharmacy or by any 7 other professional licensing board, solely for consulting with or providing 8 information with respect to the possible risks or side effects of medicinal 9 cannabis, including any potentially harmful or dangerous interactions 10 between medicinal cannabis and any other drug; 11 (f) An attorney shall not be subject to arrest, prosecution, or penalty in any 12 manner, or denied any right or privilege, including but not limited to a civil 13 penalty or disciplinary action by the Kentucky Court of Justice, the 14 Kentucky Bar Association, or any other professional licensing board, solely 15 for providing an individual or cannabis business with legal assistance 16 related to activity that is no longer subject to criminal penalties under stat e 17 law pursuant to Sections 1 to 30 of this Act; and 18 (g) No person shall be subject to arrest, prosecution, or penalty in any manner, 19 or denied any right or privilege, including but not limited to a civil penalty 20 or disciplinary action by an occupational or professional licensing board, 21 solely for providing assistance or services, including but not limited to 22 accounting services, financial services, security services, or business 23 consulting services, to any individual or cannabis business related to 24 activity that is no longer subject to criminal penalties under state law 25 pursuant to Sections 1 to 30 of this Act. 26 (3) Nothing in subsection (2) of this section shall be construed or interpreted to: 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 9 of 141 HB013610.100 - 50 - XXXX GA (a) Prohibit the arrest, prosecution, or imposition of any other penalty arising 1 from but not limited to breach of contract, breach of fiduciary duty, 2 negligence, or engaging in criminal activity that would constitute a felony 3 or misdemeanor; 4 (b) Prevent a practitioner from being subject to administrative penalties 5 impo sed by his or her state licensing board for any violation of Section 1 to 6 30 of this Act or any administrative regulation promulgated under Section 9 7 of this Act; or 8 (c) Prevent a pharmacist from being subject to administrative penalties 9 imposed by the Ken tucky Board of Pharmacy for any violation of Section 1 10 to 30 of this Act or any administrative regulation promulgated under 11 Section 10 of this Act. 12 (4) Notwithstanding subsection (2) of this section and any other provision of law to 13 the contrary, a cardhol der who is licensed under KRS Chapter 311 or KRS 14 Chapter 314 may be subject to intervention or disciplinary action by his or her 15 state licensing board if: 16 (a) There is probable cause to believe that the cardholder has become impaired 17 by, or otherwise abuse d, medicinal cannabis; or 18 (b) The cardholder has a medically diagnosable disease that is characterized by 19 chronic, habitual, or periodic use of medicinal cannabis resulting in 20 interference with the cardholder's professional, social, or economic 21 functions i n the community or the loss of powers of self -control regarding 22 the use of medicinal cannabis. 23 SECTION 3. A NEW SECTION OF KRS CHAPTER 218A IS CREATED TO 24 READ AS FOLLOWS: 25 (1) The Division of Medicinal Cannabis is hereby established within the Department 26 for Public Health and is charged with the implementation, operation, oversight, 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 10 of 141 HB013610.100 - 50 - XXXX GA and regulation of the medicinal cannabis program established in Sections 1 to 30 1 of this Act. 2 (2) The Board of Physicians and Advisors is here by established within the Division 3 of Medicinal Cannabis which shall consist of the following members: 4 (a) Five (5) physicians appointed by the Kentucky Board of Medical Licensure. 5 In order to be eligible to be appointed to the board, a physician shall be 6 authorized, pursuant to Section 9 of this Act, to provide written 7 certifications for the use of medicinal cannabis and shall be certified by the 8 appropriate board in one (1) of the following specialties: 9 1. Addiction medicine; 10 2. Anesthesiology; 11 3. Gastroe nterology; 12 4. Obstetrics and gynecology; 13 5. Ophthalmology; 14 6. Optometry; 15 7. Infectious disease; 16 8. Neurology; 17 9. Oncology; 18 10. Pain management; 19 11. Pain medicine; 20 12. Pediatrics; 21 13. Physical medicine and rehabilitation; or 22 14. Psychiatry. 23 One (1) of the physicians appointed to the board pursuant to this paragraph 24 shall be designated by the commissioner to serve as chairperson; 25 (b) Three (3) advanced practice registered nurses appointed by the Kentucky 26 Board of Nursing. In order to be eligib le to be appointed to the board, an 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 11 of 141 HB013610.100 - 50 - XXXX GA advanced practice registered nurse shall be authorized, pursuant to Section 1 9 of this Act, to provide written certifications for the use of medicinal 2 cannabis; 3 (c) One (1) pharmacist appointed by the Kentucky Board of Ph armacy. In 4 order to be eligible to be appointed to the board, a pharmacist shall be 5 authorized, pursuant to Section 10 of this Act, to provide medicinal 6 cannabis consultation services to cardholders and to enter into cannabis 7 consultation agreements with d ispensaries; 8 (d) Six (6) patient advocates selected by the commissioner of the department; 9 (e) The commissioner of the department, who shall serve as a non -voting ex 10 officio member; and 11 (f) The director of the Division of Medicinal Cannabis, who shall serv e as a 12 non-voting ex officio member. 13 (3) The members of the Board of Physicians and Advisors appointed by the 14 commissioner shall: 15 (a) Serve for a term of four (4) years and until their successors are appointed, 16 except that the term for members appointed to fill the initial appointments 17 after the effective date of this section shall be as follows: 18 1. Five (5) members shall be appointed for a term of two (2) years; 19 2. Five (5) members shall be appointed for a term of three (3) years; 20 3. Five (5) members shall be appointed for a term of four (4) years; and 21 4. The respective terms of the first members shall be designated by the 22 commissioner at the time of their appointment; 23 (b) Be eligible for reappointment; and 24 (c) Serve without compensation, but each member of the board not otherwise 25 compensated for his or her time or expenses shall be entitled to 26 reimbursement for his or her actual and necessary expenses in carrying out 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 12 of 141 HB013610.100 - 50 - XXXX GA his or her duties with reimbursement for expenses being made in 1 accordance with administrat ive regulations relating to travel expenses. 2 (4) The Board of Physicians and Advisors shall not be subject to reorganization 3 under KRS Chapter 12. 4 (5) The Board of Physicians and Advisors shall: 5 (a) Review and recommend to the department an approved list o f qualifying 6 medical conditions for which a medicinal cannabis practitioner may provide 7 a patient with a written certification; 8 (b) Accept and review petitions to add diseases or medical conditions to the 9 approved list of qualifying medical conditions for which a medicinal 10 cannabis practitioner may provide a patient with a written certification; 11 (c) Review and recommend to the department medicinal cannabis dosing 12 guidelines to b e used by medicinal cannabis practitioners when providing 13 patients with medicinal cannabis dosing recommendations; 14 (d) Convene at least twice per year to conduct public hearings and to evaluate 15 petitions, which shall be maintained as confidential pursuant to subsection 16 (7) of this section, for the purpose of adding diseases or medical conditions 17 to the approved list of qualifying medical conditions for which a medicinal 18 cannabis practitioner may provide a patient with a written certification; 19 (e) Review and recommend to the department protocols for determining: 20 1. The amount of medicinal cannabis or delta -9 tetrahydrocannabinol 21 that constitutes: 22 a. A ten (10) day maximum allowance of medicinal cannabis and a 23 thirty (30) day maximum allowance of medicinal can nabis for 24 registered qualified patients and visiting qualified patients who 25 are over eighteen (18) years of age; and 26 b. A ten (10) day maximum allowance of medicinal cannabis and a 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 13 of 141 HB013610.100 - 50 - XXXX GA thirty (30) day maximum allowance of medicinal cannabis for 1 registered qual ified patients who are under eighteen (18) years of 2 age; and 3 2. The amount of raw plant material that medicinal cannabis products 4 are considered to be equivalent to; 5 (f) Review and recommend to the department evolving continuous quality 6 improvement metrics and minimal performance standards for the biennial 7 accreditation process of licensed cannabis businesses; 8 (g) Review relevant scientific data related to the delta -9 tetrahydrocannabinol 9 content limits established in subsection (2)(b) of Section 19 of this Act and 10 make recommendations to the General Assembly regarding revisions to the 11 limits as the board deems appropriate; 12 (h) Review relevant scientific data related to the various methods of use and 13 consumption of medicinal cannabis and make recommendations to the 14 General Assembly to approve or restrict certain methods as the board deems 15 appropriate; and 16 (i) Perform other duties related to the use of medicinal cannabis upon request 17 by the commissioner of the department or the director of the Division of 18 Medi cinal Cannabis. 19 (6) When, in accordance with paragraphs (a) to (c) of subsection 5 of this section, 20 the Board of Physicians and Advisors considers which diseases and medical 21 conditions to recommend to the department for inclusion on the approved list of 22 qualifying medical conditions for which a medicinal cannabis practitioner may 23 provider a patient with a written certification, the board shall prioritize 24 consideration of, but not limit their consideration to, end -of-life conditions and 25 terminal diseases as defined in KRS 217.5401. 26 (7) The department shall promulgate administrative regulations, in accordance with 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 14 of 141 HB013610.100 - 50 - XXXX GA KRS Chapter 13A, to implement the provisions of this subsection, including but 1 not limited to the process by which petitions to add diseases or medi cal conditions 2 to the approved list of qualifying medical conditions for which a medicinal 3 cannabis practitioner may provide a patient with a written certification shall be 4 received, reviewed, and considered. Administrative regulations promulgated 5 pursuant to this subsection shall require that any individually identifiable health 6 information contained in a petition received by the department, the Division of 7 Medicinal Cannabis, or the Board of Physicians and Advisors shall be 8 confidential and shall not be s ubject to disclosure under the Open Records Act, 9 KRS 61.870 to 61.884. 10 (8) No later than December 1 of each year beginning in 2023, the department, in 11 consultation with the University of Kentucky College of Medicine shall submit an 12 annual report to the Leg islative Research Commission. The report submitted by 13 the department shall, at a minimum, include: 14 (a) The number of applications and renewals received by the department for 15 registry identification cards for registered qualified patients, visiting 16 qualifie d patients, and designated caregivers, individually and collectively; 17 (b) The number of applications and renewals for registry identification cards 18 that were approved and denied by the department; 19 (c) The number of registry identification cards revoked by the department for 20 misconduct and the nature of the misconduct; 21 (d) The number of physicians, physician assistants, and advanced practice 22 registered nurses authorized pursuant to Section 9 of this Act to provide 23 written certifications for the use of medici nal cannabis; 24 (e) The number of pharmacists authorized pursuant to Section 10 of this Act to 25 provide consultation to cardholders; 26 (f) The nature of the qualifying medical conditions for which medicinal 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 15 of 141 HB013610.100 - 50 - XXXX GA cannabis practitioners have provided written certifica tions; 1 (g) The number of applications and renewals received by the department for 2 cannabis business licenses; the number of cannabis business licenses issued 3 for each business type and tier; and the number of cannabis business 4 license applications and rene wals that were denied by the department; 5 (h) The number of cannabis business agents associated with each type of 6 cannabis business; 7 (i) An assessment of: 8 1. The ability of cardholders in all areas of the state to obtain timely and 9 affordable access to medi cinal cannabis; 10 2. The evolving continuous quality improvement metrics and minimal 11 performance standards for the biennial accreditation process of 12 licensed cannabis businesses developed by the department pursuant to 13 Section 28 of this Act; 14 3. The effectiv eness of the cultivators, processors, and producers licensed 15 under this chapter, individually and collectively, in serving the needs 16 of processors, dispensaries, and cardholders, and whether they are 17 generating any complaints or security problems; 18 4. The e ffectiveness of the dispensaries licensed under this chapter, 19 individually and collectively, in serving the needs of cardholders, 20 including the provision of educational and support services, and 21 whether they are generating any complaints or security proble ms; 22 5. The effectiveness of the safety compliance facilities licensed under this 23 chapter, individually and collectively, in serving the needs of other 24 cannabis businesses, including the provision of testing and training 25 services, and whether they are gener ating any complaints or security 26 problems; and 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 16 of 141 HB013610.100 - 50 - XXXX GA 6. The sufficiency of the regulatory and security safeguards contained in 1 Sections 1 to 30 of this Act and adopted by the department through 2 administrative regulations to ensure that access to medicinal cannab is 3 cultivated and processed in this state is provided only to cardholders; 4 (j) The profits and expenditures by cannabis businesses, individually and 5 collectively; 6 (k) The amount of medicinal cannabis sold per month in the Commonwealth; 7 (l) The total amount of revenue generated from cannabis business licensure 8 and cardholder fees for each calendar year and aggregated by prior years; 9 (m) The total amount of revenue generated by the excise tax established in 10 Section 33 of this Act; 11 (n) The total cost of enforc ement for the medicinal cannabis program at the 12 time of the report, by city, county, and overall; 13 (o) Any recommended additions or revisions to Sections 1 to 30 of this Act or 14 administrative regulations promulgated thereunder, including those 15 relating to s ecurity, safe handling, labeling, and nomenclature; 16 (p) Any recommendations for changes to the approved list of qualifying 17 medical conditions for which a medicinal cannabis practitioner may provide 18 a patient with a written certification and the rationale f or those 19 recommendations; 20 (q) The results of any peer -reviewed, scientific research studies regarding the 21 health effects of cannabis; and 22 (r) Any other data requested by the Legislative Research Commission relating 23 to the medicinal cannabis program and Sec tions 1 to 30 of this Act. 24 (9) The department shall provide the University of Kentucky College of Medicine 25 with all information necessary to allow collaboration with the department on the 26 preparation of this report. The University of Kentucky College of Me dicine may 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 17 of 141 HB013610.100 - 50 - XXXX GA also produce its own report regarding the medicinal cannabis program 1 established in Sections 1 to 30 of this Act which, if produced, shall be submitted 2 to the Legislative Research Commission upon completion. 3 (10) The information contained in the report described in subsection (8) of this section 4 shall be presented in a manner that does not disclose any identifying information 5 about cardholders or licensed cannabis businesses. 6 (11) (a) Nothing in Sections 1 to 30 of this Act shall require the depa rtment to 7 assume duties in relation to the medicinal cannabis program that are more 8 than administrative in nature if federal law or a current and clear directive 9 from the federal government indicates that duties assumed by the 10 department that are more than administrative could result in the loss of 11 federal funds, federal prosecution, or invalidation of the medicinal 12 cannabis program established in Sections 1 to 30 of this Act. 13 (b) If the department makes a determination that it is required by Sections 1 to 14 30 of this Act to conduct duties that are more than administrative in nature, 15 then it shall continue to conduct duties that are administrative in nature 16 and designate or enter into a contract with, in accordance with KRS 17 Chapter 45A, a qualified nongovernm ental entity to conduct any duties 18 required by Sections 1 to 30 of this Act that are more than administrative in 19 nature. A nongovernmental entity contracted pursuant to this paragraph 20 shall not own, in whole or in part, any cannabis business in this state or any 21 other, or be owned, in whole or in part, by any cannabis business in this 22 state or any other. The department may reimburse the state for any costs 23 involved in working with outside consultants to implement the program. 24 SECTION 4. A NEW SECTION OF KRS CHAPTER 218A IS CREATED TO 25 READ AS FOLLOWS: 26 (1) A registered qualified patient, except as provided in subsection (6) of this section, 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 18 of 141 HB013610.100 - 50 - XXXX GA shall not be subject to arrest, prosecution, or denial of any right or privilege, 1 including but not limited to a civil penalty or disciplinary action by a court or 2 occupational or professional licensing board, for the use of medicinal cannabis, 3 if the registered qualified patient does not possess more than: 4 (a) The thirty (30) day maximum allowance of medicinal cannabis, as 5 established by the department pursuant to Section 28 of this Act, at his or 6 her residence; or 7 (b) The ten (10) day maximum allowance of medicinal cannabis, as established 8 by the department pursuant to Section 28 of this Act, on his or her person, 9 except that an amount greater than the ten (10) day maximum allowance 10 may be transported by a registered qualified patient from a dispensary 11 directly to his or her residence if the medicinal cannabis is contained in a 12 sealed pack age that requires at least a two (2) step process for initial 13 opening. 14 (2) A visiting qualified patient shall not be subject to arrest, prosecution, or denial of 15 any right or privilege, including but not limited to civil penalty or disciplinary 16 action by a court or occupational or professional licensing board, for the use of 17 medicinal cannabis, if the visiting qualified patient does not possess more than an 18 amount of medicinal cannabis determined by the department to constitute the ten 19 (10) day maximum allo wance of medicinal cannabis, as established by the 20 department pursuant to Section 28 of this Act, on his or her person. 21 (3) A designated caregiver shall not be subject to arrest, prosecution, or denial of any 22 right or privilege, including but not limited t o civil penalty or disciplinary action 23 by a court or occupational or professional licensing board, for: 24 (a) Assisting a registered qualified patient to whom the designated caregiver is 25 connected through the department's registration process with the use of 26 medicinal cannabis if the designated caregiver does not possess more than: 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 19 of 141 HB013610.100 - 50 - XXXX GA 1. The thirty (30) day maximum allowance of medicinal cannabis, as 1 established by the department pursuant to Section 28 of this Act, at his 2 or her residence for each registered qua lified patient to whom the 3 caregiver is connected through the department's registration process; 4 or 5 2. The ten (10) day maximum allowance of medicinal cannabis, as 6 established by the department pursuant to Section 28 of this Act, on 7 his or her person for each registered qualified patient to whom the 8 caregiver is connected through the department's registrati on process, 9 except that an amount greater than the ten (10) day maximum 10 allowance may be transported by a designated caregiver from a 11 dispensary directly to his or her residence if the medicinal cannabis is 12 contained in a sealed package that requires at le ast a two (2) step 13 process for initial opening; or 14 (b) Receiving reimbursement for documented expenses associated with 15 assisting a registered qualified patient in the use of medicinal cannabis if 16 the designated caregiver is connected to the registered qual ified patient 17 through the department's registration process. 18 (4) A cardholder shall not be subject to arrest, prosecution, or denial of any right or 19 privilege, including but not limited to a civil penalty or disciplinary action by a 20 court or occupational o r professional licensing board, for: 21 (a) Possession of medicinal cannabis that is incidental to the use of medicinal 22 cannabis; 23 (b) Possession of medicinal cannabis accessories; or 24 (c) Transferring medicinal cannabis to a safety facility for testing. 25 (5) No person shall be subject to arrest, prosecution, or denial of any right or 26 privilege, including but not limited to a civil penalty or disciplinary action by a 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 20 of 141 HB013610.100 - 50 - XXXX GA court or occupational or professional licensing board, solely for: 1 (a) Selling medicinal cannabis accessories to a cardholder who is over eighteen 2 (18) years of age upon presentation of a valid registry identification card 3 issued by the department or, for a visiting qualified patient, a valid out -of- 4 state registry identification card; 5 (b) Being in the presence or vicinity of the use of medicinal cannabis; or 6 (c) Assisting a registered qualified patient or visiting qualified patient with 7 using or administering medicinal cannabis. For purposes of illustration and 8 not limitation, this includes preparing r aw plant material or brewing tea for 9 a registered qualified patient or visiting qualified patient. This does not 10 include providing medicinal cannabis to a patient that the patient did not 11 already possess. 12 (6) Notwithstanding subsection (1) of this section, a registered qualified patient who 13 is under eighteen (18) years of age shall not be permitted to possess, purchase, or 14 acquire medicinal cannabis and shall only engage in the use of medicinal 15 cannabis with the assistance of a designated caregiver. 16 (7) Notwithstanding subsections (1), (2), and (3) of this section: 17 (a) A registered qualified patient shall not be permitted to purchase more 18 medicinal cannabis than the thirty (30) day maximum allowance of 19 medicinal cannabis, as determined by the department purs uant to Section 20 28 of this Act, during a given twenty -five (25) day period; 21 (b) A designated caregiver shall not be permitted to purchase more medicinal 22 cannabis than the thirty (30) day maximum allowance of medicinal 23 cannabis, as determined by the departm ent pursuant to Section 28 of this 24 Act, for each registered qualified patient to whom the caregiver is connected 25 through the department's registration process during a given twenty -five 26 (25) day period; and 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 21 of 141 HB013610.100 - 50 - XXXX GA (c) 1. A visiting qualified patient who has appli ed for and obtained a registry 1 identification card issued by the department shall not be permitted to 2 purchase more medicinal cannabis than the ten (10) day maximum 3 allowance of medicinal cannabis, as determined by the department 4 pursuant to Section 28 of this Act, during a given eight (8) day period. 5 2. A visiting qualified patient who has not applied for and obtained a 6 registry identification card issued by the department but possesses a 7 valid out -of-state registry identification card shall not be permitt ed to 8 purchase medicinal cannabis in this state more than once per 9 calendar year and shall not be permitted to purchase more medicinal 10 cannabis than the ten (10) day maximum allowance of medicinal 11 cannabis, as determined by the department pursuant to Secti on 28 of 12 this Act. 13 (8) (a) All medicinal cannabis possessed by a cardholder in accordance with 14 subsections (1), (2), (3), and (7) of this section shall be kept in the original 15 container in which the cardholder received the medicinal cannabis from a 16 dispens ary. 17 (b) An individual who violates paragraph (a) of this subsection may be fined up 18 to one hundred dollars ($100) per violation. 19 (9) Notwithstanding any other provision of law to the contrary, a registered qualified 20 patient who is injured or defrauded, in cluding by theft or deprivation of the use 21 and benefit of any money, personal property including medicinal cannabis, or 22 articles of value of any kind, by his or her designated caregiver shall have a civil 23 cause of action in Circuit Court to recover the act ual damages sustained, together 24 with the costs of the lawsuit, including a reasonable fee for the individual's 25 attorney of record. 26 SECTION 5. A NEW SECTION OF KRS CHAPTER 218A IS CREATED TO 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 22 of 141 HB013610.100 - 50 - XXXX GA READ AS FOLLOWS: 1 (1) (a) Any m edicinal cannabis, medicinal cannabis accessories, lawful property, 2 or interest in lawful property that is possessed, owned, or used in connection 3 with the use of medicinal cannabis or acts incidental to that use shall not be 4 subject to seizure or forfeitu re under KRS 218A.405 to 218A.460. 5 (b) Sections 1 to 30 of this Act shall not prevent the seizure or forfeiture of 6 marijuana exceeding the amounts allowed under Section 4 of this Act nor 7 shall it prevent seizure or forfeiture if the basis for that action i s unrelated 8 to the use of medicinal cannabis in accordance with Sections 1 to 30 of this 9 Act and any administrative regulation promulgated thereunder. 10 (2) Possession of, or application for, a registry identification card, an out -of-state 11 registry identific ation card, or cannabis business license shall not constitute 12 probable cause or reasonable suspicion, nor shall it be used to support the search 13 of the person, property, or home of the person possessing or applying for the 14 registry identification card, an out-of-state registry identification card, or 15 cannabis business license. The possession of, or application for, a registry 16 identification card, an out -of-state registry identification card, or cannabis 17 business license shall not preclude the existence of p robable cause or reasonable 18 suspicion if probable cause or reasonable suspicion exists on other grounds. 19 (3) (a) There shall be a rebuttable presumption that a cardholder is engaged in the 20 lawful use of medicinal cannabis, or in the case of a designated ca regiver, 21 assisting with the lawful use of medicinal cannabis, if the cardholder: 22 1. Possesses a valid registry identification card or, in the case of a 23 visiting qualified patient, a valid out -of-state registry identification 24 card; and 25 2. Possesses an amount of medicinal cannabis that does not exceed the 26 amount the cardholder is permitted to possess under Section 4 of this 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 23 of 141 HB013610.100 - 50 - XXXX GA Act. 1 (b) This presumption may be rebutted by a preponderance of evidence that 2 conduct was unrelated to the use of medic inal cannabis or was otherwise in 3 violation of Sections 1 to 30 of this Act. 4 SECTION 6. A NEW SECTION OF KRS CHAPTER 218A IS CREATED TO 5 READ AS FOLLOWS: 6 (1) Sections 1 to 30 of this Act do not authorize any person to eng age in, and shall 7 not prevent the imposition of any civil, criminal, or other penalties, including but 8 not limited to criminal prosecution or disciplinary action by the department or an 9 occupational or professional licensing board, for engaging in, the fol lowing 10 conduct: 11 (a) Operating, navigating, or being in actual physical control of any aircraft, 12 vehicle, vessel, or any other device known, or hereafter invented, that is 13 powered by machinery and that is or may be used to transport persons or 14 property whil e under the influence of medicinal cannabis; 15 (b) Consuming medicinal cannabis while operating, navigating, or being in 16 actual physical control of an aircraft, vehicle, vessel, or any other device 17 known, or hereafter invented, that is powered by machinery a nd that is or 18 may be used to transport persons or property; 19 (c) Possessing medicinal cannabis that is within the operator's arm's reach or 20 that is not contained in a package that requires at least a two (2) step 21 process for initial opening, in accordance w ith administrative regulations 22 promulgated pursuant to subsection (1)(c)12.a. of Section 28 of this Act, 23 while operating, navigating, or being in actual physical control of an 24 aircraft, vehicle, vessel, or any other device known, or hereafter invented, 25 that is powered by machinery and that is or may be used to transport 26 persons or property; 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 24 of 141 HB013610.100 - 50 - XXXX GA (d) Undertaking any task under the influence of medicinal cannabis, when 1 doing so would constitute negligence or professional malpractice; 2 (e) Possessing medicinal canna bis, or otherwise engaging in the use of 3 medicinal cannabis: 4 1. On the grounds of any preschool or primary or secondary school, 5 except as permitted in accordance with policies enacted pursuant to 6 subsection (4)(c) of Section 8 of this Act; 7 2. In any correc tional facility; or 8 3. On any property of the federal government; 9 (f) Using marijuana, if that person is not a registered qualified patient or 10 visiting qualified patient; 11 (g) Using or consuming marijuana by smoking; or 12 (h) Cultivating marijuana unless that person is licensed by the department as a 13 cannabis cultivator or cannabis producer pursuant to Sections 16, 17, and 14 18 of this Act or is a cultivator or producer agent. 15 (2) Sections 1 to 30 of this Act shall not prevent enforcement of current laws 16 pertain ing to the operation of any aircraft, vehicle, or vessel, including under 17 KRS Chapters 183, 189, 189A, and 235. 18 (3) If a cardholder violates subsection (1)(a) or (b) of this section, in addition to 19 penalties that may be imposed under KRS Chapters 183, 189, 189A, or 235, the 20 cardholder's registry identification card shall be revoked. 21 (4) (a) An individual who violates subsection (1)(g) of this section shall not be 22 considered to be in possession of medicinal cannabis or engaged in the use 23 of medicinal cannabi s and may not benefit from the legal protections 24 afforded by Sections 1 to 30 of this Act. 25 (b) The odor or smell of medicinal cannabis shall not constitute conclusive 26 evidence of use or consumption of medicinal cannabis by smoking. 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 25 of 141 HB013610.100 - 50 - XXXX GA (c) Notwithstanding para graph (a) of this subsection: 1 1. If an individual violates subsection (1)(g) of this section by using or 2 consuming marijuana by smoking while on any form of public 3 transportation, in any public place as defined in KRS 525.010, or in 4 any place of public acc ommodation, resort, or amusement as defined 5 in KRS 344.130: 6 a. The department may suspend or revoke the individual's registry 7 identification card; and 8 b. The individual may be subject to prosecution under Section 39 of 9 this Act. 10 2. For any individual who v iolates subsection (1)(g) of this section by 11 using or consuming marijuana by smoking on residential property 12 owned or leased by that individual or with the permission of the owner 13 or lessee of the residential property on which the violation occurred, 14 the p enalty shall be a fine of not more than one hundred dollars 15 ($100) per violation. 16 (5) As used in this section: 17 (a) \"Aircraft\" has the same meaning as in KRS 183.011; 18 (b) \"Vehicle\" has the same meaning as in KRS 189.010; and 19 (c) \"Vessel\" has the same meaning as in KRS 235.010. 20 SECTION 7. A NEW SECTION OF KRS CHAPTER 218A IS CREATED TO 21 READ AS FOLLOWS: 22 (1) Nothing in Sections 1 to 30 of this Act shall: 23 (a) Require an employer to permit or accommo date the use, consumption, 24 possession, transfer, display, transportation, distribution, sale, or growing 25 of medicinal cannabis in the workplace; 26 (b) Prohibit an employer from implementing policies promoting workplace 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 26 of 141 HB013610.100 - 50 - XXXX GA health and safety by: 1 1. Restricting th e use of medicinal cannabis by employees; or 2 2. Restricting or prohibiting the use of equipment, machinery, or power 3 tools by an employee who is a registered qualified patient, if the 4 employer believes that the use of such equipment, machinery, or 5 power to ols by an employee who is a registered qualified patient poses 6 an unreasonable safety risk; 7 (c) Prohibit an employer from including in any contract, provisions that 8 prohibit the use of medicinal cannabis by employees; 9 (d) Subject an employer to liability f or wrongful discharge or discrimination; 10 (e) Except as provided in Section 8 of this Act, prohibit a person, employer, 11 corporation, or any other entity who occupies, owns, or controls a property 12 from prohibiting or otherwise regulating the use, consumption , possession, 13 transfer, display, transportation, sale, or growing of medicinal cannabis on 14 or in that property; or 15 (f) Prohibit an employer from establishing and enforcing a drug testing policy, 16 drug -free workplace, or zero -tolerance drug policy. 17 (2) An em ployee who is discharged from employment for consuming medicinal 18 cannabis in the workplace, working while under the influence of medicinal 19 cannabis, or testing positive for a controlled substance shall not be eligible to 20 receive benefits under KRS Chapter 341 if such actions are in violation of an 21 employment contract or established personnel policy. 22 (3) An employer shall not be penalized or denied any benefit under state law for 23 employing a cardholder. 24 SECTION 8. A NEW SE CTION OF KRS CHAPTER 218A IS CREATED TO 25 READ AS FOLLOWS: 26 (1) Except as provided in Section 7 of this Act, the lawful use of medicinal cannabis 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 27 of 141 HB013610.100 - 50 - XXXX GA by a cardholder is equivalent to the authorized use of any other medication used 1 at the direction of a practition er, shall not constitute the use of an illicit 2 substance, and shall not constitute an acceptable basis for disqualifying a 3 cardholder from any rights or privileges that he or she may otherwise be entitled 4 to, including those guaranteed under KRS Chapter 34 4. 5 (2) A cardholder otherwise entitled to custody of or visitation time or parenting time 6 with a minor child shall not be denied that right, and there shall be no 7 presumption of dependency, neglect, or abuse, for conduct permitted under 8 Sections 1 to 30 of this Act unless the person's actions in relation to medicinal 9 cannabis create a danger that is not in the best interest of the safety of the minor 10 child as established by clear and convincing evidence. 11 (3) (a) For the purposes of medical care, including o rgan transplants, a patient's 12 authorized use of medicinal cannabis is the equivalent of the authorized use 13 of any other medication used at the direction of a practitioner, and shall not 14 constitute the use of an illicit substance or otherwise disqualify a p atient 15 from needed medical care. 16 (b) A health facility as defined in KRS 216B.015 may develop policies to allow a 17 patient who is a registered qualified patient or visiting qualified patient to 18 use medicinal cannabis on the premises of the health facility. 19 (4) (a) A school shall not refuse to enroll, or otherwise penalize, a person solely for 20 his or her status as a cardholder, unless failing to do so would violate 21 federal law or regulations and cause the school to lose a monetary or 22 licensing -related benefit under federal law or regulations. 23 (b) A school shall not be penalized or denied any benefit under state law for 24 enrolling a cardholder. 25 (c) Each local board of education and each board of directors of a public 26 charter school shall, within ninety (90) days after the effective date of this 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 28 of 141 HB013610.100 - 50 - XXXX GA section, establish policies to permit a pupil who is a registered qualified 1 patient to consume medicinal cannabis on school property as deemed 2 necessary by the pupil's parent or legal guardian. Policies enacted pursuant 3 to this paragraph shall require that medicinal cannabis be administered by 4 a school nurse or under the supervision of appropriate school staff. 5 (5) (a) No landlord may be penalized or denied any benefit under state law for 6 leasing to a cardholder. 7 (b) A landlord shall not include in a rental agreement terms and conditions 8 that prohibit the use of medicinal cannabis by a cardholder. 9 SECTION 9. A NEW SECTION OF KRS CHAPTER 218A IS CREATED TO 10 READ AS FOLLOWS: 11 (1) Except as provided in subsection (13) of this section, a physician, a physician 12 assistant, or an advanced practice registered nurse seeking to become a medicinal 13 cannabis practitioner and provide written certifications for the use of medicinal 14 cannabis shall appl y to the same state licensing board that issued his or her 15 professional practice license, on a form prescribed by the state licensing board, 16 for authorization to provide written certifications for the use of medicinal 17 cannabis. 18 (2) (a) A state licensing bo ard shall approve an application for authorization to 19 provide written certifications for the use of medicinal cannabis if the 20 application is complete and meets the requirements established in 21 administrative regulations promulgated by the state licensing bo ard. 22 (b) A state licensing board shall deny an application for authorization to 23 provide written certifications for the use of medicinal cannabis if the 24 applicant has an ownership or investment interest in or compensation 25 agreement with a cannabis business licensed under this chapter. A state 26 licensing board may consult with the department to determine if an 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 29 of 141 HB013610.100 - 50 - XXXX GA applicant has an ownership or investment interest in or compensation 1 agreement with a cannabis business. 2 (3) Authorization to provide written certificat ions for the use of medicinal cannabis 3 granted under this section shall expire, and may be renewed, in accordance with 4 administrative regulations promulgated by a state licensing board. 5 (4) A medicinal cannabis practitioner may provide a patient with a wri tten 6 certification only after the practitioner has: 7 (a) Established a bona fide practitioner -patient relationship with the patient; 8 (b) Diagnosed the patient with a qualifying medical condition or confirmed a 9 diagnosis for a qualifying medical condition pr ovided by another health 10 care provider; 11 (c) Reviewed a report of information from the electronic monitoring system 12 established pursuant to Section 41 of this Act related to the patient for a 13 period of time that covers at least the twelve (12) months immed iately 14 preceding the date of the report; 15 (d) Consulted with the patient, or the patient's custodial parent or legal 16 guardian responsible for providing consent to treatment if the patient is a 17 minor child, with respect to the possible risks and side effects associated 18 with medicinal cannabis, including possible interactions between medicinal 19 cannabis and any other drug or medication that the patient is taking at that 20 time; and 21 (e) Obtained the consent of the patient's custodial parent or legal guardian 22 respo nsible for providing consent to treatment, if the patient is a minor 23 child. 24 (5) A bona fide practitioner -patient relationship may be established following a 25 referral from the patient's primary care provider and may be maintained via 26 telehealth. However, a bona fide practitioner -patient relationship shall not be 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 30 of 141 HB013610.100 - 50 - XXXX GA established via telehealth. 1 (6) (a) When issuing a written certification for the use of medicinal cannabis to a 2 patient, the medicinal cannabis practitioner shall, to the best of his or her 3 professio nal medical knowledge, provide the patient with recommendations 4 for: 5 1. The strains of medicinal cannabis and types of medicinal cannabis 6 products that may be most effective in providing medical, therapeutic, 7 or palliative relief to the patient; and 8 2. Medicinal cannabis dosing including the quantity and frequency of 9 doses. 10 (b) Recommendations provided pursuant to paragraph (a) of this subsection 11 shall comply with medicinal cannabis dosing guidelines and the ten (10) 12 day and thirty (30) day maximum allowanc e of medicinal cannabis 13 developed by the department pursuant to Section 28 of this Act. 14 (7) (a) A written certification for the use of medicinal cannabis shall be provided to 15 a patient on a form prescribed by the department. 16 (b) An initial written certific ation for the use of medicinal cannabis shall be 17 provided during the course of an in -person examination of the patient by 18 the medicinal cannabis practitioner. Subsequent written certifications, 19 including for the purpose of renewing a registry identificatio n card, may be 20 provided electronically or during the course of a telehealth consultation. 21 (c) For the purpose of applying for a registry identification card, a written 22 certification provided under this section shall be valid for ninety (90) days 23 after the date of issuance by a medicinal cannabis practitioner. The 24 medicinal cannabis practitioner may renew a written certification for not 25 more than three (3) additional periods of not more than ninety (90) days 26 each. Thereafter, the medicinal cannabis practitio ner may issue another 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 31 of 141 HB013610.100 - 50 - XXXX GA certification to the patient only after conducting an additional examination 1 of the patient in person or via telehealth. 2 (d) Within twenty -four (24) hours of providing a patient with a written 3 certification for the use of medicinal ca nnabis, a medicinal cannabis 4 practitioner shall record the issuance of the written certification in the 5 electronic monitoring system established pursuant to Section 41 of this Act. 6 (8) A medicinal cannabis practitioner shall not: 7 (a) Dispense medicinal can nabis; or 8 (b) Provide a written certification for the use of medicinal cannabis to a family 9 member or to himself or herself. 10 (9) Nothing in Sections 1 to 30 of this Act shall prevent a practitioner from being 11 sanctioned for: 12 (a) Issuing a written certification without first obtaining authorization to 13 provide written certifications from a state licensing board; 14 (b) Issuing a written certification to a patient with whom the practitioner does 15 not have a bona fide practitioner -patient relationship; 16 (c) Failing to properly evaluate a patient's medical history and current medical 17 condition prior to issuing a written certification; 18 (d) Otherwise failing to use good faith in his or her treatment of the patient; or 19 (e) Any other violation o f this section or any administrative regulation 20 promulgated thereunder. 21 (10) A state licensing board may suspend or revoke a medicinal cannabis 22 practitioner's authorization to provide written certification for the use of 23 medicinal cannabis and practice lic ense for multiple violations or a serious 24 violation of this section or any administrative regulation promulgated 25 thereunder. 26 (11) The state licensing boards shall: 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 32 of 141 HB013610.100 - 50 - XXXX GA (a) No later than January 1, 2023, promulgate, in accordance with KRS 1 Chapter 13A, administr ative regulations to establish at least the following: 2 1. The application and renewal process for authorization to provide 3 written certifications for the use of medicinal cannabis. Any 4 administrative regulation promulgated pursuant to this subparagraph 5 shall include an application and renewal fee which shall be sufficient 6 to generate the funds necessary to enable the state licensing board to 7 process applications and enforce administrative regulations 8 promulgated under this section; 9 2. The conditions that mu st be met to be eligible for authorization to 10 provide written certifications. Eligibility criteria established by 11 administrative regulations promulgated pursuant to this paragraph 12 shall require that: 13 a. An advanced practice registered nurse be authorized t o prescribe 14 controlled substances under KRS 314.042; and 15 b. A physician assistant: 16 i. Be authorized to prescribe controlled substances under 17 KRS 311.858; and 18 ii. Have and maintain a supervision agreement, established in 19 accordance with KRS Chapter 311, wit h a physician who is 20 authorized to provide written certifications; 21 3. Continuing education requirements for medicinal cannabis 22 practitioners related to the use of medicinal cannabis and the 23 recommending of cannabis for medicinal use. The continuing 24 educati on requirements established pursuant to this subparagraph 25 shall include continuing education requirements related to medicinal 26 cannabis dosing and dosing guidelines established by the department 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 33 of 141 HB013610.100 - 50 - XXXX GA pursuant to Section 28 of this Act; 1 4. The reasons for which authorization to provide written certifications 2 for the use of medicinal cannabis may be suspended or revoked; and 3 5. The minimal standards of care when providing written certifications; 4 (b) On a regular basis, provide the department with the names of all medicinal 5 cannabis practitioners; and 6 (c) Immediately provide the department with the name of any medicinal 7 cannabis practitioner whose authorization to provide written certifications 8 is suspended or revoked. 9 (12) Nothing in Sections 1 to 30 of this Act sh all be construed or interpreted to limit or 10 restrict a state licensing board's authority or ability to enforce administrative 11 regulations promulgated pursuant to subsection (11) of this section. 12 (13) This section does not apply to a practitioner who recomm ends treatment with 13 cannabis or a drug derived from cannabis under any of the following that are 14 approved by an investigational review board or equivalent entity, the United 15 States Food and Drug Administration, or the National Institutes for Health or 16 any of its cooperative groups or centers under the United States Department of 17 Health and Human Services: 18 (a) A research protocol; 19 (b) A clinical trial; 20 (c) An investigational new drug application; or 21 (d) An expanded access submission. 22 SECTION 10. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 23 TO READ AS FOLLOWS: 24 (1) Except as provided in subsection (2) of this section, prior to making an initial 25 purch ase of medicinal cannabis in this state and at least annually thereafter, a 26 registered qualified patient shall be required to complete a consultation with a 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 34 of 141 HB013610.100 - 50 - XXXX GA pharmacist who is authorized by the Kentucky Board of Pharmacy to provide 1 medicinal cannabis consul tation services to cardholders. The consultation shall, 2 at a minimum, cover the possible risks and side effects of medicinal cannabis and 3 any potential drug interactions between medicinal cannabis and any other drug 4 that the registered qualified patient or visiting qualified patient is taking. The 5 consultation required by this subsection may be completed via telehealth. 6 (2) (a) A designated caregiver shall be permitted to complete the consultation 7 required by subsection (1) of this section on behalf of any registered 8 qualified patient to whom the designated caregiver is connected through the 9 department's registration process. 10 (b) If the registered qualified patient is under eighteen (18) years of age, the 11 registered qualified patient's parent or legal guardi an who is responsible for 12 providing consent for medical treatment shall be present for the 13 consultation required by subsection (1) of this section and may complete the 14 consultation on behalf of the registered qualified patient. 15 (c) A visiting qualified pat ient who has not applied for and obtained a registry 16 identification card issued by the department but presents a valid out -of-state 17 registry identification card to purchase medicinal cannabis in this state not 18 more than once per calendar year shall not be required to complete the 19 consultation required by subsection (1) of this section. 20 (3) A pharmacist who wishes to be authorized by the Kentucky Board of Pharmacy to 21 provide medicinal cannabis consultation services to cardholders or to enter into a 22 cannabis consultation agreement with dispensaries, as required by Section 22 of 23 this Act, shall apply to the board on a form prescribed by the board. 24 (4) No later than January 1, 2023, the Kentucky Board of Pharmacy shall, in 25 accordance with KRS Chapter 13A, promul gate administrative regulations to: 26 (a) Establish the application and renewal process for authorization to provide 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 35 of 141 HB013610.100 - 50 - XXXX GA medicinal cannabis consultation services to cardholders and to enter into a 1 cannabis consultation agreement with dispensaries. Any administra tive 2 regulation promulgated pursuant to this paragraph shall include an 3 application and renewal fee which shall be sufficient to generate the funds 4 necessary to enable the Board of Pharmacy to process applications and 5 enforce administrative regulations pro mulgated under this section; 6 (b) Establish continuing education and training requirements for pharmacists 7 who are authorized to provide medicinal cannabis consultation services to 8 cardholders and to enter into cannabis consultation agreements with 9 dispensa ries; 10 (c) Define the standards of care for medicinal cannabis consultation services 11 provided by a pharmacist to a cardholder; 12 (d) Define the nature and scope of a cannabis consultation agreement between 13 a pharmacist and a dispensary, including the process by which a 14 pharmacist and dispensary may establish a cannabis consultation 15 agreement. Administrative regulations promulgated pursuant to this 16 paragraph: 17 1. Shall not require a pharmacist to be present at a dispensary; and 18 2. May limit the number of cannabi s consultation agreements a 19 pharmacist is permitted to maintain at any given time; 20 (e) Establish the fee that a pharmacist may charge a cardholder for medicinal 21 cannabis consultation services. The fee established pursuant to this 22 paragraph shall not exceed forty dollar ($40) per consultation; and 23 (f) Establish a cannabis consultation agreement fee to be paid by a dispensary 24 to a pharmacist. 25 (5) Nothing in Sections 1 to 30 of this Act shall be construed or interpreted to limit or 26 restrict the Kentucky Board of Pharmacy's authority or ability to enforce 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 36 of 141 HB013610.100 - 50 - XXXX GA administrative regulations promulgated pursuant to subsection (4) of this section. 1 (6) (a) Members of the Kentucky Board of Pharmacy, its agents, and its employees 2 shall be immune from suit for discretionary ac ts in a civil action or criminal 3 action which is based upon any act that is conducted in accordance with 4 this section and administrative regulations promulgated thereunder. 5 (b) A pharmacist authorized by the board to provide medicinal cannabis 6 consultation services to cardholders or to enter into cannabis consultation 7 agreements with dispensaries shall be immune in any civil action or 8 criminal action as long as the pharmacist acted with ordinary and 9 reasonable care as any pharmacist would in the same or sim ilar 10 circumstances and in accordance with this section and administrative 11 regulations promulgated thereunder. 12 SECTION 11. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 13 TO READ AS FOLLOWS: 14 (1) Except as provided in subsect ion (9) of this section, no person shall possess, 15 purchase, acquire, or otherwise engage or assist in the use of medicinal cannabis 16 in Kentucky without first applying for and receiving a registry identification card 17 for registered qualified patients, desig nated caregivers, or visiting qualified 18 patients issued by the department. 19 (2) A person shall be eligible to apply for a registry identification card as a registered 20 qualified patient if he or she is a resident of Kentucky, has obtained a written 21 certifica tion issued by a medicinal cannabis practitioner in accordance with 22 Section 9 of this Act and administrative regulations promulgated thereunder, and 23 has not been convicted of a disqualifying felony offense. 24 (3) A person shall be eligible to apply for a reg istry identification card as a 25 designated caregiver if he or she is a resident of Kentucky, is at least twenty -one 26 (21) years of age, has been identified as a designated caregiver on qualified 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 37 of 141 HB013610.100 - 50 - XXXX GA patient's or registered qualified patient's registry identifica tion card application 1 or renewal form, has not been convicted of a disqualifying felony offense, and 2 has agreed to assist no more than three (3) registered qualified patients with the 3 use of medicinal cannabis. 4 (4) A person shall be eligible to apply for a registry identification card as a visiting 5 qualified patient if he or she is not a resident of Kentucky or has been a resident 6 of Kentucky for less than thirty (30) days, possess a valid out -of-state registry 7 identification card, is at least twenty -one (2 1) years of age, has obtained a written 8 certification issued by a medicinal cannabis practitioner in accordance with 9 Section 9 of this Act and administrative regulations promulgated thereunder, and 10 has not been convicted of a disqualifying felony offense. 11 (5) To apply for or renew a registry identification card, a qualified patient who is 12 eighteen (18) years of age or older shall submit the following, in accordance with 13 administrative regulations promulgated by the department: 14 (a) The name, address, and dat e of birth of the qualified patient, except that if 15 the applicant is homeless an address where the applicant may be reached 16 shall be provided to the department; 17 (b) A valid written certification issued to the qualified patient; 18 (c) The name, address, and telephone number of the qualified patient's 19 medicinal cannabis practitioner; 20 (d) A statement, signed by the qualified patient, pledging not to divert medicinal 21 cannabis to anyone who is not permitted to possess medicinal cannabis 22 pursuant to Sections 1 to 30 of this Act. The statement shall contain a 23 listing of potential penalties, including criminal prosecution, for diverting 24 medicinal cannabis; 25 (e) If the qualified patient determines that he or she needs a designated 26 caregiver: 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 38 of 141 HB013610.100 - 50 - XXXX GA 1. A statement, signed by the qualified patient, attesting to such need; 1 2. The name, address, and date of birth of not more than two (2) 2 individuals chosen by the qualified patient to be designated as a 3 caregiver; and 4 3. A statement, signed by the individuals chosen by the qualified patient 5 to be designated as a caregiver agreeing to be designated as the 6 patient's designated caregiver and pledging not to divert medicinal 7 cannabis to anyone other than the registered qualified patient to 8 whom the caregiver is co nnected through the department's 9 registration process. The statement shall contain a listing of potential 10 penalties, including criminal prosecution, for diverting medicinal 11 cannabis; and 12 (f) The application or renewal fee for a registry identification card for a 13 qualified patient and the application or renewal fee for a registry 14 identification card for any designated caregiver chosen by the qualified 15 patient. 16 (6) To apply for or renew a registry identification card for a qualified patient who is 17 under eight een (18) years of age, the qualified patient's custodial parent or legal 18 guardian with responsibility for health care decisions shall submit the following, 19 in accordance with administrative regulations promulgated by the department: 20 (a) The name, address, and date of birth of the qualified patient, except that if 21 the applicant is homeless an address where the applicant may be reached 22 shall be provided to the department; 23 (b) A valid written certification issued to the qualified patient; 24 (c) The name, address , and telephone number of the qualified patient's 25 medicinal cannabis practitioner; 26 (d) A statement, signed by the qualified patient's custodial parent or legal 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 39 of 141 HB013610.100 - 50 - XXXX GA guardian with responsibility for health care decisions, attesting to the fact 1 that the custodial parent or legal guardian agrees to: 2 1. Allow the qualified patient to use medicinal cannabis; 3 2. Serve as the qualified patient's designated caregiver; and 4 3. Control the acquisition, dosage, and frequency of use of medicinal 5 cannabis by the qualified pat ient; 6 (e) A statement, signed by the qualified patient's custodial parent or legal 7 guardian with responsibility for health care decisions, pledging not to 8 divert, or to knowingly allow the qualified patient to divert, medicinal 9 cannabis to anyone who is no t permitted to possess medicinal cannabis 10 pursuant to Sections 1 to 30 of this Act. The statement shall contain a 11 listing of potential penalties, including criminal prosecution, for diverting 12 medicinal cannabis; 13 (f) If the qualified patient's custodial par ent or legal guardian with 14 responsibility for health care decisions determines that the qualified patient 15 needs an additional designated caregiver: 16 1. A statement, signed by the qualified patient's custodial parent or legal 17 guardian with responsibility for health care decisions, attesting to 18 such need; 19 2. The name, address, and date of birth of not more than one (1) 20 individual chosen by the qualified patient's custodial parent or legal 21 guardian with responsibility for health care decisions to be designated 22 as a second designated caregiver; and 23 3. A statement, signed by the individual chosen by the qualified patient's 24 custodial parent or legal guardian with responsibility for health care 25 decisions to be designated as a caregiver, agreeing to be designated as 26 the patient's designated caregiver and pledging not to divert medicinal 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 40 of 141 HB013610.100 - 50 - XXXX GA cannabis to anyone other than the registered qualified patient to 1 whom the caregiver is connected through the department's 2 registration process. The statement shall contain a listing o f potential 3 penalties, including criminal prosecution, for diverting medicinal 4 cannabis; and 5 (g) The application or renewal fee for a registry identification card for a 6 qualified patient and the application or renewal fee for a registry 7 identification card for any designated caregiver chosen by the qualified 8 patient. 9 (7) To apply for or renew a registry identification card, a visiting qualified patient 10 shall submit the following, in accordance with administrative regulations 11 promulgated by the department: 12 (a) The name, address, and date of birth of the visiting qualified patient, except 13 that if the applicant is homeless an address where the applicant may be 14 reached shall be provided to the department; 15 (b) A copy of his or her valid out -of-state registry iden tification card; 16 (c) A valid written certification issued to the qualified patient; 17 (d) The name, address, and telephone number of the qualified patient's 18 medicinal cannabis practitioner; 19 (e) A statement, signed by the qualified patient, pledging not to di vert medicinal 20 cannabis to anyone who is not permitted to possess medicinal cannabis 21 pursuant to Sections 1 to 30 of this Act. The statement shall contain a 22 listing of potential penalties, including criminal prosecution, for diverting 23 medicinal cannabis; a nd 24 (f) The application or renewal fee for a registry identification card for a 25 visiting qualified patient; 26 (8) The application for qualified patients' registry identification cards shall ask 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 41 of 141 HB013610.100 - 50 - XXXX GA whether the patient would like the department to notify him or her of any clinical 1 studies needing human subjects for research on the use of medicinal cannabis. 2 The department shall notify interested patients if it is aware of studies that will be 3 conducted in the United States. 4 (9) A visiting qualified patient who possess a valid out -of-state registry identification 5 card shall not be required to apply for or obtain a visiting q ualified patient 6 registry identification card issued by the department and may use his or her valid 7 out-of-state registry identification card for all purposes established in Sections 1 8 to 30 of this Act, except that a visiting qualified patient who has not applied for 9 and obtained a registry identification card issued by the department shall only be 10 permitted to purchase medicinal cannabis in this state once per calendar year. 11 SECTION 12. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 12 TO READ AS FOLLOWS: 13 (1) The department shall establish, implement, and operate a registry identification 14 card program for registered qualified patients, visiting qualified patients, and 15 designated caregivers. 16 (2) The following shall be clearly and visibly printed on registry identification cards: 17 (a) The name of the cardholder; 18 (b) A designation of whether the cardholder is a registered qualified patient, 19 visiting qualified patient, or designated caregiver; 20 (c) The date of issuance and expiratio n date of the registry identification card; 21 (d) A random alphanumeric identification number of at least ten (10) 22 characters, containing at least four (4) numbers and at least four (4) letters, 23 that is unique to the cardholder; 24 (e) A photograph of the cardh older, if the department's administrative 25 regulations require one; 26 (f) The telephone number and Web site address for the electronic monitoring 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 42 of 141 HB013610.100 - 50 - XXXX GA system established pursuant to Section 41 of this Act; 1 (g) If the cardholder is a designated caregiver, the rando m alphanumeric 2 identification number of the registered qualified patient the designated 3 caregiver is receiving the registry identification card to assist; 4 (h) If the cardholder is under eighteen (18) years of age, a clear and obvious 5 designation or identif ier indicating that the cardholder is under eighteen 6 (18) years of age; and 7 (i) A bar code or other marking that can be scanned electronically to provide 8 access to the information described in subsection (4) of this section. 9 (3) (a) Except as provided in t his subsection, the expiration date for registry 10 identification cards shall be one (1) year after the date of issuance. 11 (b) If a medicinal cannabis practitioner states in the written certification that 12 the qualified patient would benefit from the use of me dicinal cannabis until 13 a specified earlier date, then the registry identification card shall expire on 14 that date. 15 (4) The department shall electronically store in the card at least all of the 16 information listed in subsection (2) of this section, the cardho lder's address, and 17 the cardholder's date of birth, so that it may be read electronically by law 18 enforcement agents and licensed cannabis businesses. 19 (5) The registry identification card application and renewal fees shall be as follows: 20 (a) A registry iden tification card for a qualified patient who is a Kentucky 21 resident shall be sixty dollars ($60); 22 (b) A registry identification card for a visiting qualified patient shall be sixty 23 dollars ($60); and 24 (c) A registry identification card for a designated careg iver shall be twenty 25 dollars ($20) per registered qualified patient to whom the designated 26 caregiver is connected unless the designated caregiver is the parent, legal 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 43 of 141 HB013610.100 - 50 - XXXX GA guardian, spouse, or adult child of the qualified patient, in which case there 1 shall be n o fee for a registry identification card. 2 (6) (a) The department shall operate a provisional registration receipt system for 3 registered qualified patients, designated caregivers, and visiting qualified 4 patients that shall be valid for forty -five (45) days, or until a permanent card 5 can be issued, as if it is a registry identification card issued pursuant to this 6 section and Sections 11 and 13 of this Act. This program shall be 7 implemented and operational simultaneously with the department's 8 implementation o f the registry identification card program established in 9 this section. A provisional registration receipt shall contain the following: 10 1. A temporary identification number; 11 2. A barcode or other marking that can be scanned electronically; 12 3. The name of the applicant; 13 4. A designation of whether the cardholder is a registered qualified 14 patient, visiting qualified patient, or designated caregiver; 15 5. If the cardholder is under eighteen (18) years of age, a clear and 16 obvious designation or ident ifier indicating that the cardholder is 17 under eighteen (18) years of age; 18 6. The effective date of the receipt; 19 7. The expiration date of the receipt; 20 8. An indication that the cardholder fee has been paid; 21 9. An indication that the application has been su bmitted and is 22 apparently complete; and 23 10. The name of the qualified patient's medicinal cannabis practitioner. 24 (b) The registration receipt system shall be designed so that this provisional 25 registration receipt shall be produced by the application Web si te upon 26 completion of an application that includes a valid written certification for 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 44 of 141 HB013610.100 - 50 - XXXX GA the use of medicinal cannabis issued by medicinal cannabis practitioner 1 and payment of the cardholder fee. To reduce application errors and 2 processing time, medicinal cann abis practitioners and licensed dispensaries 3 may offer a service that allows an applicant to use a computer and printer 4 on the premises of the practitioner's office or dispensary to complete an 5 application and receive a provisional registration receipt pur suant to this 6 subsection. 7 (c) Notwithstanding any other provision of Sections 1 to 30 of this Act, a valid 8 provisional registration receipt issued pursuant to this subsection shall 9 convey to the individual whose name appears on the provisional registration 10 receipt all of the same rights and privileges as a registry identification card 11 issued pursuant to this section and Sections 11 and 13 of this Act and shall 12 be accepted by a cannabis business in place of a registry identification card. 13 (7) All registry id entification card fees collected by the department pursuant to 14 subsection (5) of this section shall be forwarded to the medicinal cannabis trust 15 fund established in Section 31 of this Act. 16 SECTION 13. A NEW SECTION OF KR S CHAPTER 218A IS CREATED 17 TO READ AS FOLLOWS: 18 (1) Except as provided in subsections (2) to (5) of this section, the department shall: 19 (a) Acknowledge receipt of an application or renewal within fifteen (15) days of 20 receipt, and approve or deny an applicati on or renewal within thirty (30) 21 days of receiving a completed application or renewal application; and 22 (b) Issue registry identification cards to a qualified patient and any individual 23 designated by the qualified patient as a designated caregiver, or a vis iting 24 qualified patient within five (5) days of approving the application or 25 renewal. An individual designated as a caregiver shall be issued a 26 designated caregiver registry identification card for each registered 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 45 of 141 HB013610.100 - 50 - XXXX GA qualified patient to whom he or she is con nected through the department's 1 registration process. 2 (2) The department shall not issue a registry identification card to a qualified patient 3 who is younger than eighteen (18) years of age unless: 4 (a) The custodial parent or legal guardian with responsibi lity for health care 5 decisions for the qualified patient consents in writing to: 6 1. Allow the qualified patient's use of medicinal cannabis; 7 2. Serve as the qualified patient's designated caregiver; and 8 3. Control the acquisition of the medicinal cannabis, the dosage, and the 9 frequency of the use by the qualified patient; and 10 (b) The designated caregiver application for the custodial parent or legal 11 guardian with responsibility for health care decisions for the qualified 12 patient is approved. 13 (3) (a) The dep artment shall deny an application or renewal for a qualified 14 patient's or visiting qualified patient's registry identification card if the 15 applicant: 16 1. Did not provide the information or materials required by Section 11 of 17 this Act; 18 2. Previously had a re gistry identification card revoked; 19 3. Provided false or falsified information; or 20 4. Does not meet the eligibility requirements established in Section 11 of 21 this Act. 22 (b) The department may deny an application or renewal for a qualified 23 patient's or visiting qualified patient's registry identification card for any 24 reason that the department, in the exercise of sound discretion, deems 25 sufficient. 26 (4) (a) The department shall deny an application or renewal for a designated 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 46 of 141 HB013610.100 - 50 - XXXX GA caregiver's registration card if the applicant: 1 1. Is already registered as a designated caregiver for three (3) registered 2 qualified patients; 3 2. Does not meet the eligibility requirements established in Se ction 11 of 4 this Act; 5 3. Did not provide the information or materials required by Section 11 of 6 this Act; 7 4. Previously had a registry identification card revoked; 8 5. Provided false or falsified information; or 9 6. Has applied as a designated caregiver for a qualified patient whose 10 application or renewal for a registry identification card was denied. 11 (b) The department may deny application or renewal for a designated 12 caregiver's registration card for any reason that the department, in the 13 exercise of sound d iscretion, deems sufficient. 14 (5) The department may conduct a criminal background check of any applicant if the 15 criminal background check is conducted solely to determine whether the 16 applicant was previously convicted of a disqualifying felony offense. 17 (6) The department shall notify the registered qualified patient who has designated 18 someone to serve as his or her designated caregiver if the individual designated as 19 a caregiver is denied a registry identification card. 20 (7) The department shall notify the a pplicant in writing of the denial and reasons for 21 the denial by registered or certified mail at the address given in the application or 22 supplement. The applicant may, within thirty (30) days after the date of the 23 mailing of the department's notice, file a written request for an administrative 24 hearing on the application. The hearing shall be conducted on the application in 25 compliance with the requirements of KRS Chapter 13B. 26 (8) Final orders of the department after administrative hearings shall be subject to 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 47 of 141 HB013610.100 - 50 - XXXX GA judicial review. Jurisdiction and venue for judicial review are vested in the 1 Circuit Court of the county in which the appealing party resides. 2 SECTION 14. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 3 TO READ AS FOLLOWS : 4 (1) Cardholders shall be required to make the following notifications to the 5 department: 6 (a) A cardholder shall notify the department of any change in his or her name 7 or address; 8 (b) If a cardholder loses his or her registry identification card, he or sh e shall 9 notify the department within ten (10) days of becoming aware that the card 10 has been lost; 11 (c) A cardholder shall immediately notify the department if he or she is 12 convicted of a disqualifying felony offense; 13 (d) A registered qualified patient sha ll notify the department within thirty (30) 14 days if he or she ceases to suffer from the qualifying medical condition for 15 which a medicinal cannabis practitioner provided a written certification; 16 (e) A registered qualified patient shall immediately notify t he department if he 17 or she wishes to terminate a designated caregiver relationship with an 18 individual who has been designated as his or her caregiver; and 19 (f) A designated caregiver shall notify the department within ten (10) days if he 20 or she becomes awar e that a registered qualified patient to whom the 21 caregiver is connected through the department's registration process has 22 died or has ceased to suffer from the qualifying medical condition for which 23 a medicinal cannabis practitioner provided a written cer tification. 24 (2) When a cardholder notifies the department of items listed in subsection (1)(a) or 25 (b) of this section, but remains eligible under Sections 1 to 30 of this Act, the 26 department shall issue the cardholder a new registry identification card wit h a 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 48 of 141 HB013610.100 - 50 - XXXX GA new random ten (10) character alphanumeric identification number. If the 1 department issues a new registry identification card to a registered qualified 2 patient, the department shall also issue a new registry identification card with a 3 new ten (10) char acter alphanumeric number to the registered qualified patient's 4 designated caregiver. New registry identification cards issued under this 5 subsection shall be issued by the department within ten (10) days of receiving the 6 updated information and a twenty do llar ($20) fee for each new registry 7 identification card to be issued. 8 (3) When a cardholder notifies the department of items listed in subsection (1)(c) to 9 (e) of this section, the cardholder shall, within ten (10) days of notification, 10 return any unused medicinal cannabis products to a licensed dispensary for 11 destruction. 12 (4) If a registered qualified patient ceases to be a registered qualified patient or 13 changes his or her designated caregiver, the department shall promptly notify the 14 designated caregive r in writing. The designated caregiver's protections under 15 Sections 1 to 30 of this Act as to that registered qualified patient shall expire 16 fifteen (15) days after notification by the department. 17 (5) A cardholder who fails to make a notification to the department that is required 18 by this section is subject to a violation, punishable by a penalty of no more than 19 one hundred fifty dollars ($150). 20 (6) All fees and penalties collected pursuant to this sect ion shall be forwarded to the 21 medicinal cannabis trust fund established in Section 31 of this Act. 22 SECTION 15. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 23 TO READ AS FOLLOWS: 24 (1) Any cardholder who sells, distributes, d ispenses, or otherwise diverts medicinal 25 cannabis to a person who is not permitted to possess or use medicinal cannabis 26 under Sections 1 to 30 of this Act shall have his or her registry identification card 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 49 of 141 HB013610.100 - 50 - XXXX GA revoked, shall be permanently ineligible for a reg istry identification card in the 1 future, and shall be subject to other penalties, including but not limited to 2 criminal prosecution, under any relevant chapter of the Kentucky Revised 3 Statutes. 4 (2) The department may revoke the registry identification card of any cardholder 5 who knowingly commits multiple violations or a serious violation of Sections 1 to 6 30 of this Act. 7 (3) The department shall provide notice of revocation, fine, or any other 8 administrative penalty by mailing, via certified mail, the same i n writing to the 9 cardholder. The cardholder may, within thirty (30) days after the date of the 10 mailing of the department's notice, file a written request for an administrative 11 hearing regarding the revocation, fine, or other penalty. The hearing shall be 12 conducted in compliance with the requirements of KRS Chapter 13B. 13 (4) Final orders of the department after administrative hearings shall be subject to 14 judicial review. Jurisdiction and venue for judicial review are vested in the 15 Circuit Court of the county in which the appealing party resides. 16 SECTION 16. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 17 TO READ AS FOLLOWS: 18 (1) No person shall cultivate, process, produce, possess, test, transfer, transport, or 19 sell medicinal ca nnabis or otherwise operate a cannabis business in this state 20 without first obtaining a cannabis business licenses issued by the department. 21 (2) The department shall create separate licenses allowing persons to operate a 22 cannabis business, pursuant to Sect ions 1 to 30 of this Act and any administrative 23 regulations promulgated thereunder, as: 24 (a) A cannabis cultivator, for which the license shall be tiered as follows: 25 1. Tier I, for which the initial licensing fee shall be five thousand dollars 26 ($5,000); 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 50 of 141 HB013610.100 - 50 - XXXX GA 2. Tier II, for which the initial licensing fee shall be ten thousand dollars 1 ($10,000); 2 3. Tier III, for which the initial licensing fee shall be twenty -five 3 thousand dollars ($25,000); and 4 4. Tier IV, for which the initial licensing fee shall be fifty thous and 5 dollars ($50,000); 6 (b) A cannabis dispensary, for which the initial licensing fee shall be ten 7 thousand dollars ($10,000); 8 (c) A cannabis processor, for which the initial licensing fee shall be twenty 9 thousand dollars ($20,000); 10 (d) A cannabis producer , for which the initial licensing fee shall be seventy -five 11 thousand dollars ($75,000); or 12 (e) A cannabis safety compliance facility, for which the initial licensing fee 13 shall be two thousand five hundred dollars ($2,500). 14 (3) (a) Except as provided in par agraph (b) of this subsection, a cannabis business 15 shall be required to apply for and obtain from the department a separate 16 license for each location it intends to operate. 17 (b) A cannabis business licensed as a producer may operate cultivation and 18 processi ng activities at separate locations, but shall not operate more than 19 one (1) cultivation and one (1) processing facility per license. 20 (4) (a) A cannabis business license issued under this section and Sections 17 and 21 18 of this Act shall be valid for one (1 ) year from the date of issuance. The 22 department shall notify each licensee ninety (90) days prior to the date on 23 which the license expires to allow the licensee to begin the renewal process 24 established by the department through the promulgation of adminis trative 25 regulations pursuant to Section 28 of this Act. 26 (b) The renewal of a cannabis business license shall be contingent upon 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 51 of 141 HB013610.100 - 50 - XXXX GA successful achievement of minimal performance standards established by 1 the department as part of the biennial accreditation proc ess established 2 pursuant to Section 28 of this Act. 3 (c) Cannabis business licensure renewal fees shall be: 4 1. Five hundred dollars ($500) plus one percent (1%) of all gross receipts 5 during the previous calendar year for a cannabis business that, upon 6 apply ing for renewal of a cannabis business license, had no more than 7 two million dollars ($2,000,000) of gross receipts during the previous 8 calendar year; 9 2. Two thousand dollars ($2,000) plus one and one -half percent (1.5%) 10 of all gross receipts during the previous calendar year for a cannabis 11 business that, upon applying for renewal of a cannabis business 12 license, had more than two million dollars ($2,000,000 ) but not more 13 than eight million dollars ($8,000,000) of gross receipts during the 14 previous calendar year; and 15 3. Four thousand dollars ($4,000) plus two percent (2%) of all gross 16 receipts during the previous calendar year for a cannabis business 17 that, up on applying for renewal of a cannabis business license, had 18 over eight million dollars ($8,000,000) of gross receipts during the 19 previous calendar year. 20 (5) All licensure fees collected pursuant to this section shall be forwarded to the 21 medicinal cannabis trust fund established in Section 31 of this Act. 22 (6) The department shall approve a license holder's sale of a license issued pursuant 23 to this section and Sections 17 and 18 of this Act if the purchaser and any new 24 facilities meet the requirements of Sect ions 1 to 30 of this Act and any 25 administrative regulations promulgated thereunder. 26 SECTION 17. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 52 of 141 HB013610.100 - 50 - XXXX GA TO READ AS FOLLOWS: 1 (1) The department shall create a uniform application form for the cannabis 2 business licenses established in Section 16 of this Act. 3 (2) When applying for a cannabis business license, the applicant shall submit the 4 following in accordance with the department's administrative regulations: 5 (a) The proposed legal nam e of the cannabis business; 6 (b) The proposed physical address of the cannabis business and the global 7 positioning system coordinates for any proposed cultivation activities; 8 (c) The name, address, and date of birth of each principal officer and board 9 membe r of the cannabis business; 10 (d) Any instances in which a business or not -for-profit entity that any of the 11 prospective board members managed or served on the board of was 12 convicted, fined, censured, or had a registration or license suspended or 13 revoked in any administrative or judicial proceeding; 14 (e) Any other information required by the department pursuant to 15 administrative regulations; and 16 (f) A nonrefundable licensure application fee of one hundred dollars ($100). 17 (3) The application fee required under subsection (2) of this section shall be applied 18 to the initial licensing fee if the license is approved; otherwise it shall be retained 19 by the department for administrative purposes. 20 (4) If a cannabis business license application is approved: 21 (a) The canna bis business shall, before it begins operations: 22 1. Submit the initial license fee established in Section 16 of this Act, 23 minus the one hundred dollars ($100) application fee, to the 24 department; and 25 2. If a physical address or the global positioning system coordinates for 26 any cultivation activities had not been finalized when it applied, 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 53 of 141 HB013610.100 - 50 - XXXX GA submit its complete physical address and the global positioning system 1 coordinates for any cultivation activities; and 2 (b) The department shall issue a copy of the license that includes the business's 3 identification number. The department shall also provide each licensed 4 dispensary with contact and access information for the electronic 5 monitoring system established pursuant to Section 41 of this Act. 6 SECTION 18. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 7 TO READ AS FOLLOWS: 8 (1) The department shall: 9 (a) Acknowledge receipt of an application for a cannabis business license 10 within fifteen (15) days of receipt; and 11 (b) Provide notification t o the cannabis business license applicant as to whether 12 the application for a cannabis business license has been approved or denied 13 within forty -five (45) days of receiving a completed application. 14 (2) (a) The department shall deny an application for a can nabis business license if: 15 1. The applicant failed to submit the materials required by Section 17 of 16 this Act, including if the applicant's plans do not satisfy the security, 17 oversight, or recordkeeping administrative regulations promulgated by 18 the departm ent pursuant to Section 28 of this Act; 19 2. The applicant provided false or falsified information on the licensure 20 application; 21 3. The applicant would not be in compliance with local cannabis 22 business prohibitions enacted pursuant to Section 26 of this Act; 23 4. The applicant does not meet, or in the opinion of the department is 24 unlikely to meet, the requirements for cannabis businesses established 25 in Section 19 of this Act; 26 5. One (1) or more of the prospective principal officers or board 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 54 of 141 HB013610.100 - 50 - XXXX GA members: 1 a. Has been convicted of a disqualifying felony offense, the 2 provisions of KRS 335B.020 and 335B.030 notwithstanding; 3 b. Has served as a principal officer or board member for a 4 cannabis business that has had its license revoked; 5 c. Is younger than twenty -one (21) yea rs of age; or 6 d. Is a medicinal cannabis practitioner authorized by a state 7 licensing board to provide patients with written certifications; or 8 6. a. For a safety compliance facility, one (1) or more of the 9 prospective principal officers or board members i s a principal 10 officer or board member of a cultivator, processor, producer, or 11 dispensary licensed to operate in Kentucky; or 12 b. For a cultivator, processor, producer, or dispensary, one (1) or 13 more of the prospective principal officers or board members is a 14 principal officer or board member of a safety compliance facility 15 licensed to operate in Kentucky. 16 (b) The department may deny an application for a cannabis business license for 17 any reason that the department, in the exercise of sound discretion, deems 18 sufficient. 19 (3) The department shall notify the applicant in writing of a license denial and 20 reasons by registered or certified mail at the address given in the application or 21 supplement. Except for license denials based upon subsection (2)(a) of this 22 section, the applicant may, within thirty (30) days after the mailing of the 23 department's notice, file a written request for an administrative hearing on the 24 application. The hearing shall be conducted on the application in compliance 25 with the requirements of KRS Chapter 13B. 26 (4) Final orders of the department after administrative hearings shall be subject to 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 55 of 141 HB013610.100 - 50 - XXXX GA judicial review as provided in KRS 13B.140. Jurisdiction and venue for judicial 1 review are vested in the Circuit Court of the county in which the applican t's 2 business would be located. 3 SECTION 19. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 4 TO READ AS FOLLOWS: 5 (1) A cannabis business licensed under this chapter shall: 6 (a) Comply with Sections 1 to 30 of this Act and any administrative regulations 7 promulgated thereunder by the department; 8 (b) Conduct a criminal background check into the criminal history of each 9 person seeking to become a principal officer, board member, agen t, 10 volunteer, or employee before that person begins work. A cannabis business 11 shall not employ, accept as a volunteer, or have as a board member, 12 principal officer, or agent any person who: 13 1. Was convicted of a disqualifying felony offense; or 14 2. Is under twenty -one (21) years of age; 15 (c) Implement appropriate security measures required pursuant to 16 administrative regulations promulgated by the department in accordance 17 with Section 28 of this Act to deter and prevent the theft or diversion of 18 medicinal cann abis and unauthorized entrance into areas containing 19 medicinal cannabis; 20 (d) Display its license on the premises in a conspicuous place and manner at all 21 times; and 22 (e) Only acquire, possess, cultivate, process, manufacture, deliver, transfer, 23 transport, s upply, sell, or dispense medicinal cannabis: 24 1. For the purposes of distributing medicinal cannabis to cardholders 25 who possess a valid registry identification card issued by the 26 department, or for visiting qualified patients, a valid out -of-state 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 56 of 141 HB013610.100 - 50 - XXXX GA registry identification card; and 1 2. Cultivated and processed by a cannabis business licensed under 2 Sections 16, 17, and 18 of this Act. 3 (2) A cannabis business licensed under Sections 16, 17, and 18 of this Act this 4 chapter shall not: 5 (a) Be located within one thousand (1,000) feet of an elementary or secondary 6 school or a day -care center; 7 (b) Acquire, possess, cultivate, process, manufacture, deliver, transfer, 8 transport, supply, dispense, or sell: 9 1. Raw plant material with a delta -9 tetr ahydrocannabinol content of 10 more than thirty -five percent (35%); 11 2. Medicinal cannabis products intended for oral consumption as an 12 edible, oil, or tincture with more than ten (10) milligrams of delta -9 13 tetrahydrocannabinol per serving; 14 3. Any medicinal ca nnabis product not described in subparagraph 1. or 15 2. of this paragraph with a delta -9 tetrahydrocannabinol content of 16 more than seventy percent (70%); 17 4. Any medicinal cannabis product that contains vitamin E acetate; or 18 5. Medicinal cannabis cultivated, processed, or manufactured in another 19 state; 20 (c) Permit a person under eighteen (18) years of age to enter or remain on the 21 premises of a cannabis business; 22 (d) Permit a person who is not a cardholder to enter or remain on the premises 23 of a cannabis busine ss, except in accordance with subsection (6) of this 24 section; 25 (e) Employ, have as a board member, or be owned by, in part or in whole, a 26 medicinal cannabis practitioner authorized by a state licensing board to 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 57 of 141 HB013610.100 - 50 - XXXX GA provide patients with written certifications; or 1 (f) Advertise medicinal cannabis sales in print, broadcast, online, by paid in - 2 person solicitation of customers, or by any other advertising device as 3 defined in KRS 177.830, except that this paragraph shall not prevent 4 appropriate signs on the property of a licensed cannabis business, listings in 5 business directories including phone books, listings in trade or medical 6 publications, or sponsorship of health or not -for-profit charity or advocacy 7 events. 8 (3) The operating documents of a cannabis business s hall include procedures for its 9 oversight and procedures to ensure accurate recordkeeping and inventory control 10 in accordance with administrative regulations promulgated by the department 11 pursuant to Section 28 of this Act. 12 (4) When transporting medicinal cannabis on behalf of a licensed cannabis business, 13 a cannabis business agent shall have: 14 (a) A copy of the cannabis business license for the business that employs the 15 agent; 16 (b) Documentation that specifies the amount of medicinal cannabis being 17 transport ed and the date on which it is being transported; and 18 (c) The cannabis business license number and a working telephone number for 19 any other cannabis business receiving or otherwise involved in the 20 transportation of the medicinal cannabis. 21 (5) The cultivati on of medicinal cannabis for cannabis businesses licensed in this 22 state shall only be done by cultivators and producers licensed under this chapter 23 and shall take place in an enclosed, locked facility which can be accessed by only 24 cannabis business agents working on behalf of the cultivator or producer at the 25 physical address or global positioning system coordinates provided to the 26 department during the license application process. 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 58 of 141 HB013610.100 - 50 - XXXX GA (6) A person who is at least eighteen (18) years of age but not a cardholder may be 1 allowed to enter and remain on the premises of a cannabis business if: 2 (a) The person is present at the cannabis business to perform contract work, 3 including but not limited to electrical, plumbing, or security maintenance, 4 that does not involve ha ndling medicinal cannabis; or 5 (b) The person is a government employee and is at the cannabis business in the 6 course of his or her official duties. 7 SECTION 20. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 8 TO READ AS FOLLO WS: 9 (1) Cannabis businesses shall be subject to reasonable inspection by the department 10 pursuant to the department's procedures and administrative regulations. The 11 department may inspect any licensed cannabis business premises without having 12 to first obtai n a search warrant. 13 (2) (a) Except as provided in Section 22 of this Act, the department may issue a 14 civil fine of up to three thousand dollars ($3,000) to a cannabis business for 15 a violation of Sections 1 to 30 of this Act or any administrative regulation 16 promulgated thereunder. All fines collected pursuant to this subsection 17 shall be forwarded to the medicinal cannabis trust fund established in 18 Section 31 of this Act. 19 (b) The department may, on its own motion or on complaint and after 20 investigation, suspe nd or revoke a cannabis business license for multiple 21 violations or a serious violation of Sections 1 to 30 of this Act or any 22 administrative regulations promulgated thereunder by the licensee or any of 23 its agents. A suspension shall not be for a period of time longer than six (6) 24 months. 25 (c) The department shall, via certified mail, provide a written notice of license 26 suspension, revocation, fine to the cannabis business at the address on the 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 59 of 141 HB013610.100 - 50 - XXXX GA license. 1 (3) Subsection (2) of this section notwithstanding, the department shall not suspend 2 or revoke a cannabis business's license or impose a civil fine without first 3 providing the cannabis business with the opportunity for an administrative 4 hearing at which the ca nnabis business is afforded an opportunity to appear and 5 be heard pursuant to KRS Chapter 13B. A cannabis business may, within thirty 6 (30) days after the mailing of a written notice required by subsection (2)(c) of this 7 section, file a written request for an administrative hearing regarding the 8 suspension, revocation, or fine. If a cannabis business requests an administrative 9 hearing, prior to the disposition of the administrative hearing, the cannabis 10 business shall be allowed to operate as normally permit ted by Sections 1 to 30 of 11 this Act. 12 (4) Final orders of the department after administrative hearings shall be subject to 13 judicial review. Jurisdiction and venue for judicial review are vested in the 14 Circuit Court of the county in which the cannabis busine ss is physically located. 15 (5) Under a suspended license: 16 (a) A cultivator may continue to cultivate and possess cannabis plants, but it 17 shall not transfer or sell medicinal cannabis during a suspension; 18 (b) A dispensary may continue to possess its existin g medicinal cannabis 19 inventory, but it shall not acquire additional medicinal cannabis, or 20 dispense, transfer, or sell medicinal cannabis to any cardholder or any 21 other cannabis business; 22 (c) A processor may continue to process and possess its existing med icinal 23 cannabis inventory, but it shall not acquire additional medicinal cannabis, 24 or dispense, transfer, or sell medicinal cannabis products to any other 25 cannabis business; 26 (d) A producer may continue to cultivate, process, and possess cannabis plants 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 60 of 141 HB013610.100 - 50 - XXXX GA and its existing medicinal cannabis inventory, but it shall not acquire 1 additional medicinal cannabis, or dispense, transfer, or sell medicinal 2 cannabis to any other cannabis business; and 3 (e) A safety compliance facility may continue to possess medicinal can nabis, 4 but it shall not receive any new medicinal cannabis, test or otherwise 5 analyze medicinal cannabis, or transfer or transport medicinal cannabis. 6 SECTION 21. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 7 TO READ AS F OLLOWS: 8 (1) A cultivator or cultivator agent acting on behalf of a cultivator shall not be 9 subject to prosecution under state or local law, to search or inspection except by 10 the department pursuant to Section 20 of this Act, to seizure or penalty in any 11 manner, or be denied any right or privilege, including but not limited to civil 12 penalty or disciplinary action by a court or business licensing board, for acting 13 pursuant to Sections 1 to 30 of this Act and the department's administrative 14 regulations promulg ated thereunder for: 15 (a) Acquiring, possessing, planting, cultivating, raising, harvesting, trimming, 16 or storing cannabis seeds, seedlings, plants, or raw plant material; 17 (b) Delivering, transporting, transferring, supplying, or selling raw plant 18 material or related supplies to other licensed cannabis businesses in this 19 state; or 20 (c) Selling cannabis seeds or seedlings to similar entities that are licensed to 21 cultivate cannabis in this state or in any other jurisdiction. 22 (2) Cultivators and cultivator agent s acting on behalf of a cultivator shall: 23 (a) Only deliver raw plant material to a licensed processor, licensed producer, 24 licensed safety compliance facility, or licensed dispensary for fair market 25 value; 26 (b) Only deliver raw plant material to a licensed d ispensary, processor, or 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 61 of 141 HB013610.100 - 50 - XXXX GA producer after it has been checked by a safety compliance facility agent for 1 cannabinoid contents and contaminants in accordance with administrative 2 regulations promulgated by the department; 3 (c) Not supply a dispensary with more t han the amount of raw plant material 4 reasonably required by a dispensary; and 5 (d) Not deliver, transfer, or sell raw plant material with a delta -9 6 tetrahydrocannabinol content of more than thirty -five percent (35%) to a 7 licensed dispensary, processor, or p roducer. 8 (3) (a) A Tier I cultivator shall not exceed an indoor growth area of two thousand 9 five hundred (2,500) square feet. 10 (b) A Tier II cultivator shall not exceed an indoor growth area of ten thousand 11 (10,000) square feet. 12 (c) A Tier III cultivator sh all not exceed an indoor growth area of twenty -five 13 thousand (25,000) square feet. 14 (d) A Tier IV cultivator shall not exceed an indoor growth area of fifty 15 thousand (50,000) square feet. 16 SECTION 22. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 17 TO READ AS FOLLOWS: 18 (1) A dispensary or dispensary agent acting on behalf of a dispensary shall not be 19 subject to prosecution under state or local law, to search or inspection except by 20 the department pursuant to Section 20 of this Act, to seizure or penalty in any 21 manner, or be denied any right or privilege, including but not limited to a civil 22 penalty or disciplinary action by a court or business licensing board, for acting 23 pursuant to Sections 1 to 30 of this Act and the departmen t's administrative 24 regulations promulgated thereunder for: 25 (a) Acquiring or possessing medicinal cannabis from a cultivator, processor, or 26 producer in this state; 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 62 of 141 HB013610.100 - 50 - XXXX GA (b) Acquiring or possessing medicinal cannabis accessories or educational 1 material; 2 (c) Supplying, selling, dispensing, distributing, or delivering medicinal 3 cannabis, medicinal cannabis accessories, and educational material to 4 cardholders or other licensed dispensaries; 5 (d) Selling cannabis seeds to an entity that are licensed to cultivate c annabis in 6 this state or in any other jurisdiction; or 7 (e) Acquiring, accepting, or receiving medicinal cannabis products from a 8 cardholder, except that a dispensary may not offer anything of monetary 9 value in return for medicinal cannabis received from a cardholder. Any 10 medicinal cannabis received by a dispensary under this paragraph or 11 pursuant to Section 14 of this Act shall be destroyed by the dispensary or its 12 agents and shall not be sold, dispensed, or distributed to another 13 cardholder. 14 (2) A dispensa ry or dispensary agent acting on behalf of a dispensary shall: 15 (a) Maintain records that include specific notations of the type and quantity of 16 medicinal cannabis products being dispensed to a cardholder and whether it 17 was dispensed directly to a registere d qualified patient, a visiting qualified 18 patient, or a registered qualified patient's designated caregiver. Each entry 19 shall include sufficient information to identify the product or products 20 dispensed, the quantity dispensed, and the date and time of the dispensing. 21 The data required to be recorded by this paragraph shall be entered into the 22 electronic monitoring system established pursuant to Section 41 of this Act 23 in accordance with administrative regulations promulgated by the 24 department for the record ing of medicinal cannabis dispensing; 25 (b) Only dispense or sell medicinal cannabis after it has been checked by a 26 safety compliance facility agent for cannabinoid contents and contaminants 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 63 of 141 HB013610.100 - 50 - XXXX GA in accordance with administrative regulations promulgated by the 1 department; 2 (c) Only dispense or sell medicinal cannabis to a cardholder after making a 3 good faith, reasonable effort to verify: 4 1. That the registry identification card or, for visiting qualified patients, 5 the out -of-state registry identification card prese nted to the dispensary 6 is valid, including by checking the verification system, if it is 7 operational, or other department -designated databases; 8 2. That the person presenting the registry identification card or, for 9 visiting qualified patients, the out -of-state registry identification card 10 is at least eighteen (18) years of age and is the person identified on the 11 card by examining at least one (1) other form of government -issued 12 photo identification; 13 3. That the person presenting the registry identification card has 14 consulted with a pharmacist as required by Section 10 of this Act; 15 4. The amount of medicinal cannabis the person is legally permitted to 16 purchase pursuant to subsection (4) of Section 4 of this Act at the time 17 of verification by checking the elec tronic monitoring system 18 established pursuant to Section 41 of this Act; and 19 5. For a visiting qualified patient who presents an out -of-state registry 20 identification card, that the visiting qualified patient has not 21 purchased medicinal cannabis in this sta te during the current 22 calendar year by checking the electronic monitoring system 23 established pursuant to Section 41 of this Act; 24 (d) Require a visiting qualified patient who presents a valid out -of-state registry 25 identification card to sign a statement att esting to the fact that the visiting 26 qualified patient has been diagnosed with a disease or medical condition 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 64 of 141 HB013610.100 - 50 - XXXX GA included on the list of qualifying medical conditions established by the 1 department; 2 (e) Not acquire, possess, dispense, sell, offer for sale, tra nsfer, or transport: 3 1. Raw plant material with a delta -9 tetrahydrocannabinol content of 4 more than thirty -five percent (35%); 5 2. Medicinal cannabis products intended for oral consumption as an 6 edible, oil, or tincture with more than ten (10) milligrams of delta -9 7 tetrahydrocannabinol per serving; 8 3. Any medicinal cannabis product not described in subparagraph 1. or 9 2. of this paragraph with a delta -9 tetrahydrocannabinol content of 10 more than seventy percent (70%); or 11 4. Any medicinal cannabis product that contains vitamin E acetate; 12 (f) Not acquire medicinal cannabis from any person other than a cannabis 13 business licensed under Sections 16, 17, and 18 of this Act or an agent 14 thereof, or a registered qualified patient or a designated caregiver as 15 provided fo r in Section 14 of this Act; 16 (g) Not sell or dispense medicinal cannabis products intended for consumption 17 by vaporizing to a cardholder who is less than twenty -one (21) years of age; 18 (h) Not dispense or sell medicinal cannabis to a minor; 19 (i) Not dispense or sell more medicinal cannabis to a cardholder than he or she 20 is legally permitted to purchase at the time of the transaction; and 21 (j) Not rent office space to a medicinal cannabis practitioner. 22 (3) A dispensary shall be required to establish and maintai n a cannabis consultation 23 agreement, as described in Section 10 of this Act and any administrative 24 regulation promulgated thereunder, with a pharmacist authorized by the 25 Kentucky Board of Pharmacy to enter into a cannabis consultation agreement 26 with a disp ensary. 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 65 of 141 HB013610.100 - 50 - XXXX GA (4) (a) A dispensary may operate a delivery service for cardholders and may deliver 1 medicinal cannabis, medicinal cannabis accessories, and educational 2 material to cardholders at the address identified on the cardholder's registry 3 identification. 4 (b) All delivery services operated or offered by a dispensary shall comply with 5 administrative regulations promulgated by the department pursuant to this 6 section and Section 28 of this Act. 7 (5) If a dispensary fails to comply with subsection (2)(c) of this section, the 8 department may issue the dispensary a civil fine of up to fifty thousand dollars 9 ($50,000), except that the fine shall be one hundred thousand dollars ($100,000) 10 if the person purc hasing or attempting to purchase medicinal cannabis is a 11 minor. All fines collected pursuant to this subsection shall be forwarded to the 12 medicinal cannabis trust fund established in Section 31 of this Act. 13 (6) If a dispensary or dispensary agent fails to comply with subsection (2)(c), (d), (e), 14 (f), or (g) of this section, the dispensary and dispensary agent are liable in a civil 15 action for compensatory and punitive damages and reasonable attorney's fees to 16 any person or the representative of the estate of any person who sustains injury, 17 death, or loss to person or property as a result of the failure to comply. In any 18 action under this subsection, the court may also award any injunctive or 19 equitable relief that the court considers appropriate. 20 SECTION 23. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 21 TO READ AS FOLLOWS: 22 (1) A processor or processor agent acting on behalf of a processor shall not be 23 subject to prosecution under state or local law, to search or inspection exc ept by 24 the department pursuant to Section 20 of this Act, to seizure or penalty in any 25 manner, or be denied any right or privilege, including but not limited to civil 26 penalty or disciplinary action by a court or business licensing board, for acting 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 66 of 141 HB013610.100 - 50 - XXXX GA pursuan t to Sections 1 to 30 of this Act and the department's administrative 1 regulations promulgated thereunder for: 2 (a) Acquiring or purchasing raw plant material from a cultivator, processor, or 3 producer in this state; 4 (b) Possessing, processing, preparing, man ufacturing, manipulating, blending, 5 preparing, or packaging medicinal cannabis; 6 (c) Transferring, transporting, supplying, or selling medicinal cannabis and 7 related supplies to other cannabis businesses in this state; or 8 (d) Selling cannabis seeds or seedl ings to similar entities that are licensed to 9 cultivate cannabis in this state or in any other jurisdiction. 10 (2) A processor licensed under this section shall not possess, process, produce, or 11 manufacture: 12 (a) Raw plant material with a delta -9 tetrahydroca nnabinol content of more 13 than thirty -five percent (35%); 14 (b) Medicinal cannabis products intended for oral consumption as an edible, 15 oil, or tincture with more than ten (10) milligrams of delta -9 16 tetrahydrocannabinol per serving; 17 (c) Any medicinal cannabis product not described in paragraph (a) or (b) of 18 this subsection with a delta -9 tetrahydrocannabinol content of more than 19 seventy percent (70%); or 20 (d) Any medicinal cannabis product that contains vitamin E acetate. 21 SECTION 24. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 22 TO READ AS FOLLOWS: 23 (1) A producer or producer agent acting on behalf of a producer shall not be subject 24 to prosecution under state or local law, to search or inspection except by the 25 department pursuan t to Section 20 of this Act, to seizure or penalty in any 26 manner, or be denied any right or privilege, including but not limited to civil 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 67 of 141 HB013610.100 - 50 - XXXX GA penalty or disciplinary action by a court or business licensing board, for acting 1 pursuant to Sections 1 to 30 of this Act and the department's administrative 2 regulations promulgated thereunder for: 3 (a) Acquiring, possessing, planting, cultivating, raising, harvesting, trimming, 4 or storing cannabis seeds, seedlings, plants, or raw plant material; 5 (b) Delivering, transport ing, transferring, supplying, or selling raw plant 6 material, medicinal cannabis products, or related supplies to other licensed 7 cannabis businesses in this state; 8 (c) Selling cannabis seeds or seedlings to similar entities that are licensed to 9 cultivate ca nnabis in this state or in any other jurisdiction; 10 (d) Acquiring or purchasing raw plant material from a cultivator in this state; 11 or 12 (e) Possessing, processing, preparing, manufacturing, manipulating, blending, 13 preparing, or packaging medicinal cannabis; 14 (2) Producers and producer agents acting on behalf of a producer shall: 15 (a) Only deliver raw plant material to a licensed processor, licensed producer, 16 licensed safety compliance facility, or licensed dispensary for fair market 17 value; 18 (b) Only deliver raw plant material to a licensed dispensary, processor, or 19 producer after it has been checked by a safety compliance facility agent for 20 cannabinoid contents and contaminants in accordance with administrative 21 regulations promulgated by the department; 22 (c) Not supply a dispensary with more than the amount of raw plant material 23 reasonably required by a dispensary; and 24 (d) Be limited to an indoor cannabis growth area of fifty thousand (50,000) 25 square feet. 26 (3) A producer licensed under this section shall not posse ss, process, produce, or 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 68 of 141 HB013610.100 - 50 - XXXX GA manufacture: 1 (a) Raw plant material with a delta -9 tetrahydrocannabinol content of more 2 than thirty -five percent (35%); 3 (b) Medicinal cannabis products intended for oral consumption as an edible, 4 oil, or tincture with more than ten (10) milligrams of delta -9 5 tetrahydrocannabinol per serving; 6 (c) Any medicinal cannabis product not described in paragraph (a) or (b) of 7 this subsection with a delta -9 tetrahydrocannabinol content of more than 8 seventy percent (70%); or 9 (d) Any medicinal cannabis product that contains vitamin E acetate. 10 SECTION 25. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 11 TO READ AS FOLLOWS: 12 A safety compliance facility or safety compliance facility agent acting on beha lf of a 13 safety compliance facility shall not be subject to prosecution, search except by the 14 department pursuant to Section 20 of this Act, seizure, or penalty in any manner, or be 15 denied any right or privilege, including but not limited to civil penalty o r disciplinary 16 action by a court or business licensing board, for acting in accordance with Sections 1 17 to 30 of this Act and the department's administrative regulations promulgated 18 thereunder to provide the following services: 19 (1) Acquiring or possessing m edicinal cannabis obtained from cardholders or 20 cannabis businesses in this state; 21 (2) Returning the medicinal cannabis to cardholders or cannabis businesses in this 22 state; 23 (3) Transporting medicinal cannabis that was produced by cannabis businesses in 24 this state; 25 (4) The production or sale of approved educational materials related to the use of 26 medicinal cannabis; 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 69 of 141 HB013610.100 - 50 - XXXX GA (5) The production, sale, or transportation of equipment or materials other than 1 medicinal cannabis, including but not limited to lab equipment a nd packaging 2 materials that are used by cannabis businesses and cardholders, to cardholders or 3 cannabis businesses licensed under this chapter; 4 (6) Testing of medicinal cannabis produced in this state, including testing for 5 cannabinoid content, pesticides, mold, contamination, vitamin E acetate, and 6 other prohibited additives; 7 (7) Training cardholders and cannabis business agents. Training may include but 8 need not be limited to: 9 (a) The safe and efficient cultivation, harvesting, packaging, labeling, and 10 distribution of medicinal cannabis; 11 (b) Security and inventory accountability procedures; and 12 (c) Up-to-date scientific and medical research findings related to use of 13 medicinal cannabis; 14 (8) Receiving compensation for actions allowed under this section; and 15 (9) Engaging in any non -cannabis -related business activities that are not otherwise 16 prohibited or restricted by state law. 17 SECTION 26. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 18 TO READ AS FOLLOWS: 19 (1) For the purpose s of this section, \"local government\" means a city, county, 20 urban -county government, consolidated local government, charter county 21 government, or unified local government. 22 (2) A local government may: 23 (a) 1. Enact ordinances, not in conflict with Sections 1 to 30 of this Act or 24 with the department's administrative regulations, regulating the time, 25 place, and manner of cannabis business operations, except that a local 26 government shall not enact ordinances that impose an undue burden 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 70 of 141 HB013610.100 - 50 - XXXX GA or make cannabis business operations unreasonable or impractical; 1 and 2 2. Enact an ordinance to assess a local fee on cannabis businesses 3 operating within the jurisdiction of the local government to 4 compensate the local government for any additional public safety 5 impact caused by th e operation of cannabis businesses within the 6 jurisdiction of the local government. Any fee established pursuant to 7 this paragraph shall not exceed the additional public safety impact 8 caused by the operation of cannabis businesses within the jurisdiction 9 of the local government; 10 (b) Prohibit all cannabis business operations within its territory through the 11 passage of an ordinance; or 12 (c) Enact resolutions directing that the question of prohibiting cannabis 13 businesses from operating within its territory be s ubmitted to the voters of 14 its territory at the next regular election pursuant to subsection (4) of this 15 section. 16 (3) If a county, consolidated local government, charter county government, or 17 unified local government prohibits all cannabis business operatio ns, the 18 legislative body of a city located within the county, consolidated local 19 government, charter county government, or unified local government may: 20 (a) Approve cannabis business operations within the limits of the city through 21 the passage of an ordina nce; or 22 (b) Enact resolutions directing that the question of allowing cannabis 23 businesses to operate within the limits of the city be submitted to the voters 24 who are eligible to vote in that city's elections at the next regular election 25 pursuant to subsection (4) of this section. 26 (4) If, not later than the second Tu esday in August preceding the day established for 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 71 of 141 HB013610.100 - 50 - XXXX GA a regular election, the county clerk has received a local government resolution 1 pursuant to subsection (2) or (3) of this section, the county clerk shall have 2 prepared to place before the voters of the affe cted territory at the next regular 3 election the question, which shall be \"Are you in favor of the sale of medicinal 4 cannabis at a licensed dispensary and the operation of other cannabis businesses 5 in (affected territory)? Yes....No....\". The county clerk s hall cause to be published 6 in accordance with KRS Chapter 424, at the same time as the remaining voter 7 information, the full text of the proposal. The county clerk shall cause to be 8 posted in each polling place one (1) copy of the full text of the proposal . 9 (5) (a) If the question submitted to the voters fails to pass, three (3) years shall 10 elapse before the question of medicinal cannabis sales and cannabis 11 business operations may be included on a regular election ballot for the 12 affected territory. 13 (b) If the question submitted to the voters passes, medicinal cannabis sales and 14 cannabis business operations may be conducted in the affected territory, 15 notwithstanding any local government ordinances which prohibit all 16 cannabis business operations within its ter ritory. 17 (6) In circumstances where a county, consolidated local government, charter county 18 government, or unified local government prohibits cannabis business operations 19 but a city within that county, consolidated local government, charter county 20 governmen t, or unified local government approves cannabis business operations 21 either through the adoption of an ordinance or following the affirmative vote of a 22 public question allowing cannabis business operations, then: 23 (a) The cannabis business operations may pr oceed within the limits of the city; 24 and 25 (b) The county, consolidated local government, charter county government, or 26 unified local government may assess an additional reasonable fee to 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 72 of 141 HB013610.100 - 50 - XXXX GA compensate for any additional public safety impact caused by the appro val 1 of cannabis business operations. Any additional fees collected pursuant to 2 this subsection shall not exceed the additional public safety impact caused 3 by the approval of cannabis business operations. 4 (7) In circumstances where both a city and the count y, consolidated local 5 government, charter county government, or unified local government in which 6 the city is located have assessed a local fee on cannabis businesses pursuant to 7 subsection (2) of this section, a cannabis business shall be allowed to credi t any 8 fee paid to the city against fees owed to the county, consolidated local 9 government, charter county government, or unified local government. 10 (8) The provisions of general election law shall apply to public questions submitted to 11 voters under this sec tion. 12 SECTION 27. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 13 TO READ AS FOLLOWS: 14 (1) The department shall maintain a confidential list of the persons to whom the 15 department has issued registry identification cards and their addresses, telephone 16 numbers, and registry identification numbers. 17 (2) The department shall, only at a cardholder's r equest, confirm his or her status as 18 a registered qualified patient, visiting qualified patient, or designated caregiver to 19 a third party, such as a landlord, employer, school, medical professional, or 20 court. 21 (3) The following information received and reco rds kept pursuant Sections 1 to 30 of 22 this Act and any administrative regulations promulgated thereunder shall be 23 confidential and exempt from the Open Records Act, KRS 61.870 to 61.884, and 24 shall not be subject to disclosure to any individual or public or private entity, 25 except as necessary for authorized employees of the department to perform 26 official duties pursuant to Sections 1 to 30 of this Act: 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 73 of 141 HB013610.100 - 50 - XXXX GA (a) Applications and renewals, their contents, and supporting information 1 submitted by qualified patients, visiting qualified patients, and designated 2 caregivers in compliance with Section 11 of this Act, including information 3 regarding their designated caregivers and medicinal cannabis practitioners; 4 (b) The individual names and other information identifying p ersons to whom 5 the department has issued registry identification cards; 6 (c) Any dispensing information required to be kept under Section 22 of this Act 7 or the department's administrative regulations which shall only identify 8 cardholders by their registry i dentification numbers and shall not contain 9 names or other personal identifying information; and 10 (d) Any department hard drives or other data -recording media that are no 11 longer in use and that contain cardholder information. These hard drives 12 and other med ia shall be destroyed after a reasonable time or after the data 13 is otherwise stored. 14 Data subject to this section shall not be combined or linked in any manner with 15 any other list or database maintained by the department or the Cabinet for Health 16 and Fami ly Services and shall not be used for any purpose not provided for in 17 Sections 1 to 30 of this Act. 18 (4) Nothing in this section shall preclude: 19 (a) Notification by the department's employees to state or local law enforcement 20 about suspected falsified or fr audulent information submitted to the 21 department or of other apparently criminal violations of Sections 1 to 30 of 22 this Act; 23 (b) Notification by the department's employees to a state licensing board if the 24 department has reasonable suspicion to believe a m edicinal cannabis 25 practitioner did not have a bona fide practitioner -patient relationship with a 26 patient for whom he or she signed a written certification, that the medicinal 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 74 of 141 HB013610.100 - 50 - XXXX GA cannabis practitioner violated the standard of care, or that the medicinal 1 cannab is practitioner has violated any provision of Sections 1 to 30 of this 2 Act; 3 (c) Notification by dispensary agents to the department of a suspected violation 4 or attempted violation of Sections 1 to 30 of this Act or the administrative 5 regulations promulgate d thereunder; 6 (d) Verification by the department of registry identification cards issued 7 pursuant to Sections 11, 12, and 13 of this Act; and 8 (e) The submission of the report required by Section 3 of this Act to the 9 General Assembly. 10 (5) It shall be a Clas s B misdemeanor for any person, including an employee or 11 official of the department or another state agency or local government, to 12 knowingly breach the confidentiality of information obtained pursuant to 13 Sections 1 to 30 of this Act. 14 SECTION 28. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 15 TO READ AS FOLLOWS: 16 (1) No later than January 1, 2023, the department shall: 17 (a) Ensure that the electronic monitoring system established pursuant to 18 Section 41 of this Act is designed to enable: 19 1. Medicinal cannabis practitioners to record the issuance of written 20 certifications to qualified patients, as required by Section 9 of this Act; 21 2. Pharmacists to perform and record the completion of consultations 22 with cardholders as required under Section 10 of this Act; 23 3. The department and state licensing boards to monitor the issuance of 24 written certifications by medicinal cannabis practi tioners; 25 4. Department personnel, law enforcement personnel, and dispensary 26 agents to verify the validity of registry identification cards issued by 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 75 of 141 HB013610.100 - 50 - XXXX GA the department by entering a registry identification number to 1 determine whether or not the identification number corresponds with 2 a current, valid registry identification card. The system shall only 3 disclose whether the identification card is valid and whether the 4 cardholder is a registered qualified patient, visiting qualified patient, 5 or designated caregiver ; 6 5. Law enforcement personnel and dispensary agents to access medicinal 7 cannabis sales data record by dispensary agents pursuant to Section 8 22 of this Act; 9 6. Dispensary agents to record the amount of medicinal cannabis that is 10 dispensed to a cardholder d uring each transaction as required by 11 Section 22 of this Act; and 12 7. The sharing of dispensing data recorded by dispensary agents 13 pursuant to Section 22 of this Act with all dispensaries in real time; 14 (b) Ensure that the electronic monitoring system establ ished pursuant to 15 Section 41 of this Act is designed to facilitate the tracking of medicinal 16 cannabis from the point of cultivation to the point of sale to cardholders; 17 (c) Promulgate administrative regulations, in accordance with KRS Chapter 18 13A, to estab lish: 19 1. A list of qualifying medical conditions for which medicinal cannabis 20 practitioners may provide a patient with a written certification for the 21 use of medicinal cannabis. The list shall include the following: 22 a. Any type or form of cancer regardless of stage; 23 b. Chronic, severe, intractable, or debilitating pain; 24 c. Epilepsy or any other intractable seizure disorder; 25 d. Multiple sclerosis, muscle spasms, or spasticity; 26 e. Chronic nausea or cyclical vomiting syndrome that has proven 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 76 of 141 HB013610.100 - 50 - XXXX GA resistant to other conventional medical treatments; and 1 f. Post-traumatic stress disorder; 2 2. Procedures for the issuance, renewal, suspension, and revocation of 3 registry identification cards, including the creation of a uniform 4 written certification form and a uniform appl ication form; 5 3. Procedures for the issuance, renewal, suspension, and revocation of 6 cannabis business licenses, including the creation of a uniform 7 licensure application form; 8 4. A convenience fee to be assessed and collected by dispensaries for 9 visiting qualified patients who do not possess a valid registry 10 identification card issued by the department and who purchase 11 medicinal cannabis with a valid out -of-state registry identification 12 card. The convenience fee established pursuant to this subparagraph 13 shall not exceed fifteen dollars ($15) per transaction; 14 5. In collaboration with the Board of Physicians and Advisors, as 15 required by Section 3 of this Act: 16 a. A definition of the amount of medicinal cannabis or delta -9 17 tetrahydrocannabinol that constitutes a ten (10) day maximum 18 allowance and a thirty (30) day maximum allowance of 19 medicinal cannabis for registered qualified patients who are over 20 eighteen (18) years of age; 21 b. A definition of the amount of medicinal cannabis or delta -9 22 tetrahydrocannabinol th at constitutes a ten (10) day maximum 23 allowance and a thirty (30) day maximum allowance of 24 medicinal cannabis for registered qualified patients who are 25 under eighteen (18) years of age; and 26 c. The amount of raw plant material that medicinal cannabis 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 77 of 141 HB013610.100 - 50 - XXXX GA produc ts are considered to be equivalent to; 1 6. Provisions governing the following matters related to cannabis 2 businesses with the goal of protecting against diversion and theft, 3 without imposing any undue burden that would make cannabis 4 business operations unre asonable or impractical or compromising the 5 confidentiality of cardholders: 6 a. Recordkeeping and inventory control requirements that facilitate 7 the tracking of medicinal cannabis from the point of cultivation 8 to the point of sale to cardholders, including the use of the 9 electronic monitoring system established pursuant to Section 41 10 of this Act; 11 b. Procedures for the verification and va lidation of registry 12 identification cards issued by the department and out -of-state 13 registry identification cards; 14 c. Security requirements for safety compliance facilities, 15 processors, producers, dispensaries, and cultivators, which shall 16 include at a min imum lighting, video security, alarm 17 requirements, on -site parking, and measures to prevent loitering; 18 d. Procedures for the secure transportation, including delivery 19 services provided by dispensaries, and storage of medicinal 20 cannabis by cannabis business licensees and their employees or 21 agents; 22 e. Employment and training requirements for licensees and their 23 agents, including requiring each licensee to create an 24 identification badge for each of the licensee's agents or 25 employees; and 26 f. Restrictions on vis its to licensed cultivation and processing 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 78 of 141 HB013610.100 - 50 - XXXX GA facilities, including requiring the use of visitor logs; 1 7. Procedures to establish, publish, and annually update a list of varieties 2 of cannabis that consist of less than five percent (5%) 3 tetrahydrocannabinol; 4 8. A rating system that tracks the terpene content of at least the twelve 5 (12) major terpenoids within each strain of cannabis available for 6 medicinal use within the Commonwealth; 7 9. Requirements for random sample testing of medicinal cannabis to 8 ensure qua lity control, including testing for cannabinoids, terpenoids, 9 residual solvents, pesticides, poisons, toxins, mold, mildew, insects, 10 bacteria, and any other dangerous adulterant; 11 10. Requirements for licensed cultivators, producers, and processors to 12 contr act with an independent safety compliance facility to test the 13 medicinal cannabis before it is sold at a dispensary. The department 14 may approve the safety compliance facility chosen by a cultivator, 15 producer, or processor and require that the safety compli ance facility 16 report test results for a designated quantity of medicinal cannabis to 17 the cultivator, producer, or processor and department; 18 11. Standards for the operation of safety compliance facilities which may 19 include: 20 a. Requirements for equipment; 21 b. Personnel qualifications; and 22 c. Requiring facilities to be accredited by a relevant certifying 23 entity; 24 12. Standards for the packaging and labeling of medicinal cannabis sold 25 or distributed by cannabis businesses which shall comply with 15 26 U.S.C. sec. 14 71 to 1476 and shall include: 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 79 of 141 HB013610.100 - 50 - XXXX GA a. Packaging that requires at least a two (2) step process of initial 1 opening; 2 b. A warning label which may include the length of time it typically 3 takes for the product to take effect, how long the effects of the 4 product typi cally last, and any other information deemed 5 appropriate or necessary by the department; 6 c. The amount of medicinal cannabis the product is considered the 7 equivalent to; 8 d. Disclosing ingredients, possible allergens, and certain bioactive 9 components, inclu ding cannabinoids and terpenoids, as 10 determined by the department; 11 e. A nutritional fact panel; 12 f. Opaque, child -resistant packaging; 13 g. A requirement that all raw plant material packaged or sold in 14 this state be marked or labeled as \"NOT INTENDED FOR 15 CONS UMPTION BY SMOKING\"; 16 h. A requirement that medicinal cannabis products be clearly 17 marked with an identifiable and standardized symbol indicating 18 that the product contains cannabis; 19 i. A requirement that all medicinal cannabis product packaging 20 include an expiration date; and 21 j. A requirement that medicinal cannabis products and their 22 packaging not be visually reminiscent of major brands of edible 23 noncannabis products or otherwise present an attractive 24 nuisance to minors; 25 13. Health and safety requirements for the processing of medicinal 26 cannabis and the indoor cultivation of medicinal cannabis by 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 80 of 141 HB013610.100 - 50 - XXXX GA licensees; 1 14. Restrictions on: 2 a. Additives to medicinal cannabis that are toxic, including vitamin 3 E acetate, or increase the likelihood of addiction; and 4 b. Pesticides, fertilizers, and herbicides used during medicinal 5 cannabis cultivation which pose a threat to human health and 6 safety; 7 15. Standards for the safe processing of medicinal cannabis products 8 created by extracting or concentrating compounds from ra w plant 9 material; 10 16. Standards for determining the amount of unprocessed raw plant 11 material that medicinal cannabis products are considered the 12 equivalent to; 13 17. Restrictions on advertising, marketing, and signage in regard to 14 operations or establishment s owned by licensees necessary to prevent 15 the targeting of minors; 16 18. The requirement that evidence -based educational materials regarding 17 dosage and impairment be disseminated to cardholders who purchase 18 medicinal cannabis products; 19 19. Policies governing insurance requirements for cultivators, 20 dispensaries, processors, producers, and safety compliance facilities; 21 20. The process by which the Board of Physicians and Advisors will 22 recommend to the department the inclusion of additional diseases and 23 medical conditions on the approved list of qualifying medical 24 conditions for which a medicinal cannabis practitioner may provide a 25 patient with a written certification for the use of medicinal cannabis, 26 including the process by which an individual may petition the board to 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 81 of 141 HB013610.100 - 50 - XXXX GA recommend the inclusion of a disease or medical condition; and 1 21. A form to be signed by visiting qualified patients who use a valid out - 2 of-state registry identification card to purchase medicinal cannabis in 3 this state that indicates that the v isiting qualified patient has been 4 diagnosed with a disease or medical condition that is included on the 5 list of qualifying medical conditions established by the department; 6 and 7 22. Standards, procedures, or restrictions that the department deems 8 necessary to ensure the efficient, transparent, and safe operation of 9 the medicinal cannabis program, including procedures for the 10 submission of complaints from individual citizens of the 11 Commonwealth regarding potential or suspected violations of Sections 12 1 to 30 of this Act or any administrative regulation promulgated 13 thereunder by a licensed cannabis business. 14 (2) When promulgating administrative regulations under Sections 1 to 30 of this Act, 15 the department: 16 (a) Shall consider standards, procedures, and restrict ions that have been found 17 to be best practices relative to the use and regulation of medicinal cannabis; 18 and 19 (b) Shall not promulgate any administrative regulation that would impose an 20 undue burden or make cannabis business operations unreasonable or 21 impra ctical. 22 (3) No later than July 1, 2023, the department shall: 23 (a) In collaboration with the Board of Physicians and Advisors established in 24 Section 3 of this Act, develop medicinal cannabis dosing guidelines to be 25 used by medicinal cannabis practitioners w hen providing patients with 26 medicinal cannabis dosing recommendations. Guidelines developed 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 82 of 141 HB013610.100 - 50 - XXXX GA pursuant to this paragraph shall be: 1 1. Regularly updated as additional scientific information on the use of 2 medicinal cannabis become available; 3 2. Made publicly a vailable on the department's Web site; and 4 3. Distributed to all medicinal cannabis practitioners who are authorized 5 to provide written certifications for the use of medicinal cannabis; and 6 (b) Develop and implement a biennial accreditation process, includ ing minimal 7 performance standards, based on evolving continuous quality improvement 8 metrics to ensure best -practice standards. Pursuant to Section 16 of this 9 Act, the renewal of cannabis business licenses shall be contingent upon 10 successfully achievement o f minimal performance standards established by 11 the department. 12 (4) If a need for additional cannabis cultivation in this state is demonstrated by 13 cannabis businesses or the department's own analysis, the department may, 14 through the promulgation of administ rative regulations, increase the cultivation 15 area square footage limits for either cultivators or producers, or both by up to 16 three (3) times the limits established in Sections 21 and 24 of this Act. Any 17 increase in the cultivation square footage limits ad opted by the department 18 pursuant to this section shall not result in an increase in the licensure application 19 or renewal fees established in Section 16 of this Act. 20 (5) The department shall not restrict or limit methods of delivery, use, or 21 consumption of medicinal cannabis or the types of products that may be 22 acquired, produced, processed, possessed, sold, or distributed by a cannabis 23 business except as provided in: 24 (a) Subsection (1)(g) of Section 6 of this Act; 25 (b) Subsection (2)(b) of Section 19 of thi s Act; 26 (c) Subsection (2)(e) of Section 22 of this Act; 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 83 of 141 HB013610.100 - 50 - XXXX GA (d) Subsection (2) of Section 23 of this Act; 1 (e) Subsection (3) of Section 24 of this Act; and 2 (f) Subsection (1)(c)9., 12.,14., and 15. of this section. 3 (6) Notwithstanding any p rovision of law to the contrary, an administrative 4 regulation promulgated pursuant to subsection (1)(c)1. of this section shall not 5 take effect until April 16 of the year following the year in which it was 6 promulgated and shall not take effect if in the in tervening time between the date 7 on which it was promulgated and April 16 of the following year, the General 8 Assembly acts to prohibit the inclusion of a disease or medical condition that is 9 included in the administrative regulation on the list of approved medical 10 conditions for which a medicinal cannabis practitioner may provide a patient 11 with a written certification for the use of medicinal cannabis. 12 SECTION 29. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 13 TO READ AS FOL LOWS: 14 Nothing in Sections 1 to 30 of this Act shall require a government medical assistance 15 program, private health insurer or workers' compensation carrier, or self -funded 16 employer providing workers' compensation benefits to reimburse a person for costs 17 associated with the use of medicinal cannabis. 18 SECTION 30. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 19 TO READ AS FOLLOWS: 20 The provisions of KRS 138.870 to 138.889 shall not apply to any individual or entity 21 for: 22 (1) Any amount of medicinal cannabis that is necessary or reasonably necessary for 23 use of a license or registry identification card issued pursuant to Sections 1 to 30 24 of this Act; or 25 (2) Any use of medicinal cannabis that complies with Sections 1 to 30 of this A ct and 26 any administrative regulations promulgated thereunder. 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 84 of 141 HB013610.100 - 50 - XXXX GA SECTION 31. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 1 TO READ AS FOLLOWS: 2 (1) The medicinal cannabis trust fund is hereby created within the State Treasury . 3 The fund shall consist of funds collected from registration fees, licensing fees, 4 fines, and penalties established pursuant to Sections 1 to 30 of this Act, excluding 5 Section 27 of this Act, and any administrative regulations promulgated 6 thereunder, a po rtion of the excise taxes imposed under Section 33 of this Act, 7 and any proceeds from grants, contributions, appropriations, or other moneys 8 made available for purposes of this fund. 9 (2) The medicinal cannabis trust fund shall be administered by the Financ e and 10 Administration Cabinet. 11 (3) The Finance and Administration Cabinet shall, no later than the fifteenth 12 calendar day of each calendar quarter, distribute the funds deposited into the 13 medicinal cannabis trust fund during the immediately preceding calend ar 14 quarter. Trust fund moneys shall be distributed as follows: 15 (a) Sixty percent (60%) shall be transferred to the Department for Public 16 Health to offset the department's actual cost and expenses for operating the 17 medicinal cannabis program and enforcement activities established in 18 Sections 1 to 30 of this Act; 19 (b) Two and one -half percent (2.5%) shall be transferred to the Department 20 For Public Health for the purpose of developing, implementing, and 21 administering a grant program to further education and sc ientific and 22 clinical research on the use of medicinal cannabis; 23 (c) Thirteen and three -quarters percent (13.75%) shall be transferred to the 24 Office of Drug Control Policy, as established in KRS 15A.020, for the 25 purpose of developing, implementing, and adm inistering a grant program 26 for city and county law enforcement agencies to enforce medicinal cannabis 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 85 of 141 HB013610.100 - 50 - XXXX GA laws, hire and train additional drug recognition experts (DRE), and provide 1 advanced roadside impaired driving enforcement (ARIDE) training; 2 (d) Thirteen and three -quarters percent (13.75%) shall be returned equally to 3 dispensaries for the use of indigent persons who are registered qualified 4 patients enrolled in Medicaid, receiving Supplemental Security Income or 5 Social Security disability insurance, or vet erans of the United States Armed 6 Forces; and 7 (e) The remaining ten percent (10%) shall be retained by the Finance and 8 Administration Cabinet in the fund to cover any additional administrative 9 costs that the Department for Public Health may incur related to its 10 operational and enforcement responsibilities as established in Sections 1 to 11 30 of this Act. If the department is able to demonstrate to the Finance and 12 Administration Cabinet a need for any portion of the retained funds, the 13 Finance and Administratio n Cabinet shall distribute the additional funds 14 for which the department has demonstrated need no later than the fifteenth 15 calendar day of the next calendar quarter. If the department cannot 16 demonstrate a need for the additional funding described in this p aragraph, 17 the retained funds shall be equally divided between the grant programs and 18 the indigent patient program described in paragraphs (b), (c), and (d) of this 19 subsection at the close of each fiscal year. 20 (4) Notwithstanding KRS 45.229, moneys in the f und not expended at the close of the 21 fiscal year shall not lapse but shall be equally divided between the grant 22 programs and the indigent patient program described in subsection (3)(b), (c), 23 and (d) of this section. 24 (5) Any interest earnings of the trust f und shall become part of the fund and shall 25 not lapse. 26 (6) Moneys transferred to the fund are hereby appropriated for the purposes set forth 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 86 of 141 HB013610.100 - 50 - XXXX GA in this section. 1 SECTION 32. A NEW SECTION OF KRS CHAPTER 218A IS CREATED 2 TO RE AD AS FOLLOWS: 3 (1) The local medicinal cannabis trust fund is hereby created within the State 4 Treasury. The fund shall consist of funds collected from a portion of the excise 5 taxes imposed under Section 33 of this Act. 6 (2) The local medicinal cannabis trus t fund shall be administered by the Finance 7 and Administration Cabinet. 8 (3) The Finance and Administration Cabinet shall, no later than the fifteenth 9 calendar day of each calendar quarter, distribute the funds deposited into the 10 local medicinal cannabis tr ust fund during the calendar quarter immediately 11 preceding the most recent calendar quarter. Funds shall be distributed among 12 those cities and counties in which at least one (1) cannabis business licensed as a 13 cultivator, dispensary, processor, or producer operated during the calendar 14 quarter immediately preceding the most recent calendar quarter as follows: 15 (a) The funds deposited into the local medicinal cannabis trust fund during the 16 calendar quarter immediately preceding the most recent calendar quarter 17 shall be divided into two (2) equal parts; 18 (b) One-half (1/2) of the funds deposited into the local medicinal cannabis trust 19 fund during the calendar quarter immediately preceding the most recent 20 calendar quarter shall be distributed to cities and countie s in which at least 21 one (1) cannabis business licensed as a cultivator, processor, or producer 22 operated during the calendar quarter immediately preceding the most recent 23 calendar quarter as follows: 24 1. a. A city in which at least one (1) cannabis business licensed as a 25 cultivator, processor, or producer operated during the calendar 26 quarter immediately preceding the most recent calendar quarter 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 87 of 141 HB013610.100 - 50 - XXXX GA shall receive an amount equal to seven and one -half percent 1 (7.5%) of the total excise tax revenue collected from a ll cannabis 2 businesses licensed to operate inside the territory of the city 3 during the calendar quarter immediately preceding the most 4 recent calendar quarter; or 5 b. If the county in which the city is located has prohibited the 6 operation of cannabis businesses, then the city shall receive an 7 amount equal to ten percent (10%) of the total excise tax revenue 8 collected from all cannabis businesses licensed to operate insi de 9 the territory of the city during the calendar quarter immediately 10 preceding the most recent calendar quarter; and 11 2. A county that has not prohibited the operation of cannabis businesses, 12 pursuant to Section 26 of this Act, and in which at least one (1) 13 cannabis business licensed as a cultivator, processor, or producer 14 operated during the calendar quarter immediately preceding the most 15 recent calendar quarter shall receive an amount equal to: 16 a. Ten percent (10%) of the total excise tax revenue collected from 17 all cannabis businesses licensed to operate within the territory of 18 the county, but outside the territory of any city in that county, 19 during the calendar quarter immediately preceding the most 20 recent calendar quarter; and 21 b. Two and one -half percent (2.5%) of the total excise tax revenue 22 collected from all cannabis businesses licensed to operate inside 23 the territory of an incorporated municipality inside the territory 24 of the county during the calendar quarter immediately preceding 25 the most recent cale ndar quarter; and 26 (c) The other one -half (1/2) of the funds deposited into the local medicinal 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 88 of 141 HB013610.100 - 50 - XXXX GA cannabis trust fund during the calendar quarter immediately preceding the 1 most recent calendar quarter shall be distributed to cities and counties in 2 which at le ast one (1) cannabis business licensed as a dispensary was 3 operated during the calendar quarter immediately preceding the most recent 4 calendar quarter as follows: 5 1. a. A city in which at least one (1) cannabis business licensed as a 6 dispensary operated du ring the calendar quarter immediately 7 preceding the most recent calendar quarter shall receive a 8 percentage of the funds described in this subparagraph equal to 9 seventy -five percent (75%) of the city's proportionate share of 10 gross receipts derived from the retail sales of medicinal cannabis 11 products by licensed dispensaries in the territory of that city 12 divided by the total statewide retail sales of medicinal cannabis 13 products by all licensed dispensaries in the state during the 14 calendar quarter immediately preceding the most recent 15 calendar quarter; or 16 b. If the county in which the city is located has prohibited the 17 operation of cannabis businesses, then the city shall receive a 18 percentage of the funds described in this subparagraph equal to 19 one hundred per cent (100%) of the city's proportionate share of 20 gross receipts derived from the retail sales of medicinal cannabis 21 products by licensed dispensaries in the territory of that city 22 divided by the total statewide retail sales of medicinal cannabis 23 products b y all licensed dispensaries in the state during the 24 calendar quarter immediately preceding the most recent 25 calendar quarter; and 26 2. A county that has not prohibited the operation of cannabis businesses, 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 89 of 141 HB013610.100 - 50 - XXXX GA pursuant to Section 26 of this Act, and in which at l east one (1) 1 cannabis business licensed as a dispensary operated during the 2 calendar quarter immediately preceding the most recent calendar 3 quarter shall receive a percentage of the funds described in this 4 subparagraph equal to: 5 a. One hundred percent (100 %) of the county's proportionate share 6 of gross receipts derived from the retail sales of medicinal 7 cannabis products by licensed dispensaries within the territory of 8 that county, but outside the territory of any city in that county, 9 divided by the total s tatewide retail sales of medicinal cannabis 10 products by all licensed dispensaries in the state during the 11 calendar quarter immediately preceding the most recent 12 calendar quarter; and 13 b. A percentage of the funds described in this subparagraph equal 14 to twen ty-five percent (25%) of the proportionate share of gross 15 receipts derived from the retail sales of medicinal cannabis 16 products by licensed dispensaries within the territory of all cities 17 in the county divided by the total statewide retail sales of 18 medicin al cannabis products by all licensed dispensaries in the 19 state during the calendar quarter immediately preceding the 20 most recent calendar quarter. 21 (4) Trust fund moneys may be used for the purposes of local enforcement of 22 medicinal cannabis laws by local l aw enforcement agencies, local medicinal 23 cannabis licensing, the hiring or training of additional drug recognition experts 24 (DRE), advanced roadside impaired driving enforcement (ARIDE) training, local 25 evidence -based drug addiction rehabilitation projects, or educational activities 26 within local jails. 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 90 of 141 HB013610.100 - 50 - XXXX GA (5) Notwithstanding KRS 45.229, moneys in the fund not expended at the close of the 1 fiscal year shall not lapse but shall be carried forward to the next fiscal year. 2 (6) Any interest earnings of the trust fund shall become part of the fund and shall 3 not lapse. 4 (7) Moneys transferred to the fund are hereby appropriated for the purposes set forth 5 in this section. 6 (8) As used in this section, \"county\" has the same meaning as in KRS 65A.010. 7 SECTION 33. A NEW SECTION OF KRS CHAPTER 138 IS CREATED TO 8 READ AS FOLLOWS: 9 (1) As used in this section: 10 (a) \"Cultivator\" has the same meaning as in Section 1 of this Act; 11 (b) \"Department\" means the Department of Revenue; 12 (c) \"Dispensary\" has t he same meaning as in Section 1 of this Act; 13 (d) \"Medicinal cannabis\" has the same meaning as in Section 1 of this Act; 14 (e) \"Processor\" has the same meaning as in Section 1 of this Act; and 15 (f) \"Producer\" has the same meaning as in Section 1 of this Act. 16 (2) Effective January 1, 2023: 17 (a) An excise tax is hereby imposed on the gross receipts of a cultivator, 18 processor, or producer received from the sale of medicinal cannabis by a 19 cultivator, processor, or producer to a dispensary, to be paid by the 20 cultivat or, processor, or producer at a rate of twelve percent (12%) of the 21 actual price for which a cultivator, processor, or producer sells medicinal 22 cannabis to a dispensary in this state; and 23 (b) The tax shall be charged against and be paid by the cultivator, processor, or 24 producer and shall not be added as a separate charge or line item on any 25 sales slip, invoice, receipt, or other statement or memorandum of the price 26 paid by the dispensary. 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 91 of 141 HB013610.100 - 50 - XXXX GA (3) (a) Eighty percent (80%) of the revenue from the excise tax established in this 1 section shall be deposited in the medicinal cannabis trust fund established 2 in Section 31 of this Act for the purpose of administration of the medicinal 3 cannabis program and for the purposes established in that section. 4 (b) Twenty percent (20%) of the revenue from the excise tax established in this 5 section shall be deposited in the local medicinal cannabis trust fund 6 established in Section 32 of this Act for the purposes of distr ibuting tax 7 proceeds among participating local governments and for the purposes 8 established in that section. 9 (4) Cultivators, processors, and producers licensed under KRS Chapter 218A shall: 10 (a) Register with the department; 11 (b) Report and pay the tax levi ed under this section on or before the twentieth 12 day of the calendar month immediately following the month in which the 13 medicinal cannabis was sold. A tax return shall be filed for each reporting 14 period whether or not tax is due; and 15 (c) Identify the count y and city, if any, in which the medicinal cannabis 16 business is located. 17 (5) Any person who violates any provision of this section shall be subject to the 18 uniform civil penalties imposed pursuant to KRS 131.180 and interest at the tax 19 interest rate as defi ned in KRS 131.010 from the date due until the date of 20 payment. 21 (6) (a) Notwithstanding any other provision of this section, the president, vice 22 president, secretary, treasurer, or any other person holding any equivalent 23 corporate office of any corporation subject to this section shall be 24 personally and individually liable, both jointly and severally, for the taxes 25 imposed under this section. 26 (b) Corporate dissolution, withdrawal of the corporation from the state, or the 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 92 of 141 HB013610.100 - 50 - XXXX GA cessation of holding any corporate o ffice shall not discharge the liability of 1 any person. The personal and individual liability shall apply to every person 2 holding a corporate office at the time the tax becomes or became due. 3 (c) Notwithstanding any other provision of this chapter, KRS 275. 150, 362.1 - 4 306(3) or predecessor law, or 362.2 -404(3) to the contrary, the managers of 5 a limited liability company, the partners of a limited liability partnership, 6 and the general partners of a limited liability limited partnership, or any 7 other person ho lding any equivalent office of a limited liability company, 8 limited liability partnership, or limited liability limited partnership subject to 9 the provisions of this section shall be personally and individually liable, 10 both jointly and severally, for the t ax imposed under this section. 11 (d) Dissolution, withdrawal of the limited liability company, limited liability 12 partnership, or limited liability limited partnership from the state, or the 13 cessation of holding any office shall not discharge the liability of any 14 person. The personal and individual liability shall apply to every manager 15 of a limited liability company, partner of a limited liability partnership, or 16 general partner of a limited liability limited partnership at the time the tax 17 becomes or became due. 18 (e) No person shall be personally and individually liable under this section who 19 had no authority to truthfully account for, or pay over, any tax imposed by 20 this section at the time the tax imposed becomes or became due. 21 (f) \"Taxes\" as used in this se ction includes interest accrued at the rate 22 provided by KRS 131.183, all applicable penalties imposed under the 23 provisions of this chapter, and all applicable penalties imposed under KRS 24 131.180, 131.410 to 131.445, and 131.990. 25 (7) The department shall ad minister the provisions of this section and shall have all 26 of the powers, rights, duties, and authority with respect to the assessment, 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 93 of 141 HB013610.100 - 50 - XXXX GA collection, refunding, and administration of the taxes levied by this section, 1 conferred generally upon the department b y the Kentucky Revised Statutes, 2 including KRS Chapters 131, 134, and 135. 3 (8) Every cultivator, processor, and producer shall keep records, receipts, invoices, 4 and other pertinent papers in such form as the department may require for not 5 less than four (4 ) years from the making of such records, receipts, invoices, and 6 other pertinent papers. 7 Section 34. KRS 139.470 is amended to read as follows: 8 There are excluded from the computation of the amount of taxes imposed by th is chapter: 9 (1) Gross receipts from the sale of, and the storage, use, or other consumption in this 10 state of, tangible personal property or digital property which this state is prohibited 11 from taxing under the Constitution or laws of the United States, or under the 12 Constitution of this state; 13 (2) Gross receipts from sales of, and the storage, use, or other consumption in this state 14 of: 15 (a) Nonreturnable and returnable containers when sold without the contents to 16 persons who place the contents in the contain er and sell the contents together 17 with the container; and 18 (b) Returnable containers when sold with the contents in connection with a retail 19 sale of the contents or when resold for refilling; 20 As used in this section the term \"returnable containers\" means c ontainers of a kind 21 customarily returned by the buyer of the contents for reuse. All other containers are 22 \"nonreturnable containers\"; 23 (3) Gross receipts from occasional sales of tangible personal property or digital 24 property and the storage, use, or other consumption in this state of tangible personal 25 property or digital property, the transfer of which to the purchaser is an occasional 26 sale; 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 94 of 141 HB013610.100 - 50 - XXXX GA (4) Gross receipts from sales of tangible personal property to a common carrier, 1 shipped by the retailer via the purc hasing carrier under a bill of lading, whether the 2 freight is paid in advance or the shipment is made freight charges collect, to a point 3 outside this state and the property is actually transported to the out -of-state 4 destination for use by the carrier in the conduct of its business as a common carrier; 5 (5) Gross receipts from sales of tangible personal property sold through coin -operated 6 bulk vending machines, if the sale amounts to fifty cents ($0.50) or less, if the 7 retailer is primarily engaged in makin g the sales and maintains records satisfactory 8 to the department. As used in this subsection, \"bulk vending machine\" means a 9 vending machine containing unsorted merchandise which, upon insertion of a coin, 10 dispenses the same in approximately equal portions , at random and without 11 selection by the customer; 12 (6) Gross receipts from sales to any cabinet, department, bureau, commission, board, or 13 other statutory or constitutional agency of the state and gross receipts from sales to 14 counties, cities, or special districts as defined in KRS 65.005. This exemption shall 15 apply only to purchases of tangible personal property, digital property, or services 16 for use solely in the government function. A purchaser not qualifying as a 17 governmental agency or unit shall not be entitled to the exemption even though the 18 purchaser ma y be the recipient of public funds or grants; 19 (7) (a) Gross receipts from the sale of sewer services, water, and fuel to Kentucky 20 residents for use in heating, water heating, cooking, lighting, and other 21 residential uses. As used in this subsection, \"fuel\" shall include but not be 22 limited to natural gas, electricity, fuel oil, bottled gas, coal, coke, and wood. 23 Determinations of eligibility for the exemption shall be made by the 24 department; 25 (b) In making the determinations of eligibility, the department sha ll exempt from 26 taxation all gross receipts derived from sales: 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 95 of 141 HB013610.100 - 50 - XXXX GA 1. Classified as \"residential\" by a utility company as defined by applicable 1 tariffs filed with and accepted by the Public Service Commission; 2 2. Classified as \"residential\" by a municipally ow ned electric distributor 3 which purchases its power at wholesale from the Tennessee Valley 4 Authority; 5 3. Classified as \"residential\" by the governing body of a municipally owned 6 electric distributor which does not purchase its power from the 7 Tennessee Valle y Authority, if the \"residential\" classification is 8 reasonably consistent with the definitions of \"residential\" contained in 9 tariff filings accepted and approved by the Public Service Commission 10 with respect to utilities which are subject to Public Service Commission 11 regulation. 12 If the service is classified as residential, use other than for \"residential\" 13 purposes by the customer shall not negate the exemption; 14 (c) The exemption shall not apply if charges for sewer service, water, and fuel are 15 billed to an owner or operator of a multi -unit residential rental facility or 16 mobile home and recreational vehicle park other than residential 17 classification; and 18 (d) The exemption shall apply also to residential property which may be held by 19 legal or equitable title, by the entireties, jointly, in common, as a 20 condominium, or indirectly by the stock ownership or membership 21 representing the owner's or member's proprietary interest in a corporation 22 owning a fee or a leasehold initially in excess of ninety -eight (98) yea rs; 23 (8) Gross receipts from sales to an out -of-state agency, organization, or institution 24 exempt from sales and use tax in its state of residence when that agency, 25 organization, or institution gives proof of its tax -exempt status to the retailer and the 26 retailer maintains a file of the proof; 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 96 of 141 HB013610.100 - 50 - XXXX GA (9) (a) Gross receipts derived from the sale of tangible personal property, as provided 1 in paragraph (b) of this subsection, to a manufacturer or industrial processor if 2 the property is to be directly used in the manuf acturing or industrial 3 processing process of: 4 1. Tangible personal property at a plant facility; 5 2. Distilled spirits or wine at a plant facility or on the premises of a 6 distiller, rectifier, winery, or small farm winery licensed under KRS 7 243.030 that inc ludes a retail establishment on the premises; or 8 3. Malt beverages at a plant facility or on the premises of a brewer or 9 microbrewery licensed under KRS 243.040 that includes a retail 10 establishment; 11 and which will be for sale. 12 (b) The following tangible p ersonal property shall qualify for exemption under 13 this subsection: 14 1. Materials which enter into and become an ingredient or component part 15 of the manufactured product; 16 2. Other tangible personal property which is directly used in the 17 manufacturing or ind ustrial processing process, if the property has a 18 useful life of less than one (1) year. Specifically these items are 19 categorized as follows: 20 a. Materials. This refers to the raw materials which become an 21 ingredient or component part of supplies or industr ial tools exempt 22 under subdivisions b. and c. below; 23 b. Supplies. This category includes supplies such as lubricating and 24 compounding oils, grease, machine waste, abrasives, chemicals, 25 solvents, fluxes, anodes, filtering materials, fire brick, catalysts, 26 dyes, refrigerants, and explosives. The supplies indicated above 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 97 of 141 HB013610.100 - 50 - XXXX GA need not come in direct contact with a manufactured product to be 1 exempt. \"Supplies\" does not include repair, replacement, or spare 2 parts of any kind; and 3 c. Industrial tools. This group is li mited to hand tools such as jigs, 4 dies, drills, cutters, rolls, reamers, chucks, saws, and spray guns 5 and to tools attached to a machine such as molds, grinding balls, 6 grinding wheels, dies, bits, and cutting blades. Normally, for 7 industrial tools to be co nsidered directly used in the manufacturing 8 or industrial processing process, they shall come into direct contact 9 with the product being manufactured or processed; and 10 3. Materials and supplies that are not reusable in the same manufacturing 11 or industrial processing process at the completion of a single 12 manufacturing or processing cycle. A single manufacturing cycle shall 13 be considered to be the period elapsing from the time the raw materials 14 enter into the manufacturing process until the finished product e merges 15 at the end of the manufacturing process. 16 (c) The property described in paragraph (b) of this subsection shall be regarded as 17 having been purchased for resale. 18 (d) For purposes of this subsection, a manufacturer or industrial processor 19 includes an in dividual or business entity that performs only part of the 20 manufacturing or industrial processing activity, and the person or business 21 entity need not take title to tangible personal property that is incorporated into, 22 or becomes the product of, the activi ty. 23 (e) The exemption provided in this subsection does not include repair, 24 replacement, or spare parts; 25 (10) Any water use fee paid or passed through to the Kentucky River Autho rity by 26 facilities using water from the Kentucky River basin to the Kentucky River 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 98 of 141 HB013610.100 - 50 - XXXX GA Authority in accordance with KRS 151.700 to 151.730 and administrative 1 regulations promulgated by the authority; 2 (11) Gross receipts from the sale of newspaper inserts or ca talogs purchased for storage, 3 use, or other consumption outside this state and delivered by the retailer's own 4 vehicle to a location outside this state, or delivered to the United States Postal 5 Service, a common carrier, or a contract carrier for delivery outside this state, 6 regardless of whether the carrier is selected by the purchaser or retailer or an agent 7 or representative of the purchaser or retailer, or whether the F.O.B. is retailer's 8 shipping point or purchaser's destination. 9 (a) As used in this su bsection: 10 1. \"Catalogs\" means tangible personal property that is printed to the special 11 order of the purchaser and composed substantially of information 12 regarding goods and services offered for sale; and 13 2. \"Newspaper inserts\" means printed materials that are placed in or 14 distributed with a newspaper of general circulation. 15 (b) The retailer shall be responsible for establishing that delivery was made to a 16 non-Kentucky location through shipping documents or other credible evidence 17 as determined by the depart ment; 18 (12) Gross receipts from the sale of water used in the raising of equine as a business; 19 (13) Gross receipts from the sale of metal retail fixtures manufactured in this state and 20 purchased for storage, use, or other consumption outside this state and delivered by 21 the retailer's own vehicle to a location outside this state, or delivered to the United 22 States Postal Service, a common carrier, or a contract carrier for delivery outside 23 this state, regardless of whether the carrier is selected by the purcha ser or retailer or 24 an agent or representative of the purchaser or retailer, or whether the F.O.B. is the 25 retailer's shipping point or the purchaser's destination. 26 (a) As used in this subsection, \"metal retail fixtures\" means check stands and 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 99 of 141 HB013610.100 - 50 - XXXX GA belted and non belted checkout counters, whether made in bulk or pursuant to 1 specific purchaser specifications, that are to be used directly by the purchaser 2 or to be distributed by the purchaser. 3 (b) The retailer shall be responsible for establishing that delivery was m ade to a 4 non-Kentucky location through shipping documents or other credible evidence 5 as determined by the department; 6 (14) Gross receipts from the sale of unenriched or enriched uranium purchased for 7 ultimate storage, use, or other consumption outside this state and delivered to a 8 common carrier in this state for delivery outside this state, regardless of whether the 9 carrier is selected by the purchaser or retailer, or is an agent or representative of the 10 purchaser or retailer, or whether the F.O.B. is the retailer's shipping point or 11 purchaser's destination; 12 (15) Amounts received from a tobacco buydown. As used in this subsection, \"buydown\" 13 means an agreement whereby an amount, whether paid in money, credit, or 14 otherwise, is received by a retailer from a ma nufacturer or wholesaler based upon 15 the quantity and unit price of tobacco products sold at retail that requires the retailer 16 to reduce the selling price of the product to the purchaser without the use of a 17 manufacturer's or wholesaler's coupon or redempti on certificate; 18 (16) Gross receipts from the sale of tangible personal property or digital property 19 returned by a purchaser when the full sales price is refunded either in cash or credit. 20 This exclusion shall not apply if the purchaser, in order to obtain the refund, is 21 required to purchase other tangible personal property or digital property at a price 22 greater than the amount charged for the property that is returned; 23 (17) Gross receipts from the sales of gasoline and special fuels subject to tax under KRS 24 Chapter 138; 25 (18) The amount of any tax imposed by the United States upon or with respect to retail 26 sales, whether imposed on the retailer or the consumer, not including any 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 100 of 141 HB013610.100 - 50 - XXXX GA manufacturer's excise or import duty; 1 (19) Gross receipts from the sale of any mo tor vehicle as defined in KRS 138.450 which 2 is: 3 (a) Sold to a Kentucky resident, registered for use on the public highways, and 4 upon which any applicable tax levied by KRS 138.460 has been paid; or 5 (b) Sold to a nonresident of Kentucky if the nonresident r egisters the motor 6 vehicle in a state that: 7 1. Allows residents of Kentucky to purchase motor vehicles without 8 payment of that state's sales tax at the time of sale; or 9 2. Allows residents of Kentucky to remove the vehicle from that state 10 within a specific period for subsequent registration and use in Kentucky 11 without payment of that state's sales tax; 12 (20) Gross receipts from the sale of a semi -trailer as defined in KRS 189.010(12) and 13 trailer as defined in KRS 189.010(17); 14 (21) Gross receipts from the col lection of: 15 (a) Any fee or charge levied by a local government pursuant to KRS 65.760; 16 (b) The charge imposed by KRS 65.7629(3); 17 (c) The fee imposed by KRS 65.7634; and 18 (d) The service charge imposed by KRS 65.7636; 19 (22) Gross receipts derived from charges for labor or services to apply, install, repair, or 20 maintain tangible personal property directly used in manufacturing or industrial 21 processing process of: 22 (a) Tangible personal property at a plant facility; 23 (b) Distilled spirits or wine at a plant facility or on the premises of a distiller, 24 rectifier, winery, or small farm winery licensed under KRS 243.030; or 25 (c) Malt beverages at a plant facility or on the premises of a brewer or 26 microbrewery licensed under KRS 243.040 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 101 of 141 HB013610.100 - 50 - XXXX GA that is not otherwise exempt under subsection (9) of this section or KRS 1 139.480(10), if the charges for labor or services are separately stated on the invoice, 2 bill of sale, or similar document given to purchaser; 3 (23) (a) For persons selling services included in KRS 139.200( 2)(g) to (q) prior to 4 January 1, 2019, gross receipts derived from the sale of those services if the 5 gross receipts were less than six thousand dollars ($6,000) during calendar 6 year 2018. When gross receipts from these services exceed six thousand 7 dollars ($6,000) in a calendar year: 8 1. All gross receipts over six thousand dollars ($6,000) are taxable in that 9 calendar year; and 10 2. All gross receipts are subject to tax in subsequent calendar years. 11 (b) The exemption provided in this subsection shall not appl y to a person also 12 engaged in the business of selling tangible personal property, digital property, 13 or services included in KRS 139.200(2)(a) to (f); [ and] 14 (24) (a) For persons that first begin making sales of services included in KRS 15 139.200(2)(g) to (q) on or after January 1, 2019, gross receipts derived from 16 the sale of those services if the gross receipts are less than six thousand dollars 17 ($6,000) within the first calendar year of operation. When gross receipts from 18 these services exceed six thousand d ollars ($6,000) in a calendar year: 19 1. All gross receipts over six thousand dollars ($6,000) are taxable in that 20 calendar year; and 21 2. All gross receipts are subject to tax in subsequent calendar years. 22 (b) The exemption provided in this subsection shall n ot apply to a person that is 23 also engaged in the business of selling tangible personal property, digital 24 property, or services included in KRS 139.200(2)(a) to (f) ; and 25 (25) Gross receipts from the sale of medicinal cannabis as defined in Section 1 of this 26 Act and subject to tax under Section 33 of this Act . 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 102 of 141 HB013610.100 - 50 - XXXX GA Section 35. KRS 138.870 is amended to read as follows: 1 As used in KRS 138.870 to 138.889, unless the context requires otherwise: 2 (1) \"Marijuana\" means marijuana, whet her real or counterfeit, as defined in KRS 3 218A.010 and does not include medicinal cannabis as defined in Section 1 of this 4 Act. 5 (2) \"Controlled substance\" means any controlled substance, whether real or counterfeit, 6 as defined in KRS 218A.010 or any regul ation promulgated thereunder, except that 7 it shall not include marijuana. 8 (3) \"Offender\" means a person who engages in this state in a taxable activity as defined 9 in subsection (4) of this section. 10 (4) \"Taxable activity\" means producing, cultivating, manuf acturing, importing, 11 transporting, distributing, acquiring, purchasing, storing, selling, using, or otherwise 12 possessing, in violation of KRS Chapter 218A, more than five (5) marijuana plants 13 with foliation, 42.5 grams of marijuana which has been detached from the plant on 14 which it grew, seven (7) grams of any controlled substance, or fifty (50) or more 15 dosage units of any controlled substance which is not sold by weight. The weight or 16 dosage units in this subsection shall include the weight of marijuana or the weight 17 or dosage units of the controlled substance, whether pure, impure, or diluted. A 18 quantity of a controlled substance is diluted if it consists of a detectable quantity of 19 a pure controlled substance and any excipients or fillers. 20 (5) \"Dosage uni t\" means a tablet, capsule, vial, or ampule of a controlled substance or, 21 in cases of mass volume or diluted quantities, the proper dose or quantity of a 22 controlled substance to be taken all at one (1) time or in fractional amounts within a 23 given period, a s defined and adopted by the United States Pharmacopeia. 24 (6) \"Possessing\" includes either actual possession or constructive possession, or a 25 combination of both actual and constructive possession. Mere possession or 26 ownership of real estate or an interest therein does not establish constructive 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 103 of 141 HB013610.100 - 50 - XXXX GA possession. 1 Section 36. KRS 216B.402 is amended to read as follows: 2 (1) When a person is admitted to a hospital emergency department or hospital 3 emergency room for treatment of a drug overdose: 4 (a)[(1)] The person shall be informed of available substance use disorder 5 treatment services known to the hospital that are provided b y that hospital, 6 other local hospitals, the local community mental health center, and any other 7 local treatment programs licensed pursuant to KRS 222.231; 8 (b)[(2)] The hospital may obtain permission from the person when stabilized, or 9 the person's legal re presentative, to contact any available substance use 10 disorder treatment programs offered by that hospital, other local hospitals, the 11 local community mental health center, or any other local treatment programs 12 licensed pursuant to KRS 222.231, on behalf of the person to connect him or 13 her to treatment; and 14 (c)[(3)] The local community mental health center may provide an on -call 15 service in the hospital emergency department or hospital emergency room for 16 the person who was treated for a drug overdose to provide information about 17 services and connect the person to subst ance use disorder treatment, as funds 18 are available. These services, when provided on the grounds of a hospital, 19 shall be coordinated with appropriate hospital staff. 20 (2) When a person who is a registered qualified patient or a visiting qualified patient 21 as defined in Section 1 of this Act is admitted to a hospital emergency department 22 or a hospital emergency room for treatment of cannabinoid hyperemesis 23 syndrome, the hospital shall notify the Department for Public Health within 24 forty -eight (48) hours. Noti fication shall include the registered qualified patient's 25 or a visiting qualified patient's name and registry identification card number, if 26 available. The department shall record all cases of cannabinoid hyperemesis 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 104 of 141 HB013610.100 - 50 - XXXX GA syndrome in the electronic monitoring s ystem established pursuant to Section 41 1 of this Act. 2 Section 37. KRS 218A.010 is amended to read as follows: 3 As used in this chapter: 4 (1) \"Administer\" means the direct application of a controlled substance, whether by 5 injection, inhalation, ingestion, or any other means, to the body of a patient or 6 research subject by: 7 (a) A practitioner or by his or her authorized agent under his or her immediate 8 supervision and pursuant to his or her order; or 9 (b) The patient or resear ch subject at the direction and in the presence of the 10 practitioner; 11 (2) \"Anabolic steroid\" means any drug or hormonal substance chemically and 12 pharmacologically related to testosterone that promotes muscle growth and includes 13 those substances classified a s Schedule III controlled substances pursuant to KRS 14 218A.020 but does not include estrogens, progestins, and anticosteroids; 15 (3) \"Cabinet\" means the Cabinet for Health and Family Services; 16 (4) \"Carfentanil\" means any substance containing any quantity of c arfentanil, or any of 17 its salts, isomers, or salts of isomers; 18 (5) \"Certified community based palliative care program\" means a palliative care 19 program which has received certification from the Joint Commission; 20 (6) \"Child\" means any person under the age of majority as specified in KRS 2.015; 21 (7) \"Cocaine\" means a substance containing any quantity of cocaine, its salts, optical 22 and geometric isomers, and salts of isomers; 23 (8) \"Controlled substance\" means methamphetamine, or a drug, substance, or 24 immediate pr ecursor in Schedules I through V and includes a controlled substance 25 analogue; 26 (9) (a) \"Controlled substance analogue,\" except as provided in paragraph (b) of this 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 105 of 141 HB013610.100 - 50 - XXXX GA subsection, means a substance: 1 1. The chemical structure of which is substantially similar t o the structure 2 of a controlled substance in Schedule I or II; and 3 2. Which has a stimulant, depressant, or hallucinogenic effect on the 4 central nervous system that is substantially similar to or greater than the 5 stimulant, depressant, or hallucinogenic ef fect on the central nervous 6 system of a controlled substance in Schedule I or II; or 7 3. With respect to a particular person, which such person represents or 8 intends to have a stimulant, depressant, or hallucinogenic effect on the 9 central nervous system tha t is substantially similar to or greater than the 10 stimulant, depressant, or hallucinogenic effect on the central nervous 11 system of a controlled substance in Schedule I or II. 12 (b) Such term does not include: 13 1. Any substance for which there is an approved n ew drug application; 14 2. With respect to a particular person, any substance if an exemption is in 15 effect for investigational use for that person pursuant to federal law to 16 the extent conduct with respect to such substance is pursuant to such 17 exemption; or 18 3. Any substance to the extent not intended for human consumption before 19 the exemption described in subparagraph 2. of this paragraph takes 20 effect with respect to that substance; 21 (10) \"Counterfeit substance\" means a controlled substance which, or the contai ner or 22 labeling of which, without authorization, bears the trademark, trade name, or other 23 identifying mark, imprint, number, or device, or any likeness thereof, of a 24 manufacturer, distributor, or dispenser other than the person who in fact 25 manufactured, d istributed, or dispensed the substance; 26 (11) \"Dispense\" means to deliver a controlled substance to an ultimate user or research 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 106 of 141 HB013610.100 - 50 - XXXX GA subject by or pursuant to the lawful order of a practitioner, including the packaging, 1 labeling, or compounding necessary to pre pare the substance for that delivery; 2 (12) \"Dispenser\" means a person who lawfully dispenses a Schedule II, III, IV, or V 3 controlled substance to or for the use of an ultimate user; 4 (13) \"Distribute\" means to deliver other than by administering or dispensing a controlled 5 substance; 6 (14) \"Dosage unit\" means a single pill, capsule, ampule, liquid, or other form of 7 administration available as a single unit; 8 (15) \"Drug\" means: 9 (a) Substances r ecognized as drugs in the official United States Pharmacopoeia, 10 official Homeopathic Pharmacopoeia of the United States, or official National 11 Formulary, or any supplement to any of them; 12 (b) Substances intended for use in the diagnosis, care, mitigation, t reatment, or 13 prevention of disease in man or animals; 14 (c) Substances (other than food) intended to affect the structure or any function of 15 the body of man or animals; and 16 (d) Substances intended for use as a component of any article specified in this 17 subse ction. 18 It does not include devices or their components, parts, or accessories; 19 (16) \"Fentanyl\" means a substance containing any quantity of fentanyl, or any of its salts, 20 isomers, or salts of isomers; 21 (17) \"Fentanyl derivative\" means a substance containin g any quantity of any chemical 22 compound, except compounds specifically scheduled as controlled substances by 23 statute or by administrative regulation pursuant to this chapter, which is structurally 24 derived from 1 -ethyl -4-(N-phenylamido) piperadine: 25 (a) By substitution: 26 1. At the 2 -position of the 1 -ethyl group with a phenyl, furan, thiophene, or 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 107 of 141 HB013610.100 - 50 - XXXX GA ethyloxotetrazole ring system; and 1 2. Of the terminal amido hydrogen atom with an alkyl, alkoxy, cycloalkyl, 2 or furanyl group; and 3 (b) Which may be further modified in one (1) or more of the following ways: 4 1. By substitution on the N -phenyl ring to any extent with alkyl, alkoxy, 5 haloalkyl, hydroxyl, or halide substituents; 6 2. By substitution on the piperadine ring to any extent with alkyl, allyl, 7 alkoxy, hydroxy, or halide substituents at the 2 -, 3-, 5-, and/or 6 - 8 positions; 9 3. By substitution on the piperadine ring to any extent with a phenyl, 10 alkoxy, or carboxylate ester substituent at the 4 - position; or 11 4. By substitution on the 1 -ethyl group to any extent with al kyl, alkoxy, or 12 hydroxy substituents; 13 (18) \"Good faith prior examination,\" as used in KRS Chapter 218A and for criminal 14 prosecution only, means an in -person medical examination of the patient conducted 15 by the prescribing practitioner or other health -care p rofessional routinely relied 16 upon in the ordinary course of his or her practice, at which time the patient is 17 physically examined and a medical history of the patient is obtained. \"In -person\" 18 includes telehealth examinations. This subsection shall not be a pplicable to hospice 19 providers licensed pursuant to KRS Chapter 216B; 20 (19) \"Hazardous chemical substance\" includes any chemical substance used or intended 21 for use in the illegal manufacture of a controlled substance as defined in this section 22 or the illega l manufacture of methamphetamine as defined in KRS 218A.1431, 23 which: 24 (a) Poses an explosion hazard; 25 (b) Poses a fire hazard; or 26 (c) Is poisonous or injurious if handled, swallowed, or inhaled; 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 108 of 141 HB013610.100 - 50 - XXXX GA (20) \"Heroin\" means a substance containing any quantity of hero in, or any of its salts, 1 isomers, or salts of isomers; 2 (21) \"Hydrocodone combination product\" means a drug with: 3 (a) Not more than three hundred (300) milligrams of dihydrocodeinone, or any of 4 its salts, per one hundred (100) milliliters or not more than f ifteen (15) 5 milligrams per dosage unit, with a fourfold or greater quantity of an 6 isoquinoline alkaloid of opium; or 7 (b) Not more than three hundred (300) milligrams of dihydrocodeinone, or any of 8 its salts, per one hundred (100) milliliters or not more th an fifteen (15) 9 milligrams per dosage unit, with one (1) or more active, nonnarcotic 10 ingredients in recognized therapeutic amounts; 11 (22) \"Immediate precursor\" means a substance which is the principal compound 12 commonly used or produced primarily for use, and which is an immediate chemical 13 intermediary used or likely to be used in the manufacture of a controlled substance 14 or methamphetamine, the control of which is necessary to prevent, curtail, or limit 15 manufacture; 16 (23) \"Industrial hemp\" has the same meaning as in KRS 260.850; 17 (24) \"Industrial hemp products\" has the same as in KRS 260.850; 18 (25) \"Intent to manufacture\" means any evide nce which demonstrates a person's 19 conscious objective to manufacture a controlled substance or methamphetamine. 20 Such evidence includes but is not limited to statements and a chemical substance's 21 usage, quantity, manner of storage, or proximity to other che mical substances or 22 equipment used to manufacture a controlled substance or methamphetamine; 23 (26) \"Isomer\" means the optical isomer, except the Cabinet for Health and Family 24 Services may include the optical, positional, or geometric isomer to classify any 25 substance pursuant to KRS 218A.020; 26 (27) \"Manufacture,\" except as provided in KRS 218A.1431, means the production, 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 109 of 141 HB013610.100 - 50 - XXXX GA preparation, propagation, compounding, conversion, or processing of a controlled 1 substance, either directly or indirectly by extraction from substances of natural 2 origin or independently by means of chemical synthesis, or by a combination of 3 extraction and chemical synthesis, and includes any packaging or repackaging of the 4 substance or labeling or relabeling of its container except that this t erm does not 5 include activities: 6 (a) By a practitioner as an incident to his or her administering or dispensing of a 7 controlled substance in the course of his or her professional practice; 8 (b) By a practitioner, or by his or her authorized agent under his supervision, for 9 the purpose of, or as an incident to, research, teaching, or chemical analysis 10 and not for sale; or 11 (c) By a pharmacist as an incident to his or her dispensing of a controlled 12 substance in the course of his or her professional practice; 13 (28) \"Marijuana\" means all parts of the plant Cannabis sp., whether growing or not; the 14 seeds thereof; the resin extracted from any part of the plant; and every compound, 15 manufacture, salt, derivative, mixture, or preparation of the plant, its seeds or resin 16 or any compound, mixture, or preparation which contains any quantity of these 17 substances. The term \"marijuana\" does not include: 18 (a) Industrial hemp that is in the possession, custody, or control of a person who 19 holds a license issued by the Department of Agriculture permitting that person 20 to cultivate, handle, or process industrial hemp; 21 (b) Industrial hemp products that do not include any living plants, viable seeds, 22 leaf materials, or floral materials; 23 (c) The substance cannabidiol, when transferred, di spensed, or administered 24 pursuant to the written order of a physician practicing at a hospital or 25 associated clinic affiliated with a Kentucky public university having a college 26 or school of medicine; 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 110 of 141 HB013610.100 - 50 - XXXX GA (d) For persons participating in a clinical trial or in an expanded access program, 1 a drug or substance approved for the use of those participants by the United 2 States Food and Drug Administration; 3 (e) A cannabidiol product derived from industrial hemp, as defined in KRS 4 260.850; 5 (f) For the purpose of conduct ing scientific research, a cannabinoid product 6 derived from industrial hemp, as defined in KRS 260.850; [ or] 7 (g) A cannabinoid product approved as a prescription medication by the United 8 States Food and Drug Administration; or 9 (h) Medicinal cannabis as def ined in Section 1 of this Act; 10 (29) \"Medical history,\" as used in KRS Chapter 218A and for criminal prosecution only, 11 means an accounting of a patient's medical background, including but not limited to 12 prior medical conditions, prescriptions, and family ba ckground; 13 (30) \"Medical order,\" as used in KRS Chapter 218A and for criminal prosecution only, 14 means a lawful order of a specifically identified practitioner for a specifically 15 identified patient for the patient's health -care needs. \"Medical order\" may or may 16 not include a prescription drug order; 17 (31) \"Medical record,\" as used in KRS Chapter 218A and for criminal prosecution only, 18 means a record, other than for financial or billing purposes, relating to a patient, 19 kept by a practitioner as a result of the practitioner -patient relationship; 20 (32) \"Methamphetamine\" means any substance that contains any quantity of 21 methamphetamine, or any of its salts, isomers, or salts of isomers; 22 (33) \"Narcotic drug\" means any of the following, whether produced directly or in directly 23 by extraction from substances of vegetable origin, or independently by means of 24 chemical synthesis, or by a combination of extraction and chemical synthesis: 25 (a) Opium and opiate, and any salt, compound, derivative, or preparation of 26 opium or opia te; 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 111 of 141 HB013610.100 - 50 - XXXX GA (b) Any salt, compound, isomer, derivative, or preparation thereof which is 1 chemically equivalent or identical with any of the substances referred to in 2 paragraph (a) of this subsection, but not including the isoquinoline alkaloids 3 of opium; 4 (c) Opium poppy and poppy straw; 5 (d) Coca leaves, except coca leaves and extracts of coca leaves from which 6 cocaine, ecgonine, and derivatives of ecgonine or their salts have been 7 removed; 8 (e) Cocaine, its salts, optical and geometric isomers, and salts of isomers; 9 (f) Ecgonine, its derivatives, their salts, isomers, and salts of isomers; and 10 (g) Any compound, mixture, or preparation which contains any quantity of any of 11 the substances referred to in paragraphs (a) to (f) of this subsection; 12 (34) \"Opiate\" means any s ubstance having an addiction -forming or addiction -sustaining 13 liability similar to morphine or being capable of conversion into a drug having 14 addiction -forming or addiction -sustaining liability. It does not include, unless 15 specifically designated as control led under KRS 218A.020, the dextrorotatory 16 isomer of 3 -methoxy -n-methylmorphinan its salts It does 17 racemic and levorotatory forms; 18 (35) \"Opium poppy\" means the plant of the species papaver somniferum L., except its 19 seeds ; 20 (36) \"Person\" means individual, corporation, government or governmental subdivision 21 or agency, business trust, estate, trust, partnership or association, or any other legal 22 entity; 23 (37) \"Physical injury\" has the same meaning it has in KRS 500.080; 24 (38) \"Poppy straw\" means all parts, except the seeds, of the opium poppy, after mowing; 25 (39) \"Pharmacist\" means a natural person licensed by this state to engage in the practice 26 of the profession of pharmacy; 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 112 of 141 HB013610.100 - 50 - XXXX GA (40) \"Practitioner\" means a physician, dentist, podia trist, veterinarian, scientific 1 investigator, optometrist as authorized in KRS 320.240, advanced practice 2 registered nurse as authorized under KRS 314.011, physician assistant as authorized 3 under KRS 311.858, or other person licensed, registered, or otherw ise permitted by 4 state or federal law to acquire, distribute, dispense, conduct research with respect to, 5 or to administer a controlled substance in the course of professional practice or 6 research in this state. \"Practitioner\" also includes a physician, de ntist, podiatrist, 7 veterinarian, or advanced practice registered nurse authorized under KRS 314.011 8 who is a resident of and actively practicing in a state other than Kentucky and who 9 is licensed and has prescriptive authority for controlled substances und er the 10 professional licensing laws of another state, unless the person's Kentucky license 11 has been revoked, suspended, restricted, or probated, in which case the terms of the 12 Kentucky license shall prevail; 13 (41) \"Practitioner -patient relationship,\" as used in KRS Chapter 218A and for criminal 14 prosecution only, means a medical relationship that exists between a patient and a 15 practitioner or the practitioner's designee, after the practitioner or his or her 16 designee has conducted at least one (1) good faith pr ior examination; 17 (42) \"Prescription\" means a written, electronic, or oral order for a drug or medicine, or 18 combination or mixture of drugs or medicines, or proprietary preparation, signed or 19 given or authorized by a medical, dental, chiropody, veterinarian , optometric 20 practitioner, or advanced practice registered nurse, and intended for use in the 21 diagnosis, cure, mitigation, treatment, or prevention of disease in man or other 22 animals; 23 (43) \"Prescription blank,\" with reference to a controlled substance, mea ns a document 24 that meets the requirements of KRS 218A.204 and 217.216; 25 (44) \"Presumptive probation\" means a sentence of probation not to exceed the maximum 26 term specified for the offense, subject to conditions otherwise authorized by law, 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 113 of 141 HB013610.100 - 50 - XXXX GA that is presumed to be the appropriate sentence for certain offenses designated in 1 this chapter, notwithstanding contrary provisions of KRS Chapter 533. That 2 presumption shall only be overcome by a finding on the record by the sentencing 3 court of substantial and compelling reasons why the defendant cannot be safely and 4 effectively supervised in the community, is not amenable to community -based 5 treatment, or poses a significant risk to public safety; 6 (45) \"Production\" includes the manufacture, planting, cultivation, growing, or harvesting 7 of a controlled substance; 8 (46) \"Recovery program\" means an evidence -based, nonclinical service that assists 9 individuals and families working toward sustained recovery from substance use and 10 other criminal risk factors. This can be done thro ugh an array of support programs 11 and services that are delivered through residential and nonresidential means; 12 (47) \"Salvia\" means Salvia divinorum or Salvinorin A and includes all parts of the plant 13 presently classified botanically as Salvia divinorum, wh ether growing or not, the 14 seeds thereof, any extract from any part of that plant, and every compound, 15 manufacture, derivative, mixture, or preparation of that plant, its seeds, or its 16 extracts, including salts, isomers, and salts of isomers whenever the ex 17 such salts, isomers, and salts of isomers is possible within the specific chemical 18 designation of that plant, its seeds, or extracts. The term shall not include any other 19 species in the genus salvia; 20 (48) \"Second or subsequent offense\" means tha t for the purposes of this chapter an 21 offense is considered as a second or subsequent offense, if, prior to his or her 22 conviction of the offense, the offender has at any time been convicted under this 23 chapter, or under any statute of the United States, or of any state relating to 24 substances classified as controlled substances or counterfeit substances, except that 25 a prior conviction for a nontrafficking offense shall be treated as a prior offense 26 only when the subsequent offense is a nontrafficking offense. For the purposes of 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 114 of 141 HB013610.100 - 50 - XXXX GA this section, a conviction voided under KRS 218A.275 or 218A.276 shall not 1 constitute a conviction under this chapter; 2 (49) \"Sell\" means to dispose of a controlled substance to another person for 3 consideration or in furtherance of comm ercial distribution; 4 (50) \"Serious physical injury\" has the same meaning it has in KRS 500.080; 5 (51) \"Synthetic cannabinoids or piperazines\" means any chemical compound which is 6 not approved by the United States Food and Drug Administration or, if approved , 7 which is not dispensed or possessed in accordance with state and federal law, that 8 contains Benzylpiperazine (BZP); Trifluoromethylphenylpiperazine dexanabinol (HU -211); or any 11 compound in the following structural classes: 12 (a) Naphthoylindoles: Any compound containing a 3 -(1-naphthoyl)indole 13 structure with substitution at the nitrogen atom of the indole ring by an alkyl, or 2 -(4-morpholinyl)ethyl group, whether or not further 16 substituted in the indole ring to any extent and whether or not substituted in 17 the naphthyl ring to any extent. Exa mples of this structural class include but 18 are not (b) Phenylacetylindoles: Any compound containing a 3 -phenylacetylindole 21 structure with substitution at the nitrogen at om of the indole ring by an alkyl, or 2 -(4-morpholinyl)ethyl group whether or not further 24 substituted in the indole ring to any extent and whether or not substituted i n 25 the phenyl ring to any extent. Examples of this structural class include but are 26 not limited to JWH -167, JWH -250, JWH -251, 22 RS HB 136/GA Page 115 of 141 HB013610.100 - 50 - XXXX GA (c) Benzoylindoles: Any compound containing a 3 -(benzoyl)indole structure with 1 substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, -(N-methyl -2-piperidinyl)methyl, 3 or 2-(4-morpholinyl)ethyl group whether or not further substituted in the 4 indole ring to any extent and whether or not substituted in the phen yl ring to 5 any extent. Examples of this structural class include but are not limited to 6 AM-630, AM -2233, AM -694, Pravadoline (WIN 48,098), and RCS -4; 7 (d) Cyclohexylphenols: Any compound containing a 2 -(3- 8 hydroxycyclohexyl)phenol structure with substitution at the 5 -position of the 9 phenolic ring by -(N-methyl -2-piperidinyl)methyl, or 2 -(4-morpholinyl)ethyl 11 group whether or not substituted in the cyclohexyl ring to any extent. 12 Examples of this structural class include but are not limited to CP 47,497 and 13 its C8 homologue (cannabicyclohexanol); compound containing a 1H -indol -3-yl-(1- 15 naphthyl)methane structure with substitution at the nitrogen atom of the indole 16 ring by an alkyl, haloalkyl, alkenyl, -(N- 17 methyl -2-piperidinyl)methyl, or 2 -(4-morpholinyl)ethyl group whether or not 18 further substituted in the indole ring to any extent and whether or not 19 substituted in the naphthyl ring t o any extent. Examples of this structural class 20 include but are not limited to JWH -175, JWH -184, and JWH -185; 21 (f) Naphthoylpyrroles: Any compound containing a 3 -(1-naphthoyl)pyrrole 22 structure with substitution at the nitrogen atom of the pyrrole ring by an alkyl, or 2 -(4-morpholinyl)ethyl group whether or not further 25 substituted in the pyrrole ring to any extent and whether or not substituted in 26 the naphthyl ring to any extent. Examples of this structural class include but 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 116 of 141 HB013610.100 - 50 - XXXX GA are not compound containing a 1 -(1- 2 naphthylmethyl)indene structure with substitution at the 3 -position of the 3 indene ring -2-piperidinyl)methyl, or 2 -(4-morpholinyl)ethyl group whether 5 or not further substituted in the indene ring to any extent and whether or not 6 substituted in the naph thyl ring to any extent. Examples of this structural class 7 include but are not limited to JWH -176; 8 (h) Tetramethylcyclopropanoylindoles: Any compound containing a 3 -(1- 9 tetramethylcyclopropoyl)indole structure with substitution at the nitrogen 10 atom of the i ndole ring by an alkyl, haloalkyl, cycloalkylmethyl, 11 cycloalkylethyl, 1 -(N-methyl -2-piperidinyl)methyl, or 2 -(4-morpholinyl)ethyl 12 group, whether or not further substituted in the indole ring to any extent and 13 whether or not further substituted in the tetra methylcyclopropyl ring to any 14 extent. Examples of this structural class include but are not limited to UR -144 15 and XLR -11; 16 (i) Adamantoylindoles: Any compound containing a 3 -(1-adamantoyl)indole 17 structure with substitution at the nitrogen atom of the indole ring by an alkyl, -(4-morpholiny l)ethyl group, whether or not further 20 substituted in the indole ring to any extent and whether or not substituted in 21 the adamantyl ring system to any extent. Examples of this structural class 22 include but are not limited to AB -001 and AM -1248; or 23 (j) Any ot her synthetic cannabinoid or piperazine which is not approved by the 24 United States Food and Drug Administration or, if approved, which is not 25 dispensed or possessed in accordance with state and federal law; 26 (52) \"Synthetic cathinones\" means any chemical co mpound which is not approved by the 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 117 of 141 HB013610.100 - 50 - XXXX GA United States Food and Drug Administration or, if approved, which is not dispensed 1 or possessed in accordance with state and federal law (not including bupropion or 2 compounds listed under a different schedule) structural ly derived from 2 - 3 aminopropan -1-one by substitution at the 1 -position with either phenyl, naphthyl, or 4 thiophene ring systems, whether or not the compound is further modified in one (1) 5 or more of the following ways: 6 (a) By substitution in the ring system to any extent with alkyl, alkylenedioxy, 7 alkoxy, haloalkyl, hydroxyl, or halide substituents, whether or not further 8 substituted in the ring system by one (1) or more other univalent substituents. 9 Examples of this class include but are not limited to 3,4 - 10 Methylenedioxycathinone (bk -MDA); 11 (b) By substitution at the 3 -position with an acyclic alkyl substituent. Examples of 12 this class include but are not limited to 2 -methylamino -1-phenylbutan -1-one 13 (buphedrone); 14 (c) By substitution at the 2 -amino nitrogen atom with alkyl, dialkyl, benzyl, or 15 methoxybenzyl groups, or by inclusion of the 2 -amino nitrogen atom in a 16 cyclic structure. Examples of this class include but are not limited to 17 Dimethylcathinone, Ethcathinone, and -Pyrrolidino propiophenone ( -PPP); 18 or 19 (d) Any other synthetic cathinone which is not approved by the United States 20 Food and Drug Administration or, if approved, is not dispensed or possessed 21 in accordance with state or federal law; 22 (53) \"Synthetic drugs\" means any synthetic cannabinoids or piperazines or any synthetic 23 cathinones; 24 (54) \"Telehealth\" has the same meaning it has in KRS 311.550; 25 (55) \"Tetrahydrocannabinols\" means synthetic equivalents of the substances contained in 26 the plant, or in the resinous extractives of the plant Cannabis, sp. or synthetic 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 118 of 141 HB013610.100 - 50 - XXXX GA substances, derivatives, and their isomers with similar chemical structure and 1 pharmacological activity such as the following: 2 (a) Delta 1 cis or trans tetrahydrocannabinol, and their opt ical isomers; 3 (b) Delta 6 cis or trans tetrahydrocannabinol, and their optical isomers; and 4 (c) Delta 3, 4 cis or trans tetrahydrocannabinol, and its optical isomers; 5 (56) \"Traffic,\" except as provided in KRS 218A.1431, means to manufacture, distribute, 6 dispense, sell, transfer, or possess with intent to manufacture, distribute, dispense, 7 or sell a controlled substance; 8 (57) \"Transfer\" means to dispose of a controlled substance to another person without 9 consideration and not in furtherance of commercial dis tribution; and 10 (58) \"Ultimate user\" means a person who lawfully possesses a controlled substance for 11 his or her own use or for the use of a member of his or her household or for 12 administering to an animal owned by him or her or by a member of his or her 13 household. 14 Section 38. KRS 218A.1421 is amended to read as follows: 15 (1) A person is guilty of trafficking in marijuana when he or she knowingly and 16 unlawfully traffics in marijuana , and the trafficking is not in compliance with, or 17 otherwise authorized by, Sections 1 to 30 of this Act . 18 (2) Unless authorized by Sections 1 to 30 of this Act, trafficking in less than eight (8) 19 ounces of marijuana is: 20 (a) For a first offense a Class A misdemeanor. 21 (b) For a second or subsequent offense a Class D felony. 22 (3) Unless authorized by Sections 1 to 30 of this Act, trafficking in eight (8) or more 23 ounces but less than five (5) pounds of marijuana is: 24 (a) For a first offense a Class D felony. 25 (b) For a second or subsequent offense a Clas s C felony. 26 (4) Unless authorized by Sections 1 to 30 of this Act, trafficking in five (5) or more 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 119 of 141 HB013610.100 - 50 - XXXX GA pounds of marijuana is: 1 (a) For a first offense a Class C felony. 2 (b) For a second or subsequent offense a Class B felony. 3 (5) Unless authorized by Sections 1 to 30 of this Act, the unlawful possession by any 4 person of eight (8) or more ounces of marijuana shall be prima facie evidence that 5 the person possessed the marijuana with the intent to sell or transfer it. 6 (6) This section does not apply to: 7 (a) A cannabis business or a cannabis business agent, as defined in Section 1 8 of this Act, when acting in compliance with Sections 1 to 30 of this Act; or 9 (b) A cardholder, as defined in Section 1 of this Act, whose use of medicinal 10 cannabis is in compliance w ith Sections 1 to 30 of this Act. 11 Section 39. KRS 218A.1422 is amended to read as follows: 12 (1) A person is guilty of possession of marijuana when he or she knowingly and 13 unlawfully possesses marijuana , and the possession is not in compliance with, or 14 otherwise authorized by, Sections 1 to 30 of this Act . 15 (2) Possession of marijuana is a Class B misdemeanor, except that, KRS Chapter 532 16 to the contrary notwithstanding, the maximum term of incarceration shall be no 17 greater than forty -five (45) days. 18 (3) This section does not apply to: 19 (a) A cannabis business or a cannabis business agent, as defined in Section 1 20 of this Act, when acting in compliance with Sections 1 to 30 of this Act; or 21 (b) A cardholder, as defined in Section 1 of this Act, whose use of medicinal 22 cannabis is in compliance with Sections 1 to 30 of this Act. 23 Section 40. KRS 218A.1423 is amended to read as follows: 24 (1) A person is guilty of marijuana cultiv ation when he or she knowingly and 25 unlawfully plants, cultivates, or harvests marijuana with the intent to sell or transfer 26 it, and the cultivation is not in compliance with, or otherwise authorized by, 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 120 of 141 HB013610.100 - 50 - XXXX GA Sections 1 to 30 of this Act . 1 (2) Unless authorized b y Sections 1 to 30 of this Act, marijuana cultivation of five (5) 2 or more plants of marijuana is: 3 (a) For a first offense a Class D felony. 4 (b) For a second or subsequent offense a Class C felony. 5 (3) Unless authorized by Sections 1 to 30 of this Act, marijuana cultivation of fewer 6 than five (5) plants is: 7 (a) For a first offense a Class A misdemeanor. 8 (b) For a second or subsequent offense a Class D felony. 9 (4) Unless authorized by Sections 1 to 30 of this Act, the planting, cultivating, or 10 harvesting of f ive (5) or more marijuana plants shall be prima facie evidence that 11 the marijuana plants were planted, cultivated, or harvested for the purpose of sale or 12 transfer. 13 (5) This section does not apply to a cannabis business or a cannabis business agent, 14 as def ined in Section 1 of this Act, when acting in compliance with Sections 1 to 15 30 of this Act. 16 Section 41. KRS 218A.202 is amended to read as follows: 17 (1) As used in this section: 18 (a) \"Cabinet\" means the cabinet for Health and Family Services; 19 (b) \"Cannabis business\" has the same meaning as in Section 1 of this Act; 20 (c) \"Controlled substance\" means Schedules II, III, IV, and V controlled 21 substances and does not include medicinal cannabis; 22 (d) \"Dispensary\" has the same meanin g as in Section 1 of this Act; 23 (e) \"Dispensary agent\" has the same meaning as in Section 1 of this Act; 24 (f) \"Disqualifying felony offense\" has the same meaning as in Section 1 of this 25 Act; 26 (g) \"Medicinal cannabis\" has the same meaning as in Section 1 of th is Act; 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 121 of 141 HB013610.100 - 50 - XXXX GA (h) \"Medical cannabis practitioner\" has the same meaning as in Section 1 of 1 this Act; 2 (i) \"Registry identification card\" has the same meaning as in Section 1 of this 3 Act; 4 (j) \"State licensing board\" has the same meaning as in Section 1 of this Act; 5 (k) \"Use of medicinal cannabis\" has the same meaning as in Section 1 of this 6 Act; and 7 (l) \"Written certification\" has the same meaning as in Section 1 of this Act. 8 (2) The cabinet [ for Health and Family Services] shall establish and maintain an 9 electronic system for monitoring Schedules II, III, IV, and V controlled substances 10 and medicinal cannabis as defined in Section 1 of this Act . The cabinet may 11 contract for the design, upgrade, or operation of this system if the contract preserves 12 all of the rights, privileges, and protections guaranteed to Kentucky citizens under 13 this chapter and the contract requires that all other aspects of the system be operated 14 in conformity with the requirements of this or any other applicable state or federal 15 law. 16 (3)[(2)] For the purpose of monitoring the prescribing and dispensing of Schedules 17 II, III, IV, and V controlled substances: 18 (a) A practitioner or a pharmacist authorized to prescribe or dispense controlled 19 substances to humans shall register with the cabinet to use the system 20 provided for in this section and shall maintain such registration continuously 21 during the practitioner's or pharmacist's term of licensure and shall not have to 22 pay a fee or tax specifically dedicated to the operation of the system ;[.] 23 (b)[(3)] Every practitioner or pharmacy which dispenses a controlled substance 24 to a person in Kentucky, or to a person at an address in Kentucky, shall report 25 to the cabinet [ for Health and Family Services] the data required by this 26 section, which includes the repo rting of any Schedule II controlled substance 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 122 of 141 HB013610.100 - 50 - XXXX GA dispensed at a facility licensed by the cabinet and a Schedule II through 1 Schedule V controlled substance regardless of dosage when dispensed by the 2 emergency department of a hospital to an emergency department patient. 3 Reporting shall not be required for: 4 1.[(a)] A drug administered directly to a patient in a hospital, a resident of 5 a health care facility licensed under KRS Chapter 216B, a resident of a 6 child -caring facility as defined by KRS 199.011, or an ind ividual in a 7 jail, correctional facility, or juvenile detention facility; 8 2.[(b)] A Schedule III through Schedule V controlled substance dispensed 9 by a facility licensed by the cabinet provided that the quantity dispensed 10 is limited to an amount adequate to treat the patient for a maximum of 11 forty -eight (48) hours and is not dispensed by the emergency department 12 of a hospital; or 13 3.[(c)] A drug administered or dispensed to a research subject enrolled in 14 a research protocol approved by an institutional revi ew board that has an 15 active federalwide assurance number from the United States Department 16 of Health and Human Services, Office for Human Research Protections, 17 where the research involves single, double, or triple blind drug 18 administration or is additional ly covered by a certificate of 19 confidentiality from the National Institutes of Health ;[.] 20 (c)[(4)] In addition to the data required by paragraph (d) of this subsection [(5) 21 of this section] , a Kentucky -licensed acute care hospital or critical access 22 hospital shall report to the cabinet all positive toxicology screens that were 23 performed by the hospital's emergency department to evaluate the patient's 24 suspected drug overdose ;[.] 25 (d)[(5)] Data for each controlled substance that is reported shall include but not 26 be limited to the following: 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 123 of 141 HB013610.100 - 50 - XXXX GA 1.[(a)] Patient identifier; 1 2.[(b)] National drug code of the drug dispensed; 2 3.[(c)] Date of dispensing; 3 Dispenser ;[.] 6 (e)[(6)] The data shall be provided in the electronic format specified by the 7 cabinet [ for Health and Family Services] unless a waiver has been granted by 8 the cabinet to an individual dispenser. The cabinet shall establish acceptable 9 error tolerance rates for data. Dispensers shall ensure that reports fall within 10 these tolerances. Incomplete or inaccurate data shall be corrected upon 11 notification by the cabinet if the dispenser exceeds these error tolerance 12 rates ;[.] 13 (f)[(7)] The cabi net[ for Health and Family Services] shall only disclose data to 14 persons and entities authorized to receive that data under this 15 subsection [section] . Disclosure to any other person or entity, including 16 disclosure in the context of a civil action where the disclosure is sought either 17 for the purpose of discovery or for evidence, is prohibited unless specifically 18 authorized by this section. The cabinet [ for Health and Family Services] shall 19 be authorized to provide data to: 20 1.[(a)] A designated representative of a board responsible for the 21 licensure, regulation, or discipline of practitioners, pharmacists, or other 22 person who is authorized to prescribe, administer, or dispense controlled 23 substances and who is involved in a bona fide specific investigation 24 involving a designated person; 25 2.[(b)] Employees of the Office of the Inspector General of the cabinet [ 26 for Health and Family Services] who have successfully completed 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 124 of 141 HB013610.100 - 50 - XXXX GA training for the electronic system and who have been approved to use the 1 system, federal pro secutors, Kentucky Commonwealth's attorneys and 2 assistant Commonwealth's attorneys, county attorneys and assistant 3 county attorneys, a peace officer certified pursuant to KRS 15.380 to 4 15.404, a certified or full -time peace officer of another state, or a f ederal 5 agent whose duty is to enforce the laws of this Commonwealth, of 6 another state, or of the United States relating to drugs and who is 7 engaged in a bona fide specific investigation involving a designated 8 person; 9 3.[(c)] A state -operated Medicaid progr am in conformity with subsection 10 (8) of this section; 11 4.[(d)] A properly convened grand jury pursuant to a subpoena properly 12 issued for the records; 13 5.[(e)] A practitioner or pharmacist, or employee of the practitioner's or 14 pharmacist's practice acting und er the specific direction of the 15 practitioner or pharmacist, who certifies that the requested information 16 is for the purpose of: 17 a[1]. Providing medical or pharmaceutical treatment to a bona fide 18 current or prospective patient; 19 b[2]. Reviewing data on controlled substances that have been reported 20 for the birth mother of an infant who is currently being treated by 21 the practitioner for neonatal abstinence syndrome, or has 22 symptoms that suggest prenatal drug exposure; or 23 c[3]. Reviewing a nd assessing the individual prescribing or dispensing 24 patterns of the practitioner or pharmacist or to determine the 25 accuracy and completeness of information contained in the 26 monitoring system; 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 125 of 141 HB013610.100 - 50 - XXXX GA 6.[(f)] The chief medical officer of a hospital or long -term-care facility, 1 an employee of the hospital or long -term-care facility as designated by 2 the chief medical officer and who is working under his or her specific 3 direction, or a physician designee if the hospital or facility has no chief 4 medical officer, if the officer, employee, or designee certifies that the 5 requested information is for the purpose of providing medical or 6 pharmaceutical treatment to a bona fide current or prospective patient or 7 resident in the hospital or facility; 8 7.[(g)] In addition to the p urposes authorized under subparagraph 1. of 9 this paragraph [ (a) of this subsection] , the Kentucky Board of Medical 10 Licensure, for any physician who is: 11 a[1]. Associated in a partnership or other business entity with a 12 physician who is already under investi gation by the Board of 13 Medical Licensure for improper prescribing or dispensing 14 practices; 15 b[2]. In a designated geographic area for which a trend report indicates a 16 substantial likelihood that inappropriate prescribing or dispensing 17 may be occurring; or 18 c[3]. In a designated geographic area for which a report on another 19 physician in that area indicates a substantial likelihood that 20 inappropriate prescribing or dispensing may be occurring in that 21 area; 22 8.[(h)] In addition to the purposes authorized under subparagraph 1. of 23 this paragraph [ (a) of this subsection] , the Kentucky Board of Nursing, 24 for any advanced practice registered nurse who is: 25 a[1]. Associated in a partnership or other business entity with a 26 physician who is already under investigation by th e Kentucky 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 126 of 141 HB013610.100 - 50 - XXXX GA Board of Medical Licensure for improper prescribing or dispensing 1 practices; 2 b[2]. Associated in a partnership or other business entity with an 3 advanced practice registered nurse who is already under 4 investigation by the Board of Nursing for imp roper prescribing 5 practices; 6 c[3]. In a designated geographic area for which a trend report indicates a 7 substantial likelihood that inappropriate prescribing or dispensing 8 may be occurring; or 9 d[4]. In a designated geographic area for which a report on a p hysician 10 or another advanced practice registered nurse in that area indicates 11 a substantial likelihood that inappropriate prescribing or 12 dispensing may be occurring in that area; 13 9.[(i)] A judge or a probation or parole officer administering a diversion 14 or probation program of a criminal defendant arising out of a violation 15 of this chapter or of a criminal defendant who is documented by the 16 court as a substance abuser who is eligible to participate in a court - 17 ordered drug diversion or probation program; or 18 10.[(j)] A medical examiner engaged in a death investigation pursuant to 19 KRS 72.026 ;[.] 20 (g)[(8)] The Department for Medicaid Services shall use any data or reports from 21 the system for the purpose of identifying Medicaid providers or recipients 22 whose prescr ibing, dispensing, or usage of controlled substances may be: 23 1.[(a)] Appropriately managed by a single outpatient pharmacy or primary 24 care physician; or 25 2.[(b)] Indicative of improper, inappropriate, or illegal prescribing or 26 dispensing practices by a prac titioner or drug seeking by a Medicaid 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 127 of 141 HB013610.100 - 50 - XXXX GA recipient ;[.] 1 (h)[(9)] A person who receives data or any report of the system from the cabinet 2 shall not provide it to any other person or entity except as provided in this 3 subsection [section] , in another statute, or by order of a court of competent 4 jurisdiction and only to a person or entity authorized to receive the data or the 5 report under this section, except that: 6 1.[(a)] A person specified in paragraph (f)2. of this subsection [ (7)(b) of 7 this section] who is auth orized to receive data or a report may share that 8 information with any other persons specified in paragraph (f)2. of this 9 subsection [(7)(b) of this section ] authorized to receive data or a report if 10 the persons specified in paragraph (f)2. of this subsect ion[ (7)(b) of this 11 section] are working on a bona fide specific investigation involving a 12 designated person. Both the person providing and the person receiving 13 the data or report under this subparagraph [paragraph] shall document in 14 writing each person to whom the data or report has been given or 15 received and the day, month, and year that the data or report has been 16 given or received. This document shall be maintained in a file by each 17 agency engaged in the investigation; 18 2.[(b)] A representative of the Dep artment for Medicaid Services may 19 share data or reports regarding overutilization by Medicaid recipients 20 with a board designated in paragraph (f)1. of this subsection [ (7)(a) of 21 this section] , or with a law enforcement officer designated in paragraph 22 (f)2. of this subsection [ (7)(b) of this section] ; 23 3.[(c)] The Department for Medicaid Services may submit the data as 24 evidence in an administrative hearing held in accordance with KRS 25 Chapter 13B; 26 4.[(d)] If a state licensing board as defined in KRS 218A.205 i nitiates 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 128 of 141 HB013610.100 - 50 - XXXX GA formal disciplinary proceedings against a licensee, and data obtained by 1 the board is relevant to the charges, the board may provide the data to 2 the licensee and his or her counsel, as part of the notice process required 3 by KRS 13B.050, and admit the data as evidence in an administrative 4 hearing conducted pursuant to KRS Chapter 13B, with the board and 5 licensee taking all necessary steps to prevent further disclosure of the 6 data; and 7 5.[(e)] A practitioner, pharmacist, or employee who obtains data under 8 paragraph (f)5. of this subsection [ (7)(e) of this section] may share the 9 report with the patient or person authorized to act on the patient's behalf. 10 Any practitioner, pharmacist, or employee who obtains data under 11 paragraph (f)5. of this subsection [(7)(e) of this section ] may place the 12 report in the patient's medical record, in which case the individual report 13 shall then be deemed a medical record subject to disclosure on the same 14 terms and conditions as an ordinary medical record in lie u of the 15 disclosure restrictions otherwise imposed by this section ;[.] 16 (i)[(10)] The cabinet [ for Health and Family Services] , all peace officers 17 specified in paragraph (f)2. of this subsection [ (7)(b) of this section] , all 18 officers of the court, and all r egulatory agencies and officers, in using the data 19 for investigative or prosecution purposes, shall consider the nature of the 20 prescriber's and dispenser's practice and the condition for which the patient is 21 being treated ;[.] 22 (j)[(11) The data and any repo rt obtained therefrom shall not be a public record, 23 except that the Department for Medicaid Services may submit the data as 24 evidence in an administrative hearing held in accordance with KRS Chapter 25 13B. 26 (12)] Intentional failure to comply with the reportin g requirements of this 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 129 of 141 HB013610.100 - 50 - XXXX GA subsection [section] shall be a Class B misdemeanor for the first offense and a 1 Class A misdemeanor for each subsequent offense ; and [.] 2 (k) If the cabinet becomes aware of a prescriber's or dispenser's failure to 3 comply with this section, the cabinet shall notify the licensing board or 4 agency responsible for licensing the prescriber or dispenser. The licensing 5 board shall treat the notificatio n as a complaint against the licensee. 6 (4) For the purpose of monitoring the cultivation, processing, production, 7 recommending, and dispensing of medical cannabis: 8 (a) Every medicinal cannabis practitioner who is authorized, pursuant to 9 Section 9 of this A ct, to provide written certifications for the use of 10 medicinal cannabis and every cannabis business licensed under Sections 11 16, 17, and 18 of this Act shall register with the cabinet to use the system 12 provided for in this section and shall maintain such re gistration 13 continuously during the medicinal practitioner's authorization to provide 14 written certifications or a cannabis business's term of licensure and shall 15 not have to pay a fee or tax specifically dedicated to the operation of the 16 system. 17 (b) No late r than January 1, 2023, the cabinet shall ensure that the system 18 provided for in this section allows: 19 1. Medicinal cannabis practitioners to record the issuance of written 20 certifications to a patient as required by Section 9 of this Act; 21 2. Pharmacists to record the completion of consultations with 22 cardholders as required by Section 10 of this Act; 23 3. The cabinet, law enforcement personnel, and dispensary agents to 24 verify the validity of registry identification cards issued by the 25 Department for Public Heal th. When verifying the validity of an 26 identification card, system shall only disclose whether the 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 130 of 141 HB013610.100 - 50 - XXXX GA identification card is valid and whether the cardholder is a registered 1 qualified patient, visiting qualified patient, or designated caregiver; 2 4. Dispensary agents to record the amount of medicinal cannabis that is 3 dispensed to a cardholder during each transaction, as required by 4 Section 22 of this Act; 5 5. Law enforcement personnel and dispensary agents to access medicinal 6 cannabis sales data recorded by dispe nsary agents pursuant to Section 7 22 of this Act; 8 6. The sharing of dispensing data recorded by dispensary agents, 9 pursuant to Section 22 of this Act, with all licensed dispensaries in 10 real time; 11 7. Licensed cannabis businesses to record data required by 12 administrative regulations promulgated pursuant to with Section 28 of 13 this Act to facilitate the tracking of medicinal cannabis from the point 14 of cultivation to the point of sale to cardholders; and 15 8. The cabinet to track all medicinal cannabis in the state from the point 16 of cultivation to the point of sale to a cardholder. 17 (c) The cabinet shall only disclose data related to the cultivation, production, 18 recommending, and dispensing of medical cannabis to persons and entities 19 authorized to receive that data u nder this subsection. Disclosure to any 20 other person or entity, including disclosure in the context of a civil action 21 where the disclosure is sought either for the purpose of discovery or for 22 evidence, is prohibited unless specifically authorized by this s ubsection. The 23 cabinet shall be authorized to provide data to: 24 1. Any person or entity authorized to receive data pursuant to paragraph 25 (b) of this subsection; 26 2. A designated representative of a state licensing board responsible for 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 131 of 141 HB013610.100 - 50 - XXXX GA the licensure, regulat ion, or discipline of medicinal cannabis 1 practitioners and who is involved in a bona fide specific investigation 2 involving a designated person; 3 3. Employees of the Office of the Inspector General of the cabinet who 4 have successfully completed training for the electronic system and 5 who have been approved to use the system, Kentucky Commonwealth's 6 attorneys and assistant Commonwealth's attorneys, and county 7 attorneys and assistant county attorneys who are engaged in a bona 8 fide specific investigation involvin g a designated person; 9 4. A properly convened grand jury pursuant to a subpoena properly 10 issued for the records; 11 5. A medicinal cannabis practitioner or an employee of a medicinal 12 cannabis practitioner's practice acting under the specific direction of 13 the medicinal cannabis practitioner, who certifies that the request for 14 information is for the purpose of complying with subsection (4)(c) of 15 Section 9 of this Act; 16 6. The chief medical officer of a hospital or long -term -care facility, an 17 employee of the hospi tal or long -term -care facility as designated by the 18 chief medical officer and who is working under his or her specific 19 direction, or a physician designee if the hospital or facility has no 20 chief medical officer, if the officer, employee, or designee certif ies that 21 the requested information is for the purpose of providing medical or 22 pharmaceutical treatment to a bona fide current or prospective patient 23 or resident in the hospital or facility; 24 7. In addition to the purposes authorized under subparagraph 2. of this 25 paragraph, the Kentucky Board of Medical Licensure, for any 26 physician or physician assistant who is: 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 132 of 141 HB013610.100 - 50 - XXXX GA a. Associated in a partnership, other business entity, or supervision 1 agreement established pursuant to KRS 311.854 with a physician 2 or physician ass istant who is already under investigation by the 3 Board of Medical Licensure for improper issuance of written 4 certifications; 5 b. Associated in a partnership or other business entity with an 6 advanced practice registered nurse who is already under 7 investigati on by the Board of Nursing for improper issuance of 8 written certifications; 9 c. In a designated geographic area for which a trend report 10 indicates a substantial likelihood that inappropriate issuance of 11 written certifications may be occurring; or 12 d. In a de signated geographic area for which a report on another 13 physician or physician assistant in that area indicates a 14 substantial likelihood that inappropriate issuance of written 15 certifications may be occurring in that area; 16 8. In addition to the purposes auth orized under subparagraph 2. of this 17 paragraph, the Kentucky Board of Nursing, for any advanced practice 18 registered nurse who is: 19 a. Associated in a partnership or other business entity with a 20 physician or physician assistant who is already under 21 investiga tion by the Kentucky Board of Medical Licensure for 22 improper issuance of written certifications; 23 b. Associated in a partnership or other business entity with an 24 advanced practice registered nurse who is already under 25 investigation by the Board of Nursing for improper issuance of 26 written certifications; 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 133 of 141 HB013610.100 - 50 - XXXX GA c. In a designated geographic area for which a trend report 1 indicates a substantial likelihood that inappropriate issuance of 2 written certifications may be occurring; or 3 d. In a designated geographic area for which a report on a 4 physician, physician assistant, or another advanced practice 5 registered nurse i n that area indicates a substantial likelihood 6 that inappropriate issuance of written certifications may be 7 occurring in that area; 8 9. A judge or a probation or parole officer administering a diversion or 9 probation program of a criminal defendant arising o ut of a violation 10 of this chapter or of a criminal defendant who is documented by the 11 court as a substance abuser who is eligible to participate in a court - 12 ordered drug diversion or probation program; 13 10. A medical examiner engaged in a death investigation pursuant to KRS 14 72.026; or 15 11. The Legislative Research Commission or the University of Kentucky 16 College of Medicine if the cabinet determines that disclosing data 17 related to the cultivation, production, recommending, and dispensing 18 of medical cannabis to the Legislative Research Commission or the 19 University of Kentucky College of Medicine is necessary to comply 20 with the reporting requirements established in subsection (8) of 21 Section 3 of this Act. 22 (d) A person who receives data or any report of the system from the cabinet 23 shall not provide it to any other person or entity except as provided in this 24 section, in another statute, or by order of a court of competent jurisdiction 25 and only to a person or entity authorized to receive the data or the report 26 under this section, except that: 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 134 of 141 HB013610.100 - 50 - XXXX GA 1. A person specified in paragraph (c)3. of this subsection who is 1 authorized to receive data or a report may share that information with 2 any other persons specified in paragraph (c)3. of this subsection 3 authorized to receive dat a or a report if the persons specified in 4 paragraph (c)3. of this subsection are working on a bona fide specific 5 investigation involving a designated person. Both the person providing 6 and the person receiving the data or report under this subparagraph 7 shall document in writing each person to whom the data or report has 8 been given or received and the day, month, and year that the data or 9 report has been given or received. This document shall be maintained 10 in a file by each agency engaged in the investigation ; 11 2. If a state licensing board initiates formal disciplinary proceedings 12 against a licensee, and data obtained by the board is relevant to the 13 charges, the board may provide the data to the licensee and his or her 14 counsel, as part of the notice process re quired by KRS 13B.050, and 15 admit the data as evidence in an administrative hearing conducted 16 pursuant to KRS Chapter 13B, with the board and licensee taking all 17 necessary steps to prevent further disclosure of the data; and 18 3. A medicinal cannabis practiti oner or an employee of a medicinal 19 cannabis practitioner's practice acting under the specific direction of 20 the medicinal cannabis practitioner who obtains data under 21 paragraph (c)5. of this subsection may share the report with the 22 patient or person authori zed to act on the patient's behalf. Any 23 medicinal cannabis practitioner or employee who obtains data under 24 paragraph (c)5. of this subsection may place the report in the patient's 25 medical record, in which case the individual report shall then be 26 deemed a m edical record subject to disclosure on the same terms and 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 135 of 141 HB013610.100 - 50 - XXXX GA conditions as an ordinary medical record in lieu of the disclosure 1 restrictions otherwise imposed by this section. 2 (5) The data contained in, and any report obtained from, the electronic system for 3 monitoring established pursuant to this section shall not be a public record, 4 except that the Department for Medicaid Services may submit the data as 5 evidence in an administrative hearing held in accordance with KRS Chapter 13B. 6 (6)[(13)] Intentional discl osure of transmitted data to a person not authorized by 7 subsection (3)(f) to (h) or subsection (4)(c) and (d) [subsections (7) to (9) ] of this 8 section or authorized by KRS 315.121, or obtaining information under this section 9 not relating to a bona fide cur rent or prospective patient or a bona fide specific 10 investigation, shall be a Class B misdemeanor for the first offense and a Class A 11 misdemeanor for each subsequent offense. 12 (7)[(14)] The cabinet [ for Health and Family Services] may, by promulgating an 13 administrative regulation, limit the length of time that data remain in the electronic 14 system. Any data removed from the system shall be archived and subject to retrieval 15 within a reasonable time after a request from a person authorized to review data 16 under this section. 17 (8)[(15)] (a) The cabinet [ for Health and Family Services] shall work with each board 18 responsible for the licensure, regulation, or discipline of practitioners, 19 pharmacists, or other persons who are authorized to prescribe, administer, or 20 dispense controlled substances for the development of a continuing education 21 program about the purposes and uses of the electronic system for monitoring 22 established in this section. 23 (b) The cabinet shall work with each board responsible for the licensure, 24 regulation, or discipline of medicinal cannabis practitioners, as defined in 25 Section 1 of this Act, who are authorized to provider written certifications 26 for the use of medicinal cannabis for the development of a continuing 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 136 of 141 HB013610.100 - 50 - XXXX GA education program about the purpose s and uses of the electronic system for 1 monitoring established in this section. 2 (c)[(b)] The cabinet shall work with the Kentucky Bar Association for the 3 development of a continuing education program for attorneys about the 4 purposes and uses of the electro nic system for monitoring established in this 5 section. 6 (d)[(c)] The cabinet shall work with the Justice and Public Safety Cabinet for the 7 development of a continuing education program for law enforcement officers 8 about the purposes and uses of the electron ic system for monitoring 9 established in this section. 10 (e) The cabinet shall work with the Department for Public Health for the 11 development of a training program for cannabis business agents about the 12 purposes and uses of the electronic system for monitorin g established in this 13 section. 14 [(16) If the cabinet becomes aware of a prescriber's or dispenser's failure to comply with 15 this section, the cabinet shall notify the licensing board or agency responsible for 16 licensing the prescriber or dispenser. The licens ing board shall treat the notification 17 as a complaint against the licensee.] 18 (9)[(17)] The cabinet [ for Health and Family Services] , Office of Inspector General, 19 shall conduct quarterly reviews to identify patterns of potential improper, 20 inappropriate, or illegal prescribing or dispensing of a controlled substance , 21 issuance of written certifications, or cultivation, processing, or dispensing of 22 medical cannabis . The Office of Inspector General may independently investigate 23 and submit findings and recommenda tions to the appropriate boards of licensure or 24 other reporting agencies. 25 (10)[(18)] The cabinet shall promulgate administrative regulations to implement the 26 provisions of this section. Included in these administrative regulations shall be: 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 137 of 141 HB013610.100 - 50 - XXXX GA (a) An error re solution process allowing a patient to whom a report had been 1 disclosed under subsections (3) and (4) [subsection (9)] of this section to 2 request the correction of inaccurate information contained in the system 3 relating to that patient; and 4 (b) A requiremen t that data be reported to the system under subsection (3) (b) of 5 this section within one (1) day of dispensing. 6 (11)[(19)] (a) Before July 1, 2018, the Administrative Office of the Courts shall 7 forward data regarding any felony or Class A misdemeanor convi ction that 8 involves the trafficking or possession of a controlled substance or other 9 prohibited acts under KRS Chapter 218A for the previous five (5) calendar 10 years to the cabinet for inclusion in the electronic monitoring system 11 established under this sec tion. On or after July 1, 2018 , such data shall be 12 forwarded by the Administrative Office of the Courts to the cabinet on a 13 continuing basis. The cabinet shall incorporate the data received into the 14 system so that a query by patient name indicates any prio r drug conviction . 15 (b) Before January 1, 2023, the Administrative Office of the Courts shall 16 forward data regarding any disqualifying felony offense for the previous 17 five (5) calendar years to the cabinet for inclusion in the electronic 18 monitoring system e stablished under this section. On or after January 1, 19 2023, such data shall be forwarded by the Administrative Office of the 20 Courts to the cabinet on a continuing basis. The cabinet shall incorporate 21 the data received into the system so that a query by pat ient name indicates 22 any prior disqualifying felony conviction . 23 Section 42. KRS 218A.500 is amended to read as follows: 24 As used in this section and KRS 218A.510: 25 (1) \"Drug paraphernalia\" means all equipment, products and materials of any kind 26 which are used, intended for use, or designed for use in planting, propagating, 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 138 of 141 HB013610.100 - 50 - XXXX GA cultivating, growing, harvesting, manufacturing, compounding, converting, 1 producing, processing, pr eparing, testing, analyzing, packaging, repackaging, 2 storing, containing, concealing, injecting, ingesting, inhaling, or otherwise 3 introducing into the human body a controlled substance in violation of this chapter. 4 The term \"drug paraphernalia\" does not i nclude medicinal cannabis accessories 5 as defined in Section 1 of this Act. It includes but is not limited to: 6 (a) Kits used, intended for use, or designed for use in planting, propagating, 7 cultivating, growing, or harvesting of any species of plant which i s a 8 controlled substance or from which a controlled substance can be derived; 9 (b) Kits used, intended for use, or designed for use in manufacturing, 10 compounding, converting, producing, processing, or preparing controlled 11 substances; 12 (c) Isomerization devic es used, intended for use, or designed for use in increasing 13 the potency of any species of plant which is a controlled substance; 14 (d) Testing equipment used, intended for use, or designed for use in identifying, 15 or in analyzing the strength, effectiveness or purity of controlled substances; 16 (e) Scales and balances used, intended for use, or designed for use in weighing or 17 measuring controlled substances; 18 (f) Diluents and adulterants, such as quinine hydrochloride, mannitol, mannite, 19 dextrose and lactose, us ed, intended for use, or designed for use in cutting 20 controlled substances; 21 (g) Separation gins and sifters used, intended for use, or designed for use in 22 removing twigs and seeds from, or in otherwise cleaning or refining 23 marijuana; 24 (h) Blenders, bowls, c ontainers, spoons, and mixing devices used, intended for 25 use, or designed for use in compounding controlled substances; 26 (i) Capsules, balloons, envelopes, and other containers used, intended for use, or 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 139 of 141 HB013610.100 - 50 - XXXX GA designed for use in packaging small quantities of con trolled substances; 1 (j) Containers and other objects used, intended for use, or designed for use in 2 storing or concealing controlled substances; 3 (k) Hypodermic syringes, needles, and other objects used, intended for use, or 4 designed for use in parenterally injecting controlled substances into the human 5 body; and 6 (l) Objects used, intended for use, or designed for use in ingesting, inhaling, or 7 otherwise introducing marijuana, cocaine, hashish, or hashish oil into the 8 human body, such as: metal, wooden, acry lic, glass, stone, plastic, or ceramic 9 pipes with or without screens, permanent screens, hashish heads, or punctured 10 metal bowls; water pipes; carburetion tubes and devices; smoking and 11 carburetion masks; roach clips which mean objects used to hold burning 12 material, such as marijuana cigarettes, that have become too small or too short 13 to be held in the hand; miniature cocaine spoons, and cocaine vials; chamber 14 pipes; electric pipes; chillums; bongs; ice 15 pipes or chillers. 16 (2) It is unlawful for any person to use, or to possess with intent to use, drug 17 paraphernalia for the purpose of planting, propagating, cultivating, growing, 18 harvesting, manufacturing, compounding, converting, producing, processing, 19 preparing, testing, a nalyzing, packing, repacking, storing, containing, concealing, 20 injecting, ingesting, inhaling, or otherwise introducing into the human body a 21 controlled substance in violation of this chapter. 22 (3) It is unlawful for any person to deliver, possess with inte nt to deliver, or 23 manufacture with intent to deliver, drug paraphernalia, knowing, or under 24 circumstances where one reasonably should know, that it will be used to plant, 25 propagate, cultivate, grow, harvest, manufacture, compound, convert, produce, 26 process , prepare, test, analyze, pack, repack, store, contain, conceal, inject, ingest, 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 140 of 141 HB013610.100 - 50 - XXXX GA inhale, or otherwise introduce into the human body a controlled substance in 1 violation of this chapter. 2 (4) It is unlawful for any person to place in any newspaper, magazine, handbill, or other 3 publication any advertisement, knowing, or under circumstances where one 4 reasonably should know, that the purpose of the advertisement, in whole or in part, 5 is to promote the sale of objects designed or intended for use as drug paraphern alia. 6 (5) (a) This section shall not prohibit a local health department from operating a 7 substance abuse treatment outreach program which allows participants to 8 exchange hypodermic needles and syringes. 9 (b) To operate a substance abuse treatment outreach p rogram under this 10 subsection, the local health department shall have the consent, which may be 11 revoked at any time, of the local board of health and: 12 1. The legislative body of the first or home rule class city in which the 13 program would operate if located in such a city; and 14 2. The legislative body of the county, urban -county government, or 15 consolidated local government in which the program would operate. 16 (c) Items exchanged at the program shall not be deemed drug paraphernalia under 17 this section while loc ated at the program. 18 (6) (a) Prior to searching a person, a person's premises, or a person's vehicle, a peace 19 officer may inquire as to the presence of needles or other sharp objects in the 20 areas to be searched that may cut or puncture the officer and offe r to not 21 charge a person with possession of drug paraphernalia if the person declares to 22 the officer the presence of the needle or other sharp object. If, in response to 23 the offer, the person admits to the presence of the needle or other sharp object 24 prior to the search, the person shall not be charged with or prosecuted for 25 possession of drug paraphernalia for the needle or sharp object or for 26 possession of a controlled substance for residual or trace drug amounts present 27 UNOFFICIAL COPY 22 RS HB 136/GA Page 141 of 141 HB013610.100 - 50 - XXXX GA on the needle or sharp object. 1 (b) The exemption under this subsection shall not apply to any other drug 2 paraphernalia that may be present and found during the search or to controlled 3 substances present in other than residual or trace amounts. 4 (7) (a) This section shall not prohibit the retail sale of hypodermic syringes and 5 needles without a prescription in pharmacies. 6 (b) Hypodermic syringe and needle inventory of a pharmacy shall not be deemed 7 drug paraphernalia under this section. 8 (8) Any person who violates any provision of this section shall be guilty of a Class A 9 misdemeanor. 10 Section 43. KRS 342.815 is amended to read as follows: 11 (1) The authority may provide coverage for insurance, authorized in KRS 342.803, to 12 any employer in the Commonwealth, and who tenders the required premium for 13 coverage and comply with other conditions and qualifications for obtaining and 14 maintaining coverage adopted by the authority to protect and ensure its actuarial 15 soundness and solve ncy. 16 (2) The authority shall provide coverage to any employer who is unable to secure 17 coverage in the voluntary market unless : 18 (a) The employer owes undisputed premiums to a previous workers' 19 compensation carrier or to a workers' compensation residual mark et 20 mechanism ; or 21 (b) Providing coverage to the employer would subject the authority or its 22 employees to a violation of federal or state law . 23 Section 44. Section 2, Sections 4 to 8, Section 11, Sections 13 to 15, Sections 24 18 to 25, Section 30, and Sections 37 to 43 of this Act take effect July 1, 2023. 25 "}